CA2065985A1 - Quinoxalines, processes for their preparation, and their use - Google Patents
Quinoxalines, processes for their preparation, and their useInfo
- Publication number
- CA2065985A1 CA2065985A1 CA002065985A CA2065985A CA2065985A1 CA 2065985 A1 CA2065985 A1 CA 2065985A1 CA 002065985 A CA002065985 A CA 002065985A CA 2065985 A CA2065985 A CA 2065985A CA 2065985 A1 CA2065985 A1 CA 2065985A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- alkoxy
- amino
- fluorine
- hydroxyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 150000003252 quinoxalines Chemical class 0.000 title description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 143
- FFRYUAVNPBUEIC-UHFFFAOYSA-N quinoxalin-2-ol Chemical class C1=CC=CC2=NC(O)=CN=C21 FFRYUAVNPBUEIC-UHFFFAOYSA-N 0.000 claims abstract description 6
- -1 trifluoromethoxy, hydroxyl Chemical group 0.000 claims description 697
- 239000000460 chlorine Substances 0.000 claims description 261
- 229910052801 chlorine Inorganic materials 0.000 claims description 259
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 258
- 239000011737 fluorine Substances 0.000 claims description 256
- 229910052731 fluorine Inorganic materials 0.000 claims description 256
- 125000001153 fluoro group Chemical group F* 0.000 claims description 230
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 194
- 125000004043 oxo group Chemical group O=* 0.000 claims description 168
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 165
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 141
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 120
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 117
- 229910052794 bromium Inorganic materials 0.000 claims description 112
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 110
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 110
- 125000000464 thioxo group Chemical group S=* 0.000 claims description 82
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 70
- 229910052739 hydrogen Inorganic materials 0.000 claims description 69
- 239000001257 hydrogen Substances 0.000 claims description 69
- 125000004432 carbon atom Chemical group C* 0.000 claims description 48
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 46
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 42
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 40
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 37
- 229910052760 oxygen Inorganic materials 0.000 claims description 35
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 34
- 239000001301 oxygen Substances 0.000 claims description 34
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims description 30
- 125000001424 substituent group Chemical group 0.000 claims description 30
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 29
- 150000002431 hydrogen Chemical group 0.000 claims description 29
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 26
- 125000003118 aryl group Chemical group 0.000 claims description 25
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims description 24
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 23
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 claims description 23
- 125000001769 aryl amino group Chemical group 0.000 claims description 20
- 125000004768 (C1-C4) alkylsulfinyl group Chemical group 0.000 claims description 19
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 claims description 19
- 229920006395 saturated elastomer Polymers 0.000 claims description 19
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 18
- 125000005110 aryl thio group Chemical group 0.000 claims description 18
- 125000001072 heteroaryl group Chemical group 0.000 claims description 17
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 16
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 16
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 15
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 15
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 claims description 15
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 15
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 14
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 14
- 229910052717 sulfur Inorganic materials 0.000 claims description 14
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 13
- 125000000623 heterocyclic group Chemical group 0.000 claims description 13
- 239000011593 sulfur Substances 0.000 claims description 13
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 claims description 12
- 125000005125 aryl alkyl amino carbonyl group Chemical group 0.000 claims description 12
- 125000005100 aryl amino carbonyl group Chemical group 0.000 claims description 12
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 11
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims description 10
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 10
- 125000005018 aryl alkenyl group Chemical group 0.000 claims description 10
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 claims description 10
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 10
- 125000004104 aryloxy group Chemical group 0.000 claims description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims description 9
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 9
- 125000005129 aryl carbonyl group Chemical group 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 9
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims description 9
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims description 7
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 6
- 125000005015 aryl alkynyl group Chemical group 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 125000005226 heteroaryloxycarbonyl group Chemical group 0.000 claims description 6
- 125000002883 imidazolyl group Chemical group 0.000 claims description 6
- 229910052711 selenium Inorganic materials 0.000 claims description 6
- 239000011669 selenium Substances 0.000 claims description 6
- 125000005505 thiomorpholino group Chemical group 0.000 claims description 6
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 5
- 125000005222 heteroarylaminocarbonyl group Chemical group 0.000 claims description 5
- 125000005368 heteroarylthio group Chemical group 0.000 claims description 5
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 5
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 4
- DIKBFYAXUHHXCS-UHFFFAOYSA-N bromoform Chemical compound BrC(Br)Br DIKBFYAXUHHXCS-UHFFFAOYSA-N 0.000 claims description 4
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 4
- 125000004447 heteroarylalkenyl group Chemical group 0.000 claims description 4
- 125000001326 naphthylalkyl group Chemical group 0.000 claims description 4
- 150000002829 nitrogen Chemical class 0.000 claims description 4
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 4
- 125000006823 (C1-C6) acyl group Chemical group 0.000 claims description 3
- 125000000081 (C5-C8) cycloalkenyl group Chemical group 0.000 claims description 3
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 claims description 3
- 125000003282 alkyl amino group Chemical group 0.000 claims description 3
- 125000004659 aryl alkyl thio group Chemical group 0.000 claims description 3
- 150000001728 carbonyl compounds Chemical class 0.000 claims description 3
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000001544 thienyl group Chemical group 0.000 claims description 3
- 125000001425 triazolyl group Chemical group 0.000 claims description 3
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 claims description 2
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims description 2
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims description 2
- 241000700605 Viruses Species 0.000 claims description 2
- 230000002152 alkylating effect Effects 0.000 claims description 2
- 125000001691 aryl alkyl amino group Chemical group 0.000 claims description 2
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims description 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 2
- 229950005228 bromoform Drugs 0.000 claims description 2
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000005114 heteroarylalkoxy group Chemical group 0.000 claims description 2
- 125000005367 heteroarylalkylthio group Chemical group 0.000 claims description 2
- 125000005241 heteroarylamino group Chemical group 0.000 claims description 2
- 125000005553 heteroaryloxy group Chemical group 0.000 claims description 2
- 239000000651 prodrug Substances 0.000 claims description 2
- 229940002612 prodrug Drugs 0.000 claims description 2
- 238000005932 reductive alkylation reaction Methods 0.000 claims description 2
- 125000005301 thienylmethyl group Chemical group [H]C1=C([H])C([H])=C(S1)C([H])([H])* 0.000 claims description 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 1
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 230000000840 anti-viral effect Effects 0.000 abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 170
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 81
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 66
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 54
- 238000006243 chemical reaction Methods 0.000 description 47
- 239000000203 mixture Substances 0.000 description 47
- 238000002844 melting Methods 0.000 description 45
- 230000008018 melting Effects 0.000 description 45
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 36
- 150000003254 radicals Chemical class 0.000 description 36
- 238000005481 NMR spectroscopy Methods 0.000 description 35
- 239000000243 solution Substances 0.000 description 35
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 33
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 32
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 31
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 28
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 239000002904 solvent Substances 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 20
- 239000000047 product Substances 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 16
- 239000003921 oil Substances 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 16
- 239000003054 catalyst Substances 0.000 description 15
- 238000003756 stirring Methods 0.000 description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 13
- 239000002253 acid Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 238000003556 assay Methods 0.000 description 12
- 229910052799 carbon Inorganic materials 0.000 description 12
- 238000001914 filtration Methods 0.000 description 12
- 229910052740 iodine Inorganic materials 0.000 description 12
- 238000002425 crystallisation Methods 0.000 description 11
- 230000008025 crystallization Effects 0.000 description 11
- 239000003480 eluent Substances 0.000 description 11
- 239000007868 Raney catalyst Substances 0.000 description 10
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 10
- 229910000564 Raney nickel Inorganic materials 0.000 description 10
- 238000001816 cooling Methods 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- 238000001953 recrystallisation Methods 0.000 description 9
- 238000010898 silica gel chromatography Methods 0.000 description 9
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 8
- 241000725303 Human immunodeficiency virus Species 0.000 description 8
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 8
- 229960000583 acetic acid Drugs 0.000 description 8
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 8
- 235000019341 magnesium sulphate Nutrition 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000005160 1H NMR spectroscopy Methods 0.000 description 7
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 125000006239 protecting group Chemical group 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 6
- 239000012362 glacial acetic acid Substances 0.000 description 6
- 239000012442 inert solvent Substances 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 102100034343 Integrase Human genes 0.000 description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 5
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 210000001744 T-lymphocyte Anatomy 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 125000001931 aliphatic group Chemical group 0.000 description 5
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 5
- 239000000010 aprotic solvent Substances 0.000 description 5
- 238000006555 catalytic reaction Methods 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 150000002170 ethers Chemical class 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- 239000008096 xylene Substances 0.000 description 5
- LOYZVRIHVZEDMW-UHFFFAOYSA-N 1-bromo-3-methylbut-2-ene Chemical compound CC(C)=CCBr LOYZVRIHVZEDMW-UHFFFAOYSA-N 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 229910052987 metal hydride Inorganic materials 0.000 description 4
- 150000004681 metal hydrides Chemical class 0.000 description 4
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 4
- 150000007530 organic bases Chemical class 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 4
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 125000004423 acyloxy group Chemical group 0.000 description 3
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 3
- 125000004414 alkyl thio group Chemical group 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 3
- 229910001863 barium hydroxide Inorganic materials 0.000 description 3
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 description 3
- SURLGNKAQXKNSP-DBLYXWCISA-N chlorin Chemical group C\1=C/2\N/C(=C\C3=N/C(=C\C=4NC(/C=C\5/C=CC/1=N/5)=CC=4)/C=C3)/CC\2 SURLGNKAQXKNSP-DBLYXWCISA-N 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 150000008282 halocarbons Chemical class 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropyl acetate Chemical compound CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000003444 phase transfer catalyst Substances 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 229960002429 proline Drugs 0.000 description 3
- 238000002976 reverse transcriptase assay Methods 0.000 description 3
- 238000007363 ring formation reaction Methods 0.000 description 3
- 238000002821 scintillation proximity assay Methods 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- XKZZNHPZEPVUQK-JEDNCBNOSA-N (2s)-2-amino-4-methylpentanoic acid;hydron;chloride Chemical compound Cl.CC(C)C[C@H](N)C(O)=O XKZZNHPZEPVUQK-JEDNCBNOSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- XXBQLHATYQHJQC-UHFFFAOYSA-N 1,2-dihydroquinoxaline Chemical compound C1=CC=C2N=CCNC2=C1 XXBQLHATYQHJQC-UHFFFAOYSA-N 0.000 description 2
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 2
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 description 2
- WHCSYIBWZNTLAJ-UHFFFAOYSA-N 4-chloro-2-n-cyclopropylbenzene-1,2-diamine Chemical compound NC1=CC=C(Cl)C=C1NC1CC1 WHCSYIBWZNTLAJ-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 101150041968 CDC13 gene Proteins 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 description 2
- 229910001515 alkali metal fluoride Inorganic materials 0.000 description 2
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 2
- 150000008046 alkali metal hydrides Chemical class 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000003862 amino acid derivatives Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 2
- 150000004292 cyclic ethers Chemical class 0.000 description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 150000004678 hydrides Chemical class 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 2
- 230000000269 nucleophilic effect Effects 0.000 description 2
- 239000003791 organic solvent mixture Substances 0.000 description 2
- NQBKEDXHJFIEJC-UHFFFAOYSA-N phenyl 3-oxo-2,4-dihydro-1h-quinoxaline-6-sulfonate Chemical compound C1=C2NC(=O)CNC2=CC=C1S(=O)(=O)OC1=CC=CC=C1 NQBKEDXHJFIEJC-UHFFFAOYSA-N 0.000 description 2
- DXNLDBASBALMSX-UHFFFAOYSA-N phenyl 4-chloro-3-nitrobenzenesulfonate Chemical compound C1=C(Cl)C([N+](=O)[O-])=CC(S(=O)(=O)OC=2C=CC=CC=2)=C1 DXNLDBASBALMSX-UHFFFAOYSA-N 0.000 description 2
- DPXBWHZMFUFMEV-UHFFFAOYSA-N phenyl 6-chloro-4-oxo-2,3,3a,5-tetrahydro-1h-pyrrolo[1,2-a]quinoxaline-7-sulfonate Chemical compound ClC1=C2NC(=O)C3CCCN3C2=CC=C1S(=O)(=O)OC1=CC=CC=C1 DPXBWHZMFUFMEV-UHFFFAOYSA-N 0.000 description 2
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 2
- 239000011698 potassium fluoride Substances 0.000 description 2
- 235000003270 potassium fluoride Nutrition 0.000 description 2
- AMMGCGVWJMRTQI-UHFFFAOYSA-N prop-1-en-2-yl carbonochloridate Chemical compound CC(=C)OC(Cl)=O AMMGCGVWJMRTQI-UHFFFAOYSA-N 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000005987 sulfurization reaction Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- NZGRXKWFEGVXJW-YFKPBYRVSA-N (2s)-7-chloro-2-methyl-3-oxo-2,4-dihydroquinoxaline-1-carbonyl chloride Chemical compound ClC1=CC=C2NC(=O)[C@H](C)N(C(Cl)=O)C2=C1 NZGRXKWFEGVXJW-YFKPBYRVSA-N 0.000 description 1
- JZIPPAISLIBUNX-SNVBAGLBSA-N (3r)-6-chloro-3-methyl-4-(3-methylbut-2-enyl)-1,3-dihydroquinoxalin-2-one Chemical compound ClC1=CC=C2NC(=O)[C@@H](C)N(CC=C(C)C)C2=C1 JZIPPAISLIBUNX-SNVBAGLBSA-N 0.000 description 1
- ZKRIXORQZRXTCJ-AWEZNQCLSA-N (3s)-3-benzyl-7-chloro-3,4-dihydro-1h-quinoxalin-2-one Chemical compound C([C@@H]1NC2=CC=C(C=C2NC1=O)Cl)C1=CC=CC=C1 ZKRIXORQZRXTCJ-AWEZNQCLSA-N 0.000 description 1
- PWSMFPODKQXVKB-YFKPBYRVSA-N (3s)-6-chloro-3-methyl-3,4-dihydro-1h-quinoxalin-2-one Chemical compound ClC1=CC=C2NC(=O)[C@H](C)NC2=C1 PWSMFPODKQXVKB-YFKPBYRVSA-N 0.000 description 1
- RYWGPCLTVXMMHO-UHFFFAOYSA-N (4-chlorophenyl) carbonochloridate Chemical compound ClC(=O)OC1=CC=C(Cl)C=C1 RYWGPCLTVXMMHO-UHFFFAOYSA-N 0.000 description 1
- BRIFRCAMMGWVGB-VIFPVBQESA-N (4-fluorophenyl) (2s)-7-chloro-2-methyl-3-oxo-2,4-dihydroquinoxaline-1-carboxylate Chemical compound N1([C@H](C(NC2=CC=C(Cl)C=C21)=O)C)C(=O)OC1=CC=C(F)C=C1 BRIFRCAMMGWVGB-VIFPVBQESA-N 0.000 description 1
- MSBGPEACXKBQSX-UHFFFAOYSA-N (4-fluorophenyl) carbonochloridate Chemical compound FC1=CC=C(OC(Cl)=O)C=C1 MSBGPEACXKBQSX-UHFFFAOYSA-N 0.000 description 1
- 125000000204 (C2-C4) acyl group Chemical group 0.000 description 1
- 125000006763 (C3-C9) cycloalkyl group Chemical group 0.000 description 1
- CMVQZRLQEOAYSW-UHFFFAOYSA-N 1,2-dichloro-3-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC(Cl)=C1Cl CMVQZRLQEOAYSW-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 1
- AVMHMVJVHYGDOO-UHFFFAOYSA-N 1-bromobut-2-ene Chemical compound CC=CCBr AVMHMVJVHYGDOO-UHFFFAOYSA-N 0.000 description 1
- 125000006018 1-methyl-ethenyl group Chemical group 0.000 description 1
- UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical compound C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 description 1
- LJCZNYWLQZZIOS-UHFFFAOYSA-N 2,2,2-trichlorethoxycarbonyl chloride Chemical compound ClC(=O)OCC(Cl)(Cl)Cl LJCZNYWLQZZIOS-UHFFFAOYSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- 125000006069 2,3-dimethyl-2-butenyl group Chemical group 0.000 description 1
- SYZRZLUNWVNNNV-UHFFFAOYSA-N 2-bromoacetyl chloride Chemical compound ClC(=O)CBr SYZRZLUNWVNNNV-UHFFFAOYSA-N 0.000 description 1
- ZLCKDYMZBZNBMJ-UHFFFAOYSA-N 2-bromoethyl carbonochloridate Chemical compound ClC(=O)OCCBr ZLCKDYMZBZNBMJ-UHFFFAOYSA-N 0.000 description 1
- OZGMODDEIHYPRY-UHFFFAOYSA-N 2-bromopropanoyl chloride Chemical compound CC(Br)C(Cl)=O OZGMODDEIHYPRY-UHFFFAOYSA-N 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- OOZVOFMSSDTFQF-QMMMGPOBSA-N 2-methoxyethyl (2s)-7-chloro-2-methyl-3-oxo-2,4-dihydroquinoxaline-1-carboxylate Chemical compound C1=C(Cl)C=C2N(C(=O)OCCOC)[C@@H](C)C(=O)NC2=C1 OOZVOFMSSDTFQF-QMMMGPOBSA-N 0.000 description 1
- 125000006022 2-methyl-2-propenyl group Chemical group 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- MKWMSEPIFHTCGU-UHFFFAOYSA-N 3,3-dimethyl-4-(3-methylbut-2-enyl)-1h-quinoxalin-2-one Chemical compound C1=CC=C2NC(=O)C(C)(C)N(CC=C(C)C)C2=C1 MKWMSEPIFHTCGU-UHFFFAOYSA-N 0.000 description 1
- HYTIPJFUWHYQON-UHFFFAOYSA-N 3,4-dihydro-1h-quinoxalin-2-one Chemical class C1=CC=C2NC(=O)CNC2=C1 HYTIPJFUWHYQON-UHFFFAOYSA-N 0.000 description 1
- AWGBKZRMLNVLAF-UHFFFAOYSA-N 3,5-dibromo-n,2-dihydroxybenzamide Chemical compound ONC(=O)C1=CC(Br)=CC(Br)=C1O AWGBKZRMLNVLAF-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- BEAJCHFCYQOFGS-UHFFFAOYSA-N 3-methyl-3,4-dihydro-1h-quinoxalin-2-one Chemical compound C1=CC=C2NC(=O)C(C)NC2=C1 BEAJCHFCYQOFGS-UHFFFAOYSA-N 0.000 description 1
- HQADTUWWRHRZGL-UHFFFAOYSA-N 3-oxo-2,4-dihydro-1h-quinoxaline-2-carboxamide Chemical class C1=CC=C2NC(=O)C(C(=O)N)NC2=C1 HQADTUWWRHRZGL-UHFFFAOYSA-N 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- SKIUVOVOIJBJPN-UHFFFAOYSA-N 4,5-dimethoxybenzene-1,2-diamine Chemical compound COC1=CC(N)=C(N)C=C1OC SKIUVOVOIJBJPN-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- UXYUMRQZVCNBTF-UHFFFAOYSA-N 5-chloro-n-cyclopropyl-2-nitroaniline Chemical compound [O-][N+](=O)C1=CC=C(Cl)C=C1NC1CC1 UXYUMRQZVCNBTF-UHFFFAOYSA-N 0.000 description 1
- VQJWYJFQEBOUOX-UHFFFAOYSA-N 6,7-dimethoxy-3-methyl-3,4-dihydro-1h-quinoxalin-2-one Chemical compound N1C(C)C(=O)NC2=C1C=C(OC)C(OC)=C2 VQJWYJFQEBOUOX-UHFFFAOYSA-N 0.000 description 1
- WXIXSRNTPHCSPF-UHFFFAOYSA-N 6-chloro-3,4-dihydro-1h-quinoxalin-2-one Chemical compound N1C(=O)CNC2=CC(Cl)=CC=C21 WXIXSRNTPHCSPF-UHFFFAOYSA-N 0.000 description 1
- OBFKWVWIGDRZJD-UHFFFAOYSA-N 6-chloro-3-(2-methylbut-3-en-2-yl)-4-(3-methylbut-2-enyl)-1,3-dihydroquinoxalin-2-one Chemical compound C1=C(Cl)C=C2N(CC=C(C)C)C(C(C)(C)C=C)C(=O)NC2=C1 OBFKWVWIGDRZJD-UHFFFAOYSA-N 0.000 description 1
- PWSMFPODKQXVKB-UHFFFAOYSA-N 6-chloro-3-methyl-3,4-dihydro-1h-quinoxalin-2-one Chemical compound ClC1=CC=C2NC(=O)C(C)NC2=C1 PWSMFPODKQXVKB-UHFFFAOYSA-N 0.000 description 1
- WRDLOUBWCCJMEL-UHFFFAOYSA-N 6-chloro-4-(3-methylbut-2-enyl)-1,3-dihydroquinoxalin-2-one Chemical compound C1=C(Cl)C=C2N(CC=C(C)C)CC(=O)NC2=C1 WRDLOUBWCCJMEL-UHFFFAOYSA-N 0.000 description 1
- IMUPEABJEGWYIK-UHFFFAOYSA-N 6-chloro-4-cyclopropyl-3-methyl-1,3-dihydroquinoxalin-2-one Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(C)N1C1CC1 IMUPEABJEGWYIK-UHFFFAOYSA-N 0.000 description 1
- QWZKGTUTAVFZIW-UHFFFAOYSA-N 7-chloro-1-cyclopropyl-3,3-dimethyl-4h-quinoxalin-2-one Chemical compound O=C1C(C)(C)NC2=CC=C(Cl)C=C2N1C1CC1 QWZKGTUTAVFZIW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- JNFIZPGTAOSUAP-UHFFFAOYSA-N CC1(C(NC2=CC(=CC=C2N1)C)=O)C.C(=C)(C)OC(=O)N1C(C(NC2=CC(=CC=C12)C)=O)(C)C Chemical compound CC1(C(NC2=CC(=CC=C2N1)C)=O)C.C(=C)(C)OC(=O)N1C(C(NC2=CC(=CC=C12)C)=O)(C)C JNFIZPGTAOSUAP-UHFFFAOYSA-N 0.000 description 1
- BLPJOEITQSUZNM-UHFFFAOYSA-N CC1C(NC2=CC=CC=C2N1CC=C(C)C)=S.CC1C(=NC2=CC=CC=C2N1CC=C(C)C)SC Chemical compound CC1C(NC2=CC=CC=C2N1CC=C(C)C)=S.CC1C(=NC2=CC=CC=C2N1CC=C(C)C)SC BLPJOEITQSUZNM-UHFFFAOYSA-N 0.000 description 1
- 125000006519 CCH3 Chemical group 0.000 description 1
- 101100167062 Caenorhabditis elegans chch-3 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- LAQBZACRWPMKFO-UHFFFAOYSA-N ClC1=C(C(=CC=C1)Cl)[N+](=O)[O-].ClC1=C(C=CC(=C1[N+](=O)[O-])Cl)S(=O)(=O)OC1=CC=CC=C1 Chemical compound ClC1=C(C(=CC=C1)Cl)[N+](=O)[O-].ClC1=C(C=CC(=C1[N+](=O)[O-])Cl)S(=O)(=O)OC1=CC=CC=C1 LAQBZACRWPMKFO-UHFFFAOYSA-N 0.000 description 1
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- MQBOJQAJNLZACX-UHFFFAOYSA-N FC1=C(C=CC=C1)[N+](=O)[O-].C(=O)(O)CC1C(NC2=CC=CC=C2N1)=O Chemical compound FC1=C(C=CC=C1)[N+](=O)[O-].C(=O)(O)CC1C(NC2=CC=CC=C2N1)=O MQBOJQAJNLZACX-UHFFFAOYSA-N 0.000 description 1
- CTKBWHOJKKFBHP-UHFFFAOYSA-N FC1=C(C=CC=C1)[N+](=O)[O-].C1(CCC2N1C1=CC=CC=C1NC2=O)=O Chemical compound FC1=C(C=CC=C1)[N+](=O)[O-].C1(CCC2N1C1=CC=CC=C1NC2=O)=O CTKBWHOJKKFBHP-UHFFFAOYSA-N 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- 101000941450 Lasioglossum laticeps Lasioglossin-1 Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- DBTDEFJAFBUGPP-UHFFFAOYSA-N Methanethial Chemical compound S=C DBTDEFJAFBUGPP-UHFFFAOYSA-N 0.000 description 1
- GZDQNKAAZQFMFY-GIZSYDTJSA-N N[C@@H](CC1=CC=CC=C1)C(=O)O.ClC1=CC(=C(C=C1)N[C@@H](CC1=CC=CC=C1)C(=O)O)[N+](=O)[O-] Chemical compound N[C@@H](CC1=CC=CC=C1)C(=O)O.ClC1=CC(=C(C=C1)N[C@@H](CC1=CC=CC=C1)C(=O)O)[N+](=O)[O-] GZDQNKAAZQFMFY-GIZSYDTJSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 108010047620 Phytohemagglutinins Proteins 0.000 description 1
- 239000012979 RPMI medium Substances 0.000 description 1
- 101150059476 SLC44A3 gene Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- 101000870345 Vasconcellea cundinamarcensis Cysteine proteinase 1 Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- VCHDBLPQYJAQSQ-UHFFFAOYSA-N [5-(diphenylphosphanylmethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl-diphenylphosphane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CC1OC(C)(C)OC1CP(C=1C=CC=CC=1)C1=CC=CC=C1 VCHDBLPQYJAQSQ-UHFFFAOYSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 238000006359 acetalization reaction Methods 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 239000003288 aldose reductase inhibitor Substances 0.000 description 1
- 229940090865 aldose reductase inhibitors used in diabetes Drugs 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001343 alkyl silanes Chemical class 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001262 anti-secretory effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- LDAVTQMMYMGIPH-JTQLQIEISA-N benzyl (2s)-5-amino-7-chloro-2-methyl-3-oxo-2,4-dihydroquinoxaline-1-carboxylate Chemical compound N1([C@H](C(NC2=C(N)C=C(Cl)C=C21)=O)C)C(=O)OCC1=CC=CC=C1 LDAVTQMMYMGIPH-JTQLQIEISA-N 0.000 description 1
- SCFMOUVVFAPNPP-JTQLQIEISA-N benzyl (2s)-7-chloro-2-methyl-5-nitro-3-oxo-2,4-dihydroquinoxaline-1-carboxylate Chemical compound N1([C@H](C(NC2=C(C=C(Cl)C=C21)[N+]([O-])=O)=O)C)C(=O)OCC1=CC=CC=C1 SCFMOUVVFAPNPP-JTQLQIEISA-N 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- KFDKSWDECHPONU-UHFFFAOYSA-N bis(trichloromethyl) carbonate Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl.ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl KFDKSWDECHPONU-UHFFFAOYSA-N 0.000 description 1
- RLECCBFNWDXKPK-UHFFFAOYSA-N bis(trimethylsilyl)sulfide Chemical compound C[Si](C)(C)S[Si](C)(C)C RLECCBFNWDXKPK-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
- 238000000160 carbon, hydrogen and nitrogen elemental analysis Methods 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000006364 carbonyl oxy methylene group Chemical group [H]C([H])([*:2])OC([*:1])=O 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940047120 colony stimulating factors Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 description 1
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- IPZJQDSFZGZEOY-UHFFFAOYSA-N dimethylmethylene Chemical compound C[C]C IPZJQDSFZGZEOY-UHFFFAOYSA-N 0.000 description 1
- VDCSGNNYCFPWFK-UHFFFAOYSA-N diphenylsilane Chemical compound C=1C=CC=CC=1[SiH2]C1=CC=CC=C1 VDCSGNNYCFPWFK-UHFFFAOYSA-N 0.000 description 1
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- PQLFROTZSIMBKR-UHFFFAOYSA-N ethenyl carbonochloridate Chemical compound ClC(=O)OC=C PQLFROTZSIMBKR-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical group C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 125000000350 glycoloyl group Chemical group O=C([*])C([H])([H])O[H] 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000006459 hydrosilylation reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- OVEHNNQXLPJPPL-UHFFFAOYSA-N lithium;n-propan-2-ylpropan-2-amine Chemical compound [Li].CC(C)NC(C)C OVEHNNQXLPJPPL-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- JLEJCNOTNLZCHQ-UHFFFAOYSA-N methyl 2-chloropropanoate Chemical compound COC(=O)C(C)Cl JLEJCNOTNLZCHQ-UHFFFAOYSA-N 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002900 organolithium compounds Chemical class 0.000 description 1
- LMAZKPOSWVOFGY-FBAUPLQOSA-N orine Natural products CO[C@H]1C[C@H](O[C@H]2CC[C@]3(C)[C@H]4C[C@@H](OC(=O)C=Cc5ccccc5)[C@]6(C)[C@@](O)(CC[C@]6(O)[C@]4(O)CC=C3C2)[C@H](C)OC(=O)C=Cc7ccccc7)O[C@H](C)[C@H]1O LMAZKPOSWVOFGY-FBAUPLQOSA-N 0.000 description 1
- XSXHWVKGUXMUQE-UHFFFAOYSA-N osmium dioxide Inorganic materials O=[Os]=O XSXHWVKGUXMUQE-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- UGSQIVWWLBNMKO-UHFFFAOYSA-N phenyl 2,4-dichloro-3-nitrobenzenesulfonate Chemical compound [O-][N+](=O)C1=C(Cl)C=CC(S(=O)(=O)OC=2C=CC=CC=2)=C1Cl UGSQIVWWLBNMKO-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 150000004986 phenylenediamines Chemical class 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000001885 phytohemagglutinin Effects 0.000 description 1
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- WTCCPYFMSIHIMT-QMMMGPOBSA-N prop-1-en-2-yl (2s)-7-chloro-2-methyl-3-sulfanylidene-2,4-dihydroquinoxaline-1-carboxylate Chemical compound ClC1=CC=C2NC(=S)[C@H](C)N(C(=O)OC(C)=C)C2=C1 WTCCPYFMSIHIMT-QMMMGPOBSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- OSFBJERFMQCEQY-UHFFFAOYSA-N propylidene Chemical compound [CH]CC OSFBJERFMQCEQY-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- FGEJJBGRIFKJTB-UHFFFAOYSA-N silylsulfanylsilane Chemical class [SiH3]S[SiH3] FGEJJBGRIFKJTB-UHFFFAOYSA-N 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- AFNRRBXCCXDRPS-UHFFFAOYSA-N tin(ii) sulfide Chemical class [Sn]=S AFNRRBXCCXDRPS-UHFFFAOYSA-N 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- BDIWFCKBPZPBQT-UHFFFAOYSA-N tributyl(tributylstannylsulfanyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)S[Sn](CCCC)(CCCC)CCCC BDIWFCKBPZPBQT-UHFFFAOYSA-N 0.000 description 1
- FAQYAMRNWDIXMY-UHFFFAOYSA-N trichloroborane Chemical compound ClB(Cl)Cl FAQYAMRNWDIXMY-UHFFFAOYSA-N 0.000 description 1
- NBTHYJWPOYZDHL-UHFFFAOYSA-N tricyclohexyl(tricyclohexylstannylsulfanyl)stannane Chemical compound C1CCCCC1[Sn](C1CCCCC1)(C1CCCCC1)S[Sn](C1CCCCC1)(C1CCCCC1)C1CCCCC1 NBTHYJWPOYZDHL-UHFFFAOYSA-N 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- NTCQOKPUDSWFJF-UHFFFAOYSA-N triphenyl(triphenylstannylsulfanyl)stannane Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(C=1C=CC=CC=1)S[Sn](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 NTCQOKPUDSWFJF-UHFFFAOYSA-N 0.000 description 1
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicinal Preparation (AREA)
Abstract
Abstract:
Quinoxalinones, processes for their preparation, and their use Compounds of the formula I or Ia (I)
Quinoxalinones, processes for their preparation, and their use Compounds of the formula I or Ia (I)
Description
.~ECHST AKrlENGESELLSCHAFT HOE 91/F 11~K Dr. WN/fe 2 ~ 8 ~
Description 5 Quinoxalines, processes for their preparation, and their use The present invention relates to quinoxalines, to processes for their preparation, and to their use.
Quinoxalines are a well-known class of compound (O. Hinsberg, J. Liebi~s Ann.
Chem. 237, 327 (1986)).
Quinoxaline derivatives have been described in the patent literature for use in various applications in medicine.
Austrian Patent 284,848 (19.12.67) mentions 1-N-dialkylaminoalkyl-3,4-dihydroquinoxalin-2(1H)-ones as spasmolytic agents. A series of patent applications by the Japanese company Sumitomo Chem. Co. Ltd. describe 4-N-aroyl-, arylacyl- and arylsulfonyl-3,4-dihydroquinoxalin-2(1H)-ones which have an antiinflammatory action (JA 17,137t69 (11.4.66), JA 17,136/69 (8.4.66), ~IA 7,008/422 (9.8.66), BE 706,623 (16.11.66)). 3,4-Dihydroquinoxalin-2(1H)-one-3-carboxamides ars contained in US Patent US 3,654,275 (4.4.72). They, too, have an antiinflamma~ory action. In US Applications US 4,203,987 (21.5.79) and 4,032,639 (22.3.76), pyridinyl-alkyltetrahydropyrazino[1,2-a]quinoxalinone derivatives are described by Am0rican Horne Prod. Corp. as antihypertensive and antisecretory reagents. A European Patent Application by Pfizer Inc. (EP 266,102 A (30.10.86)) includes 4-N-benzenesulfonyl-3,4-dihydroquinoxalin-2(1H)-one-1-alkylcarboxylic acids as aldose reductase inhibitors.
However, an antiviral activity has not been demonstrated to date.
Surprisingly, it has now been found that quinoxalines of the formulae I and la 2 2 ~ 8 ~
I
R 1 ~N~R 3 ( I ) and their tautomeric forms of the formula la N X
R ~ R 2 ( I a ) ~N/~
R
and physiologically acceptable salts or prodrugs thereof have an antiviral action, in particular against retroviruses, for example against the human immunodeficiency virus (H IV) .
20 In the compounds of the formula I or la according to the invention, 1) n is ~ero, one, twl three or four, the individual substituents R' independently of ons another are fluorine, chlorine, bromine, iodine, trifluoromethyl, trifluoromethoxy~ hydroxyl, C1-C8-alkyl, C5-C8-cycloalkyl, C1-C~-alkoxy, (C:1-C6-alkoxy)-(C1-C4-alkoxy3, 2~g8~
C,-C6-alkylthio, C,-C6-alkylsulfinyl, C,-C6-alkylsulfonyl, ni~ro, amino, azido, C,-C6-alkylamino, di(C,-C6-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, thiomorpholino, irnidazolyl, triazolyl, tetrazolyl, C,-C6-acyl, C,-C6-acyloxy, C,-C6-acylamino, cyano, carbamoyl, carbo~
(C,-C6-alkyl)oxycarbonyl, hydroxysulfonyl, sulfamoyl or a phenyl, phenoxy, phenoxycarbonyl, phenylthio, phenylsulfinyl, phenylsulfonyl, phenoxysulfonyl, phenylsulfonyloxy, anilinosulfonyl, phenylsulfonylamino, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which is substituted by up to five radicals R6 which are independent o~ one another, where R6 can be t5 fluorine, chlorine, bromine, iodine, cyano, trifluoromethyl, trifluoromethoxy, nitro, amino, azido, C1-C6-alkyl, C3-C9-cycloalkyl, C1-C6-alkoxy, C,-C6-alkylthio, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-alkylamino, di(C,-C6-alkyl)amino, (C1-C6-alkyl)oxycarbonyl, phenyl, phenoxy, 2-, 3- or 4-pyridyl, R2 is hydrogen, C,-C6-alkoxy, hydroxyl, picolyl, cyclopropyl or isopropenyloxycarbonyl and R5 is hydrogen, hydroxyl, C1-C6-alkoxy, aryloxy, C,-C6-acyloxy, cyano, amino, 2~ C,-C6-alkylamino, di(C,-C6-alkyl~amino, arylamino, Ct-C6-acylamino, I:~,-C8-alkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C6-alkoxy, C,-C6-alkylamino, di(C1-(::6-alkyl~amino, C,-C6-alkylthio, C,-C:6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
2~9~
C2-C~-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C,-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C6-alkoxy, C1-C6-alkylamino, di~Cl-C8-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl and carbamoyl;
C3-Ca-allenyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C3-CB-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, Cl-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C8-alkoxy, C,-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, Cl-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-G6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C,-C6-alkylthio, C,-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbarnoyl;
C3-CB-cycloalkenyl, 2~ optionally ~ubstituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, Cl-C6-alkoxy, C,-C6-alkylamino, di~Cl-C6-alkyl)amino, Cl-C6-alkylthio, C,-S:~6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
2 ~ 8 ~
(C3-C8-cycloalkyl~-(C,-C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, Cl-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, Cl-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkenyl)-(C, -C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, rnercapto, hydroxyl, C,-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C,-C6-alkylamino, di(C1-C6-alkyl)amino, C,-C6-alkylthio, C,-C6 alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
1 5 C,-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C6-alkoxy, C,-C6-alkylamino, di(C1-C6-alkyl)amino, C,-C6-alkylthio, C,-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
C2-C8-alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl,C1-C4-alkoxy, oxo, phenyl;
2~ (C3-C6-cycloalkyl)carbonyl, optionally substituted by fluorine, chlorine or hya'roxyl, C,-C4-alkoxy, oxo, phenyl;
(C5-C~-cycloalkenyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C,-C4-alkoxy, oxo, phenyl;
- :
2~6~
(C3-C~-cycloalkyl)-(C1-C~-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-aikoxy, oxo, phenyl;
(C5-C6-cycloalkenyl)-(Cl-c3-alkyl)carbonyl~ optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C,-C8-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, Cl-C4-alkylarnino, di(Cl-C4-alkyl)amino, C1-C4-alkylthio;
C2-C8-alkenyloxycarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, ph~nyl;
C2-C5-alkynyloxycarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-CB-alkylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl,Cl-C4-alkoxy, oxo, phenyl;
C2-C~-alkenylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-CB-alkylamino- and di(C1-C5-alkyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydro)~yl, Cl-C4-alkoxy, oxo, phenyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperæinyl-, w 4-methylpiperazin-1-ylcarbonyl, in each case optionally substituted by ~1-C4-alkyl, C2-C6-alkenyl,C1-C4-acyl, oxo, thioxo, carboxyi, or phenyl;
C2-C5-alkenylamino- and di(C,-C6-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
2 ~ 8 5 C1-C6-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C:1-C4-alkoxy, oxo, phenyl;
C1-C6-alkenylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
or aryl, arylcarbonyl, aryl(thiocarbonyl), (arylthio)carbonyl, (arylthio~thiocarbonyl, aryloxycarbonyl, arylaminocarbonyl, ~arylamino)thiocarbonyl, arylalkylaminocarbonyl, arylsulfonyl, arylalkyl, arylalk~nyl, arylalkynyl, arylalkyl-carbonyl, arylalkenylcarbonyl, arylalkoxycarbonyl or aryl(alkylthio)carbonyl, each of which is substituted by up to five radicals R5 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 5 carbon atoms, and R6 being as defined above, or heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkylcarbonyl or heteroarylalkenylcarbonyl, heteroaryloxycarbonyl, (heteroarylthio)carbonyl, heteroarylaminocarbonyl, heteroarylalkyloxycarbonyl, heteroaryl(alkylthio)carbonyl or heteroarylalkylaminocarbonyl, each of which is substituted by up to three radicals R6 which are independent of one another, it being possible for the alkyl raclical to contain in each case 1 to 3 carbon atoms, R3 and R4 are identical or different and, independently of one another, are hydrogen, C1-C8-alkyl which is optionally substituted by fluorine, chlorine, hydroxyl, amino, mercapto, Cl-C:4-acyloxy, b~nzoyloxy, benzyloxy, phenoxy, G1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl~amino, C1-C4-alkylthio, C1-C4-alkylsulFonyl, Cl-C4-alkylsulfinyl, carboxyl or carbamoyl;
C2-C8-alkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, Gl-C"-alkoxy, C1-C4-.
2 ~ 9 3 ~
alkylamino, di(C1-C4-alkyl)amino, C1-C4 alkylthio, C,-C4-alkylsulfonyl, C;1-C4-alkylsulfinyl, carboxyi or carbamoyl;
C3-CE,-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyl, amino, mercapto, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C"-alkoxy, C,-C4-alkylamino, di(C1-C4-alkyl)amino, C,-C,-alkylthio, C1-C4-alkyisulfonyl, C,-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-~4-alkoxy, C1-C4-alkylamino, di(C,-C4-alkyl)amino, C,-C4-alkylthio, C,-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
aryl, arylalkyl, heteroaryl or heteroarylalkyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for thealkyl radical to contain 1 to 3 carbon atoms in each case, and R6 being as defined above, R3 and R4 can furthermore also be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 8 carbon atoms and which can optionally be substituted by fluorine, chlorine, hydroxyl, amino, C,-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-acyloxy, benzoyloxy, C1-C6-alkoxy, oxo, thioxo, carboxyl, carbamoyl or phenyl, ?5 X is oxygen, sulfur~ selenium or substituted nitrogen N-R2, it being possible for R2 to have the abovementioned meanings, with the exception of those compounds in which R3 and R4 are both hydrogen, and compounds in wnich R2 and R5 are hydrogen and R3 and/or R4 are/is arylalkyl, andcompounds in which X is oxygen and R2 and Rs are hydrogen.
2 ~
In a preferred group of compounds of the formula I or la, 2) n is zero, one, two or three, the individual substituents R1 independently of one another are fluorine, chlorine, bromine, trifluoromethyl, trifluoromethoxy, hydroxyl, Cl-C4-alkyl, C5-C6-cycloalkyl, C1-C4-alkoxy, (C1-C4-alkoxy)-(C1-C4-ali~o~ C~ 4-alkylthio, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonyl, nitro, amino, C1-C4-alkylamino, di(C1-C4-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpip~razinyl, thiomorpholino, imidazolyl, C1-C4-acyl, C,-C4-acyloxy, C1-C4-acylamino, cyano, carbamoyl, carboxyl, (C1-C4-alkyl)oxycarbonyl, hydroxysulfonyl or sulfamoyl or a phenyl, phenoxy, phenoxycarbonyl, phenylthio, phenylsulfinyl, phenylsulfonyl, phenoxysulfonyl, phenylsulfonyloxy, anilinosulfonyl, phenylsulfonylamino, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which is substituted by up to two radicals R6 which are independent of one another, where R6 can be fluorine, chlorine, bromine, cyano, trifluoromethyl, nltro, amino, C1-C4-alkyl, C3-C7-cycloalkyi, Cl-C4-alkoxy, C,-C4-alkylthio, Cl-C4-alkylsulfinyl, C,-C4-alkylsulfonyl, C,-C4-alkylamino, di(C,-C4-alkyl)amino, ~C:l-C4-alkyl)oxycarbonyl, phenyl or phenoxy, 2~9~ ~
R2 is hydrogen and R5 is hydrogen, hydroxyl, cyano, amino, C,-C6-alkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, rnercapto, hydroxyl, C:l-C4 acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C~-alkoxy, C,-C4-alkylamino, di(C,-C4-alkyl)amino, C,-C4-alkylthio, oxo, thioxo, oarboxyl or carbamoyl;
C2-C8-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C,-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
t5 C3-Ca-allenyl, C3-C8-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C,-C4-alkylamino, di(C,-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-CB-cycloalkyl, optiorlally subs~ituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C,-C4-alkylamino, di(C,-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, ~yano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
(C3-C~-cycloalkyl)-(C1-C2-alkyl) optionaliy substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1~C4-alkoxy, Cl-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
(C3-C~-cycloalkenyl)-(C,-C2-alkyl), optionally substituted by fiuorine, chlor;ne, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C~-C4-alkylamino, di(C,-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C1-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C~,-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C2-C6^alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl,C,-C4-alkoxy, oxo, phenyl;
~C3-C6-cycloalkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C6-cycloalkenyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
g ~ 5 ~C3-C6-cycloalkyl)-(C,-C2-alkyl)carbonyl, optionally substituted by fiuorine, chlorine or hydroxyl, Cl-C4-alkoxy, oxo, phenyl;
(C5-C6-cycloalkenyl)-(C,-C2-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkyloxycarbonyl, optionally substituted by fluorine, chlorin~, bromine, hydroxyl, C1 C4-alkoxy, C1-C~,-alkylamino, di(Cl-C4-alkyl)amino, C,-C4-alkylthio;
C2-C6-alkenyloxycarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C2-C6-alkynyloxycarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
~5 C1-C6-alkylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl,C1-C4-alkoxy, oxo, phenyl;
C2-C6-alkenylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkylamino- and di(C1-C6-alkyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1-ylcarbonyl;
C2-C6-alkenylamino- and di(C1-C5-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
~ ~ 6 ~
C1-C4-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C,-C4-alkoxy, oxo, phenyl;
C1-C4-alkenylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C,-C4-alkoxy, oxo, phenyl;
or aryl, arylcarbonyl, aryl(thiocarbonyl), (arylthio)carbonyl, (arylthio)thiocarbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino)thiocarbonyl, arylalkylaminocarbonyl, arylsulfonyl, arylalkyl, arylalkenyl, arylalkynyl, arylalkyl-carbonyl, arylalkenylcarbonyl, aryl(alkyl~hio)carbonyl or arylalkoxycarbonyl, each of which îs substituted by up to three radicals R6 which are independsnt of one another, it being possible for the alkyl radical to contain in each case 1 to 5 carbon atoms and R6 being as defined above, or 1- or 2-naphthylmethyl, 2-, 3- or 4-picolyl, 2- or 3-furylmethyl, 2- or 3-thienylmethyl, 2- or 3-pyrrolylmethyl, 2-, 3- or 4-pyridylcarbonyl, 2- or 3-furylcarbonyl, 2- or 3-thienylcarbonyl, 2- or 3-thienylacetyl, 2-, 3- or 4-picolyloxycarbonyl, 2- or 3-furylmethyloxycarbonyl, 2- or 3-thienylrnethyl-oxycarbonyl, each of which is substituted by up to two radicals R6 which are independent of one another, and R3 and R4 are identical or different and independently of 2~ one another are hydrogen, C1-C6-alkyl, optionally substituted by fluorine, chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, ben7yloxy, phenoxy, C1-C4-aikoxy, C,-C4-~lkylamino, 2 ~
di(C1-C4-alkyl)amino, C,-54-alkylthio, C1-C4-alkylsulfonyl, C,-C4-alkylsulfinyl,carboxyl or carbamoyl;
C2-Ca-alkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C,-C4-alkylamino, di(C1-C4-alkyl~amino, Cl-C4-alkylthio, C,-C4-alkylsulfonyl, C,-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-Ca-cycloalkyl, optionally substituted by fluorine, ch!orine, hydroxyl, arnino, mercapto, Cl-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C1-C4-alkylamino, di(C,-C4-alkyl)amino, C,-C4-alkylthio, C,-C4-alkylsulfonyl, C l-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-Ca-cycloalkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, Cl-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C,-C4-alkylthio, C,-C4-alkylsulfonyl, C,-C4-alkylsulfinyl, carboxyl or carbamoyl;
aryl, arylalkyl, heteroaryl or heteroarylalkyl, each of which is substituted by up to three radicals R~ which are independent o~ one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms and R6 being as defined above, R3 and R4 can furthermore also be par~ of a saturated or unsaturated carbo- or heterocyclic ring which has 3 tQ 7 carbon atoms and which can optionally be substitut~d by fluorine, chlorine, hydroxyl, amino, C1-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-acyloxy, benzoyloxy, C1-C4-alkoxy, oxo, thioxo, carboxyl, carbamoyl or phenyl, and X is oxygen, sulfur or selenium.
2~6~85 In a yet more preferred group of compounds of the formula I or la, 3) n is zero, one or two, the individual substituents R' independently of one another are fluorine, chlorine, bromine, trifluoromethyl, hydroxyl, C1-C4-alkyl, C,-C4-alkoxy, (C1-C4-alkoxy)-(C1-C4-alkoxy), C1-C4-alkylthio, nitro, amino, C1-C4-alkylamino, di(C,-C4-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, Cl-C4-acyl, C1-C4-acyloxy, Cl-C4-acylamino, cyano, carbamoyl, carboxyl, (C1-C4-alkyl)oxycarbonyl, hydroxysulfonyl or sulfamoyl, or a phenyl, phenoxy, phenylthio, phenylsulfonyl, phenoxysulfonyl, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which is substituted by up to two radicals R6 which are independent of one another, where R6 can be fluorine, chlorine, bromine, cyano, trifluoromethyl, nitro, amino, C1-C4-alkyl, C1-C4-alkoxy, (C1-C4-alkyl)oxycarbonyl, phenyl or phenoxy, R2 is hydrogen and R5 is C1-C6-alkyl, optionally substituted by fluorine, chlorlne, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzylo~y, phenoxy, :
2 ~
C1-C4-alkoxy, C1-C4-alkylamino, di(C,-C4-alkyl)amino, Cl-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C2-C6-alkenyl, optionally substituted by fluorine, chlorine, hydroxyl, Cl-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C,-C4-aikylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-t:~B-allenyl, C3-C8-alkynyl, optionally substituted by fluorine, chlorine, hydroxyl, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C,-C4-alkylamino, di(C,-C4-alkyl)amino, C,-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-Ca-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyl, C,-C4-alkyl, C,-C4-acyloxy, benzoyloxy, benzyloxy,phenoxy, C,-C4-alkoxy, C,-C4-alkylamino, di(C,-C4-alkyl)amino, C,-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine, chlorine, hydroxyl, C,-C4-alkyl, C;,-C4-acyloxy, ben7oyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C,-C4-alkylamino, di(C,-C4-alkyl)amino, C,-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
2~98~
(C3-Cs-cycloalkyl)-(C1-C2-alkyl~, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-acyloxy, benzoyloxy, benzyloxy,phenoxy, C1-C4-alkoxy, C1-C"-alkylamino, di~C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
(C3-C6-cycloalkenyl)-(C,-C2-alkyl), optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-acyloxy, benzoyloxy, benzyloxy,phenoxy, C1-C4-alkoxy, C1-C~-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkyithio, oxo, thioxo, carboxyl or carbamoyl;
C1 -C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-acyloxy, benzoyloxy, benzyloxy,pheroxy, C1-C4-alkoxy, C1-C4-alkylamino, C,-C4-alkenylamino, di(C1-C4-alkyl)amino, 1-pyrrolidinyl, piperidino, morpholino, 4-methylpiperazin-1-yl, Cl-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C2-C6-alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl;
(C3-C6-cycloalkyl)carbonyl, (C5-C6-cycloalkenyl)carbonyl, (C3-C6-cycloalkyl)-(C1-C2-alkyl)carbonyl, (Cs-C6-cycloalkenyl)-(C,-C2-alkyl)carbonyl, C1-C6-alkyloxycarbonyl, optionally substituted by flvorine, ehiorine, bromine, hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl~amino or C1-C4-alkylthio;
2~6~9~
C2-C6-alkenyloxycarbonyl, optionally substituted by flusrine, chlorine, hydroxyl, C,-C4-alkoxy;
C2-C6-alkynyloxycarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, Cl-C4-alkoxy;
Cl-C6-alkylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, Cl-C4-alkoxy;
C2-C6-alkenylthiocarbnnyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy;
C1-C6-alkylamino- and di(C1-C6-alkyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, Cl-G4-alkoxy;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1 -ylcarbonyl;
C2-C6-alkenylamino- and di(C1-C~-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, Cl-C4-alkoxy;
Cl-C4-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy;
C1-C4-alkenylsulfonyl;
or aryl, arylcarbonyl, (arSlthio)carbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino~thiocarbonyl, arylsulfonyl, arylalkylaminocarbonyl, arylalkyl, arylalkenyl, arylalkylcarbonyl, arylalkoxycarbonyl or aryl(alkylthio)carbonyl, each of which is substituted by up to two radicals R6 which are independent of one 2 ~
another, it being possible for the alkyl radical to contain in each oase 1 to 3 carbon atoms, and R6 being as defined above, or 1- or 2-naphthylmethyl, 2-, 3- or 4-picolyl, 2- or 3-furylmethyl, 2- or 3-thienylmethyl, 2- or 3-pyrrolylmethyl, 2-, 3- or 4-pyridylcarbonyl, 2- or 3-furylcarbonyl, 2- or 3-thienylcarbonyl, 2- or 3-thienylacetyl, 2-, 3- or 4-picolyloxycarbonyl, 2- or 3-furylmethyloxycarbonyl or 2- or 3-thienylmethyloxycarbonyl, sach of which is substituted by up to two radicals R6 which are independent of one another, and R3 and R4 are identical or different and independently of one another are hydrogen, C1-C4-alkyl, optionally substitu~ed by fluorine, chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, phenoxy, Cl-C4-alkoxy, Cl-C4-alkylamino, di(Cl-C4-alkyl)amino, Cl-C4-alkylthio, Cl-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C2-C6-alkenyl, optionally substituted by fluorine or chlorine;
C3-C6-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyi, amino,mercapto, Cl-C4-acyloxy, benzoylo~y, benzyloxy, phenoxy, C1-C4-alkoxy, Cl-C4-alkylamino, di~C,-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C~-C4-alkylsulfinyl, carboxyl or carbamoyl;
~5 C3-Ca-cycloalkenyl, optionally substituted by fluorine or chlorine;
- aryl, benzyl, heteroaryl or heteroarylmethyl, each of which is su~stituted by up to two radicals R~ which are independent of one another, 2 ~ 5 2û
R3 and R4 can furthermore also be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 6 carbon atoms and which can optionally be substituted by fluorine, chlorine, hydroxyl, amino, C1-C4-acytoxy, benzoyloxy, C,-C"-alkoxy, oxo, thioxo, carboxyl or carbamoyl, and X is oxygen or sulfur.
In a yet again preferred group of compounds of the formula I or la, 4) n is zero, one or two, the individual substituents R' independently of one another are fluorine, chlorine, bromine, trifluoromethyl, hydroxyl, C1-C4-alkyt, C1-C4-alkoxy, (C1-C4-alkoxy)-(C1-C2-alkoxy), C1-C4-alkylthio, nitro, amino, C1-C4-alkylamino, di(C,-C4-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, C1-C4-acyl, C1-C4-acyloxy, C,-C4-acylamino, cyano, carbamoyl, carboxyl, (C1-C4-alkyl)oxycarbonyl, hydroxysulfonyl or sulfamoyl or a phenyl, phenoxy, phenylthio, phenylsulfonyl, phenoxysulfonyl, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical, each of whk:h is substituted by up to two radicals R6 which are independent of one anoth0r, where R6 can be ~ ~ .
2 ~
fluorine, chlorine, bromine, cyano, trifluoromethyl, nitro, amino, C1-C"-alkyl, C1-C4-alkoxy, (C1-C4-alkyl)o~carbonyl, pheny~ or phenoxy, R2 is hydrogen and R5 is C1-C6-alkyl, optionally substituted by C1-C"-alkoxy or C1-C"-alkylthio;
C2-C6-alkenyl, optionally substituted by oxo;
C3-C6-allenyl;
C3-CB-alkynyl, in particular 2-butynyl;
C3-C6-cycloalkyl;
Cs-C6-cycloalkenyl;
(C3-C6-cycloalkyl)-(C1-C2-alkyl), in particular cyclopropyimethyl, optionally substituted by C1-C4-alkyl;
(C3-C6-cycloalkenyl)-(C,-C2-alkyl), in particular cyclohexenylmethyl;
C1-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, benzyloxy, phenoxy, C,-C4-alkoxy, C1-e;4-alkylamino, C1-C4-alkenylamino, di(C1-C4-alkyl)amino, 1-pyrrolidinyl, piperidino, morpholino, 4-methylpiperazin-1-yl or C1-C4-alkylthio;
22 2 ~ 8 C2-C6-alkenylcarbonyl;
Cl-C6-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, Ct-C4-alkylamino, di(C1-C4-alkyl)amino or C1-C4-alkylthio;
C2-C6-aikenyloxycarbonyl, in particular vinyloxycarbonyl, allyloxycarbonyl, isoprnpenyloxycarbonyl, butenyloxycarbonyl or pentenyloxycarbonyl;
C2-C6-alkynyloxycarbonyl, in particular propynyloxycarbonyl or butynyloxycarbonyl;
C1 -C6-alkylthiocarbonyl;
C2-C6-alkenylthiocarbonyl, in particular allylthiocarbonyl;
C,-C6-alkylamino- and di(C1-C6-alkyl)aminocarbonyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1-ylcarbonyl;
C2-C6-alkenylamino- and di(C,-C6-alkenyl)aminocarbonyl;
C1 -C4-alkylsulfonyl;
~5 C,-C4-alkenylsulfonyl;
or aryl which is substituted by up to two radicals R6 which are inciependent of one another, in particular phenyl, aryicarbonyl, in parSicular benzoyl, (arylthio)carbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino~thiocarbonyl,arylalkylaminocarbonyl, arylsulfonyl, arylalkyi, in particular benzyl, phenylethyl, ~$~
arylalkenyl, arylalkylcarbonyl, arylalkoxycarbonyl or aryl(alkylthio)carbonyl, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atomsand R6 being as defined above, or 1- or 2-naphthylmethyl, 2-, 3- or 4-picolyl, ~- or 3-furylmethyl, 2- or 3-thienylmethyl, 2- or 3-pyrrolylmethyl, 2-, 3- or 4-pyridylcarbonyl, 2- or 3-furylcarbonyl, 2- or 3-thienylcarbonyl, 2- or 3-thienylacetyl, 2-, 3- or 4-picolyloxycarbonyl, 2- or 3-furylmethyloxycarbonyl, or 2- or 3-thienyl-methyloxycarbonyl, each of which is substituted by up to two radicals R6 which are independent of one another, and R3 and R4 are identical or different and independently of one another are hydrogen, Cl-C4-alkyl, optionally substituted by hydroxyl, mercapto, C1-C4-alkoxy, C1-C4-alkylthio, C,-C4-alkylsulfonyl, C,-C4-alkylsulfinyl, carboxyl or carbarnoyl;
C2-C6-alkenyl, aryl, benzyl, thienyl or thienylmethyl, each of which is substituted by up to two radicals R6 which are independent of one another, R6 beinç3 as defined above, R3 and R4 can also be part o~ a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 6 carbon atoms and can optionally be substituted by oxo or thioxo, an~
2 ~ 8 ~
X is oxygen or suifur.
Compounds of the formula I or la as defined above wherein the substituents mentioned have the following meanings are very particularly important:
n is zero or one, the individual substituents R' independently of one another are fluorine, chlorine, bromine, C1-C2-alkyl, C,-C2-alkoxy, C2-C4-acyl or cyano, R2 is hydrogen and Rs is 1 5 C2-C6-alkenyl, C3-C8-alkynyl, in particular 2-butynyl;
(C3-C6-cycloalkyl)-(C1-C2-alkyl), in particular cyclopropylmethyl, optionally substituted by C1-C4-alkyl;
(C3-C6-cycloalkenyl)-(C1-C2-alkyl), in particular cyclohexenylmethyl;
C2-C6-alkylcarbonyl, C2-C6-alkenylcarbonyi;
C1 -C6-alkyloxycarbonyl;
2 ~ 5 C2-C6-alkenyloxycarbonyl, in particular vinyloxycarbonyl, allyloxycarbonyl, isopropenyloxycarbonyl, butenyloxycarbonyl or pentenyloxycarbonyl;
C~-C6-alkynyloxycarbonyl, in particular propynyloxycarbonyl or butynyloxycarbonyl;
C2-C6-alkenylthiocarbonyl, in particular allylthiocarbonyl;
Cl-C4-alkylsulfonyl;
C1 -C4-alkenylsuHonyl;
or arylalkyl, in particu!ar benzyl or arylalkenyl, which is substituted by up to two radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms and for the alkenyl radical to contain 2-3 carbon atoms, or 1-naphthylmethyl, 2- or 3-picolyl, 2-furylme~hyl or 2- or 3-thienylmethyl, each of which is substituted by up to two radicals R6 which are independent of one another, where R6 is fluorine, chlorine, bromine, cyano, C1-C2-alkyl or C1-C2-alkoxy, ~5 and R3 and R4 are identical or different and independently of one another are 2 ~
hydrogen, C1-C4-alkyl, optionally substituted by hydroxyl, mercapto, C,-C4-alkoxy. C1-C2-aikylthio, and 5 X is oxygen or sulfur.
The alkyl groups in the above definitions can be straight-chain or branched. Unless otherwise defined, they preferably contain 1-8, particularly preferably 1-6, in particular 1-4, carbon atoms. Examples are the methyl, ethyl, propyl, 1-methylethyl, butyl,10 1-methylpropyl, 2-methylpropyl and 1,1-dimethylethyl ~roup, and similar groups.
The alkenyl groups mentioned in the above definitions can be strai~ht-chain or branched and contain 1 to 3 double bonds. Unless otherwise defined, these groupspreferably contain 2-8, in particular 2-6, carbon atoms. Examples are the 2-propenyl, 1-methylethenyl, 2-butenyl, 3-butenyl, 2-methyl-2-propenyl, 3-methyl-2-butenyl, 2,3-dimethyl-2-butenyl, 3,3-dichloro-2-propenyl and pentadienyl groups and similar groups.
The alkynyl groups mentioned in the above definitions can be straight-chain or 20 branched and contain 1 to 3 triple bonds. Unless otherwise defined, they contain preferably 2-8, particularly preferably 3-6, carbon atoms. Examples are the 2-propynyl and 3-butynyl group and similar groups.
Unless otherwise defined, the cycloalkyl and cycloalkenyl groups mentioned in the 25 above definitions contain ,orefsrably 3-8, particularly preferably 4-6, carbon atoms.
Examples are the cyclopropyl, cyclobutyl, cyclopentyl, cyclopentenyl, cyclohexyl or cyclohexenyl group.
The acyl groups mentioned in the above definitions can be aliphatic, cycloaliphatic or 30 aromatic. Unless otherwise defined, they preferably contain 1-8, particularly preferably 2 ~ 5 2-7, carbon atoms. Examples of acyl ~roups are the formyl, acetyl, chloroacetyl,trifiuoroacetyl, hydroxyacetyl, propisnyl, butyryl, isobutyryl, pivaloyl, cyclohexanoyl or benzoyl group.
5 The aryl groups mentioned in the above definitions are preferably aromatic groups having 6-14 carbon atoms, in particular 6-10 carbon atoms, for example phenyl ornaphthyl.
Suitable hetero atoms in the abovementioned heterocyclic rings Dr heteroaryi groups 10 are, in particular, oxygen, sulfur and nitrogen, where, in the case of a nitrogen-containing ring which is saturated in this position, a structure N-Z is present in which Z
is H or R5 w1th the individual above-described definitions.
Unless otherwise defined, the heterocyclic rings preferably have 1-13 carbon atoms and 1-6 hetero atoms, in particular 3-9 carbon atoms and 1-4 hetero atoms.
Suitable radicals for the heteroaryl groups mentioned in the above definitions are, for example, heteroaromatic radicals such as 2- or 3-thienyl, 2- or 3-furyl, 2-, 3- or 4-pyridyl, pyrimidyl, indolyl, quinolyl or isoquinolyl.
Examples of the aralkyl groups mentioned in the above definitions are benzyl, phenylethyl, naphthylmethyl or styryl.
The abovementioned substituents R1 to Rs are preferably trisubstituted, particularly 25 preferably disubstituted, in particular monosubstituted, by the particular substituents mentioned.
In the case of the particular definitions of composite substituents (such as, for example, arylalkoxycarbonyl~, the ranges which have been described above as being 30 preferred for the individual substituents are also preferred.
2 ~ 6 ~ 9 8 ~
Depending on the various substituents, compounds of the formulae I and la can have several asymmetric carbon atoms. The invention therefore relates both to the pure stereoisomers and to mixtures thereof such as, for example, the corresponding racemate.
The pure stereoisomers of the compounds of the formulae I and la can be prepareddirectly by known methods or analogously to known methods, or they can be resolved later.
The compounds of the formulae I and la can be prepared by known methods or 10 modifications thereof (seel for example, Rodd's Chemistry of Carbon Compounds, S.
Coffey, M. F. Anse!l (Editor); Elsevier, Amsterdam, 1989; Vol. IV Part IJ, p. 301-311.
Heterocyclic Compounds. R. C. Elderfield (Editor); Wiley, New York, 1957; Vol. 6, p.
491-495)-The present invention furthermore includes a process for the preparation of 15 compounds of the formulae I and la as explained in 1) - 4) above, which comprises A) for preparing compounds of the formula I where X is oxy~en and the radicals R1, R2, R3, R4 and R5 are as defined under 1) - 4), reacting a compound of the formula ll H
I
R n~N~R 3 ( I I ) with the definitions mentioned under 1) - 4) applying to R1, R3 and R4, with a compound of the ~ormula lll R-Z
;
2 ~
where R has the meanings for R5 and R2 which have been mentioned above under 1) -4) with the exception of hydrogen, hydroxyl, Cl-C6-alkoxy, aryloxy, C1-C8-acyloxy, amino, C,-C6-alkylamino, di(C1-C;6-alkyl)amino, arylamino and C,-C6-acylamino, and Z is a leaving group, 5 or B) preparing compounds of ~he formula I where X is sulfur and R1, R2, R3, R4 and R5 are as defined under 1) - ~) by reacting a compound of the formula I where X is oxygen and the definitions mentioned under 1) - 4) apply ~o R1, R2, R3, R4 and Rs, with a sulfurizing reagent, 10 or C) preparing compounds of the formula la where X and the radicals R1 to Rs are as defined under 1) - 4), by reacting a compound of the formula IV
H
I
R ~ ~N~R 3 ( I V
20 or R 1 n~N~ ( I V ~ ) where the definitions mentioned under 1) - 4) apply to R1, R3, R4 and R5, with acompound of the tormula lll 2~3 R2 z (111) where the definitions described under 1) - 4) for formula I and la apply to R2, with the exception of hydrogen, hydroxyl, C1-C8-alkoxy, aryloxy, C1-C6-acyloxy, amino, 5 C,-C6-alkylamino, di(C1-C6-alkyl)amino, arylamino or C1-C6-acylamino, and Z is a leaving group, or D) preparing compounds of the formula I where X is oxygsn and the radicals R' to Rs are as defined under 1) - 4) by cyclizing a compound of the formula V
I
R n ~ J~R 3 V
R
where R' to Rs are as defined under 1) - 4) and Y is hydroxyl, C1-C4-alkoxy, optionally halogenated C,-C4-acyloxy, chlorine, bromine or iodine, or 20 E) preparing compounds of the formula i where X is oxygen, R4 and R5 are hydrogen and the definitions mentioned under 1) - 4) apply to R1 to R3, from the quinoxalinones of the formula Xl 25 R ~N~R 3 X I
where R1 to R3 are as defined under 1) - 4), by addition of hydrogen on the C=N
30 bond, 2 ~
or F) preparing compounds of the formuia I where X is oxygen and Rl to R5 are as defined under 1) - 4), from compounds of the formula Vl R 1 ~N H V I
N H
where R1, R2 and R5 are as defined under 1) - 4), by reacting them with chloroform or bromoform and a carbonyl cornpound of the formula Xlll R3-Co-R4 Q(lll) where R3 and R4 are as defined under 1) - 4), or with a-(trihalomethyl)alkanols of the formula XIV
Hal3C-C(OH)-R3R4 (XIV) where Hal is Cl, Br or 1, in which R3 and R4 are as defined under 1) - 4), 25 or G) praparing compounds of the formula I where X is oxygen and R', R2, R3, R4 and R5 are as defined under 1) - 4), by reacting a compound of the formula I where X isoxygen and the definitions mentioned und0r 1) - 4) apply to Rl, R2, ~5 and to R3 and R4, with the exception that at least one of the radicals R3 or R4 is hydrogen; ~ith an 30 alkylating reagent of the formula XV
2 ~
R'-Z (XV) where R' has the meanings mentioned above for R3 and R4 with the exception of hydrogen and Z is a leaving group, or H) preparing compounds of the formula I where X is oxygen, Rl, R2, R3 and R4 are as defined under 1) - ~) and R5 is C1-C8-alkyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, pheno)~y, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl, carbamoyl, C3-C8-alkenyl, optionally substitut~d by fluorine, chlorine, bromine, iodine, hydroxyl, Cl-C6-acyloxy, benzoyloxy, phenoxy, C:l-C6-alkoxy, C,-C6-alkylamino, di(C1-C6-alkyl)amino, Cl-C6-alkylthio, cyano, carboxyl or carbamoyl, C3-C8-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylarrlino, di(Cl-C6-alkyl)amino, C1-C6-alkyi-1~ thio, cyano, carboxyl or carbamoyl, C4-Ca-cycloalkyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, Cl-C6-alkoxy, C1-C6-alkylamino, di(Cl-C6-alkyl)amino, C,-C6-alkylthio, cyano, carboxyl or carbamoyl, Cs-C6-cycloalkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, Cl-C6-alkoxy, C,-C;6-alkylamino, C1-C6-dialkylamino, Cl-C6-alkylthio, cyano, carboxyl or carbamoyl, (C1-C6-alkoxy)-(C1-C6-alkyl), di(C1-C6-alkylamino)-(C1-C6-alkyl) or (C3-C6-cycloalkyl)alkyl, (C6-C8-cyclo-alkenyl)alkyl, or arylalkyl, naphthylalkyl or heteroarylalkyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 oarbon atoms, by reductive alkylation of a compound of the formula I where R5 is hydrogen and X is oxygen and the definitions mentioned under 1) - 4) ~pply to R1, F~2, R3 and R4, with a carbonyl compound of the formula XVI, 2~5~5 R''-C(=O)-R''' (XVI) whsre R" and R~" are identical or different and independently of one another arehydrogen, C,-C7-alkyl, optionally substituted by fluorine, chlnrine, bromine, iodine, hydroxyl, C,-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, Cl-C6-alkylamino, ditC.-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl, C3-C7-alkenyl, optionally substituted by fluorine, chlorin~, bromine, iodine, hydroxyl, C,-C6-acyloxy, benzoyloxy, phenoxy, C,-C6-alkoxy, Cl-C5-alkylamino, di(C,-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbarnoyl, C3-C7-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C,-C;6-acyloxy, benzoyloxy, phenoxy, C,-C6-alkoxy, C,-C6-alkylamino, di(C,-C6-alkyl)amino, C,-C6-alkylthio, cyano, carboxyl or carbamoyl, C4-C8-cycloalkyl, optionally substituted by fluorine, chlorine, brornine, iodine, hydroxyl, C1-C6-acyloxy, benzoyioxy, phenoxy, C,-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)arnino, C,-C6-alkylthio, cyano, carboxyl or carbamoyl, C6-cycloalkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C,-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, Cl-C6-alkylamino, di(C,-C5-alkyl)amino, Cl-C6-alkylthio, cyano, carboxyl or carbamoyl, (C,-C6-alkoxy)-(C,-C5-alkyl), [di(C1-C6-alkyl)aminol-(C1-Cs-alkyl) or (C4-C6-cycloalkyl)alkyl, (C6-cyeloalkenyl)alkyl, or arylalkyl, naphthylalkyl or heteroarylalkyl, each of which is substituted by up to five radicals R5 which are independent of one another, it being possible for the alkyl radical to contain in each case 0 to 2 carbon atoms, and where R" and R"' can be linked to each other to form a 4- to 8-membered ring, or 1) preparing compounds of the formula I where X is oxygen and R1, R2, R3 and R4 are as defined under 1) - 4) and R5 is Cl-C8-alkyloxycarbonyl, C1-C8-alkylthiocarbonyl, C2-C~-alkenyloxycarbonyl, C2-C8-alkenylthiocarbonyl, C2-C8-alkynyloxycarbonyl, Cl-C6-alkylaminocarbonyl, C3-C6-alkenylaminocarbonyl, di(C,-C6-alkyl)aminocarbonyi, pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, 4-methylpiperæin-1-ylcarbonyl, optionally substituted by fluorine, chlorine, bromine3 iodine, cyano, amino, mercapto, 30 hydroxyl, C1-C6-acyloxy, ben~oyloxy, benzyloxy, phenoxy, C1-G6-alkoxy, .
2 ~
C1-C6-alkylamino, di(Cl-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsul-fonyl, oxo, thioxo, carboxyl or carbamoyl;
or aryloxycarbonyl, arylthio(carbonyl), arylaminocarbonyl, heteroaryloxycarbonyl, heteroary!thiocarbonyl, hateroarylaminocarbonyl, arylalkyloxycarbonyl, (aryl-5 alkylthio)carbonyl, arylalkylaminocarbonyl, heteroalkyloxycarbonyl, (heteroalkylthio)carbonyl or heteroalkylaminocarbonyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms, by reacting a compound of the formula X\/ll n ~ ~R 3 )( V I I
to ( C H 2 ) n where the definitions mentioned under 1~ - 4) apply to R1, p~2, R3 and R4, n is 0, 1, 2 or 2a 3, X is oxygen and U is a leaving group, with a compound of the formula XVIII
Nu-H ~NIII) where Nu is Cl-C8-alkoxy, C2-Ca-alkenyloxy, C2-C~-alkynyloxy, C,-CB-alkylthio, C2-C8-alkenylthio, Cl-C8-alkylamino- and di(C,-Ca-alkyl)amino, C2-C8-alkenylamino- and di(C1-C6-alkyl)amino, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C,-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C,-C4-alkylthio, pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl- or 4-methylpipera~in-1-ylcarbonyl, optionally substituted by C,-C4-alkyl, C2-C~-alkenyl, C,-C4-acyl, oxo, thioxo, carboxyl or phenyl, or aryloxy, arylthio, arylamino, arylalkyloxy, arylalkylthio, arylalkylamino, 2 ~
heteroaryloxy, heteroarylthio, heteroarylamino, heteroarylalkyloxy, heteroarylalkylthio or heteroarylalkylamino, each of which is ~ubstituted by up to five radicals R6 (R6 is as defined at the outset) which are independent of one another, it being possible for the alkyl radical to contain in aach oase 1 to 3 carbon atoms.
The abovementioned method A preferably proceeds under the following conditions:
The substituent Z in formula lll is a suitable leaving group such as, for example, chlorine, bromine or iodine, a suitable radical of sulfuric acid, an aliphatic or aromatic 10 sulfonate, or optionally halogenated acyloxy.
The reaction is expediently carried out in an inert sol\lent. Suitable solvents are, for example, aromatic hydrocarbons such as toluene or xylene, lower alcohols such asmethanol, ethanol or 1-butanol, ethers such as tetrahydrofuran or glycol dimethyl 15 ether, dipolar aprotic solvents such as N,N-dimethylforrnamide, N-methyl-2-pyrro-lidone, acetonitrile, nitrobenzene, dimethyl sulfoxide, or mixtures of these solvents.
Two-phase systems with aqueous solutions of bases in the presence of a phase transfer catalyst such as, for example, benzyltriethylammonium chlorid~, are also possible.
The presence of a suitable base, for example of an alkali metal carbonate, alkali metal hydrogen carbonate, alkaline earth mstal carbonate or alkaline earth rnetal hydrogen carbonate such as sodium carbonate, calcium carbonate or sodium bicarbonate, of an alkali metal nydroxide or alkaline earth metal hydroxide such as potassium hydroxide 25 or barium hydroxide, an alcoholate such as sodium ethanolate or potassium tert.-butylate, an organolithium compound such as butyllithiurn or lithiumdiisopropylamine, an alkali metal hydride or alkaline earth rnetal hydride such as sodium hydride or calcium hydride, an alkali metal fluoride such as potassium fluoride, or an organic base such as triethylamine or pyridine for scavenging the acid which is liberated 30 during tne reaction, may be expedient.
2 ~
In some cases, the addition of an iodide, for example potassium iodide, is expedicnt.
The reaction is generally carried out at temperaturss between -10 and 160C, preferably at room ternperature.
5 To carry out this reaction, any nucleophilic substihJents such as, ~or example, hydroxyl, mercapto or amino groups, with the exGeption o~ the 1- and/or 4-position in compounds of the formula ll or lll, must, before the reaction is carried out, bederivatized in a suitable manner or provided with conventional protective groups such as, for example, acetyl or benzyl, which can then be eliminated.
The sulfurizing reagent which is preferably used for the reaction as described above under B) is 2,4-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphetane 2,4-disulfide (Lawesson's reagent), bis(tricyclohexyltin) sulfide, bis(tri-n-butyltin) sulfide, bis(triphenyltin) sulfide, bis(trimethylsilyl) sulfide or phosphorus pentasulfide. The 15 reaction is carried out expediently in an organic solvent or in a solvent mixture, at room temperature or above, preferably at the boiling point of the reaction mixture, and, if possible, under anhydrous conditions. Suitable substances are, for example, carbon disulfide, toluene, xylene, pyridine and 1,2-dichloroethane. If the tin sulfides or silyl sulfides which have been mentioned are used, it is advisable to carry out the 20 sulfurization reaction in the presence of a Lewis acid, such as boron trichloride.
In the presence of other carbonyl groups in a compound of the formula 1, for example in a compound where X is oxygen and one or more radicals p~1 to R6 are acyl, thecarbonyl is to be protected by known methods prior to the sulfurization reaction by a 25 suitable protective group, for example by acetalization; subsequent elimination of the protective groups results in the desired compound.
For the reaction described above under C, the substituent Z is a suitable leaving group, preferably chlorine, bromine or iodine, a suitable radical o~ sulfuric acid, an 30 aliphatic or aromatic sulfonate, or optionally halogenated acyloxy.
2~$~
The reaction conditions for this reaction correspond to those of method A.
The cyclization described under D) is effec~ed in a suitabie solvent such as rnethanol, ethanol, N,N-dimethylformamide or N-methylpyrrolidone, in the pres~nce of a base;
S suitable bases are alkali metal carbonates, alkali nnetal hydrogen carbonates, alkaline earth metal carbonates or alkaline earth metal hydrogen carbonates such as sodium carbonate, calcium carbonate or sodium bicarbonate, alkali metal hydroxides or alkaline earth metal hydroxides such as potassium hydroxide or bariu~ hydroxide,alcoholates such as sodium ethanolate or potassium tert.-butylate, organolithium10 compounds such as butyllithiurn or lithium diisopropyiamine, aikali metal hydrides or alkaline earth metal hydrides such as sodium hydride or calcium hydride, or an organic base such as triethylamine or pyridine - the latter substances can also be used as solvents, or organic or mineral acids such as glacial acetic acid, trifluoroacetic acid, hydrochloric acid or phosphoric acid. The reaction is preferably earried out at temperatures between 20 and 120C, particularly preferably at room temperature.
The compounds of the formula V, where R1 to R5 and Y are as defined under 1) - 5), can be obtained from compounds of the formula Vl R n~N H V I
where R', R2 and R5 are as defined under 1) - 4), by alkylation with a compound of the formula Vll ~.
.
2~$~
C O - Y
kR3 V I I
5 where R3, R4 and Y are as defined under 1) - 5) and Z is as defined undar A). The reaction conditions for this alkylation correspond to those given in method A.
Simultaneous cyclization to give the dihydroquinoxaline of the formula I takes place under suitable conditions.
10 Compounds of the formula V in which R', R3 to R5 and Y are as defined under 1) - 5) and R2 is hydrogen can also be prepared from compounds of the formula Vlll R 1 ~XN/~ ( V I I I ) where R', R3 to Rs and Y are as defined under 1) - 5) by reducing ~he nitro group by known processes to the amino group.
Simultaneous cyclization to give the dihydroquinoxaline of the formula I takes place under suitable conditions, for example by carrying out the reduction in the presence of an acid.
The reduction is carried out by standard methods (see, for example, Methoden derOrganischen Chemie [Methods in Organic Chemistry3 (Houben-Weyi), E. Muller (Editor); G. Thieme Verlag, Stuttgart, 1957; Vol. Xl/1, p. 360-490), for example using tin(ll) chloride in glacial acetic acid, TIC13 in hydrochloric acid, or by catalytic hydrogenation, the choice of reagent being determined by the chemical stability of the various substituents R1 and R3 to R5; if, for example, one of the radicals is alkenyl, the first method will be selected to obtain the double bond.
;
The phenylenediamines of the formula Vl which are required as startin0 materials for the syntheses described are known from the literature or commercially available or can be synthesized by methods known from the literature.
5 N-ortho-nitrophenylamino acid derivatives of the formula Vlll, where Rln and R3 to Rs are as defined under 1) - 4) and Y is oR7, where R7 is hydrogen, C,-C6-alkyl, optionally in each case for example halo~en-substituted phenyl, benzyl or 9-fiuorenylmethyl, can be obtained for example by amination of ortho-halonitro aromatic substances of the formula IX
,~N 2 R n~ t ll I x ~w where R' is as defined under 1) - 4) and W is fluorine, chlorine, bromine or iodine, with 15 amino acids or their esters of the formula X
~R~ X
R S
where R3, R4, Rs and R7 are as defined under 1) - 5). The reaction can be carried out in the presence of an inorganic or organic auxiliary base such as, for exampie, sodium carbonate, potassium carbonate, sodium hydroxide or triethylamine. It is advantageous to use an inert solvent at temperatures between 0 and 150C, preferably at reflux temperature. Suitable solvents are open-chain or cyclic ethers, for example tetrahydrofuran or glycol dimethyl ether, aromatic hydrocarbons, for example toluene or chlorobenzene, alcohols, for example ethanol, isopropanol or glycol monomethyl ether, dipolar aprotic solvents, for ~xample N,N-dimethylformamide, N-methyl-2-pyrrolidone or 1,3-dimethyl-tetrahydro-2~1H)-pyrimidinone.
2 ~
The N-ortho-nitrophenylamino acids of the formula Vlll where Y is hydroxyl can, if desired or necessary, be converted by well-known standard methods into the acid derivatives of the formula Vlll where Y is hydroxyl, C:1-C4-alkoxy, optionally halogenated C,-C4-acylo)ty, chlorine, bromine or iodine.
Ortho-halonitroaromatic compounds of the formula IX and amino acids of the formula X are known from the literature and comrnercially available or can be prepared by methods known from the literature.
The reaction described above under E) is preferably effected by means of catalytic hydrogenation (using hydrogen) or hydrosilylation (using alkylsilanes, for example diphenylsilane) in the presence of a hydrogenation ca~alyst, for example Raney nickel or palladium-on-charcoal, at a hydrogen pressure of 1 to 5 bar, or by means of areducing agent from the class of the complex metal hydrides such as sodium borohydride or sodium cyanoborohydride, or using metals, or metal salts, and acid such as, for example, zinc/glacial acetic acid or SnCI2/HCI. It is advantageous to carry out the reaction in an inert solvent such as lower aicohols, for example methanol or isopropanol, ethers such as tetrahydrofuran or glycol dimethyl ether, dipolar aprotic solvents such as N,N-dimethylformamide, aromatic hydrocarbons such as toluene orxylene, or mixtures of these solvents, at temperatures between -20 and 100C, preferably at room temperature.
If a chiral hydrogenation catalyst, for example di-/u-chloro-bis[(cycloocta-1c,5c-diene~-rhodium(l)]/(~) or (-)-4,5-bis-(diphenylphosphinomethyl)-2,2-dimethyl-1,3-dioxolane, or a chiral complex metal hydride, for example sodium tris-lN-benzyloxycarbonyl-L-prolinoyloxy)-borohydride, are used in the above-described reaction, the individual enantiomers can be prepared selectively.
If, in compounds of the formula Xl, substituents are present which can be hydrogenated or reduced under the above-described conditions, for example oxo, it is 2 ~
necessary to use an intermediate of the formula Xl with substituents which are not attacked, but which can be derivatized to give the ~roup raquired, for example hydroxyl. The substituents can also be provided with a customary protective group, for example an acetal protective group, which can then be removed after th~ above-des-5 cribed reaction.
Quinoxalinones of the formula Xl where R1 to R3 are as defined uncler 1) - 4) can be obtained by known processes by condensing a phenylenediamine of the formula Vl, where R' and R2 are as defined under 1) - 43 and Rs is hydrogen, with an alpha-10 ketocarboxylic acid of the formula Xll R3-Co-CooH (Xll) where R3 is as defined under 1) - 4).
15 The reaction is expediently carried out in an inert solvent in a temperature range of between 0 and 150C; examples of suitable solvents are alcohols, for exampls ethanol or isopropanol, open-chain or cyclic ethers, for example glycol dimethyl ether or tetrahydrofuran, or dipolar aprotic solvents, for example N,N-dimethylformamide or acetonitrile.
2~
The reaction described above under F) is expediently carried out in a two-phase system cornposed of an organic solvent or solvent mixture which is not miscible with water, composed of, for example, halogenated hydrocarbons, for example dichlorornethane or 1,2-dichloroethane, or aromatic hydrocarbons, for example toluene 25 or xylene, and a concentrated aqueous solution of an alkali metal hydroxide or alkaline earth metal hydroxide, for example sodium hydroxide or barium hydroxide. The presence of a phase transfer catalyst such as, for example, benzyltriethylammonium chloride or tetrabutylammonium ~romide, is advantageous.
The reaction is usuaily carried out at temperatures be~ween 0 and ~0C, preferably at 30 room temperatur~.
2 ~
Substituents in compounds of th~ ~ormulae Vl and Xlll, or XIV, which arc not stable under the reaction conditions must be replaced by those which can be derivatized to the required group. The substituents can also be provided with a customary protective group which can then ~e removed a~ter the above-described reaction.
In the reaction described above under G), Z in formula XV is a suitabl~ leaving group such as, for example, chlorine, bromine or iodine, a suitable sulfuric acid radical, an aliphatic or aromatic sulfonate, or optionally halogenated acyioxy.
10 The reaction conditions for this reaction correspond to those in method A.
The reaction described under H) is preferably effected by catalytic hydrog0nation (using hydrogen) in the presence o~ a hydrogena~ion catalyst, for example palladium-on-charcoal, at a hydrogen pressure of 1 to 5 bar, or by means of a reducing agent 15 from the class of the complex metal hydrides, such as sodium borohydride, sodium triacetoxyb¢rohydride or sodium cyanoborohydride.
The reaction is expediently carried out in an inert solvent, sur,h as lower alcohols, for example methanol or isopropanol, ethers, for example tetrahydrofuran or glycol 20 dimethyl ether, halogenated hydrocarbons, ~or example dichloromethane or dichloroethane, at temperatures between -20 and 100C, preferably at room tempera-ture. The presence of an acid such as, for example, acetic acid or trifluoroacetic acid, or of a Lewis acid such as, for example, titanium tetrachloride, is advantageous. If, in compounds of the formulae I and XVIJ substituents are pres~nt which can be 25 hydrogenated or reduced under the above-described conditions, for example oxo, the use of an intermediate of the formulae I and XVI with substituents which are notattacked but which can be derivatized to the required group, for example hydroxyl, is necessary. Acid-labile groups such as, for example, acetals, or groups which react under the reaction conditions, such as, ~or exarnple, primary amines, are also ~o be 30 avoided or to be provided with a customary protective group.
2 ~
The reaction described under 1) is expediently carried ou~ in an inert solvent. Examples of suitable solvents are aromatic hydrocarbons such as toluene or xylene, lower alcohols such as methanol, sthanol or 1-butanol, ethers such as tetrahydrofuran or glycol dirnethyl ether, dipolar aprotic solvents such as N,N-dimethylformamide, N-methyl-2-pyrrolidone, acetonitrile, nitrobenzene, dimethyl suHoxid~, or mixtures of these solvents. Two-phase systems wlth aqueous solutions of bases in the presence of a phase transfer catalyst such as, for example, benzyltriethylamrnonium chloride, are also possible.
The presence of a suitable base, for example an alkali metal hydroxide or alkaline earth metal hydroxide such as potassium hydroxide or barium hydroxide, of an alcoholate such as sodium ethanolate or potassium tert~-butylate, an or~anolithium compound such as butyllithium or lithium diisopropylamide, an alkali metal hydride or alkaline earth metal hydride such as sodium hydride or calciurn hydride, an alkali metal fluoride such as potassium fluoride, or an organic base such as triethylamine orpyridine, may be useful. The reaction is usually carried out at temperatures between -10 and 160C, preferably at room temperature.
To carry out this reaction, any nucleophilic ~ubstituents in compounds XVII and XVIII
which do not participate in the reaction, such as, for example, hydroxyl, mercapto or arnino groups, are to be derivatized in a suitable manner or to be provided withcustomary protective groups such as, for example, acetyl or benzyl, which can then be eliminated.
The compounds XVII which are required for the abovementioned reaction and in which the definitions described under 1) - 4) apply to R', p~2, R3 and R4, n is 0, 1, 2 or 3, X is oxygen and U is a suitable leaving group, halogen ~uch as, for example, chlorine, bromine, iodine, a halogenated aliphatic or aromatic alcoholate such as, for example, 2,2,2-trichloroethoxy, chlorophenoxy, or ~ heterocycle which is linked via nitro~en such as, for example, imidazolyl, tria~olyl or benzotri~olyl, are prepared by reac~ing a compound of the formula I where Rs is hydrogen and X is oxygen, and the definitions 2 ~ 8 ~
~4 described under 1) - 4) apply to R', R2, R3 and R4, with a suitable carbonic acid derivative, for exarnple phosgene, diphosgene, triphosgene, trichloroethyl chloroformate or carbonyldiimidazole, or with a suitable halo carbonyl halide, for example bromoacetyl chloride.
The reaction is expediently carried out in an inert solvent. Examples of suitable solvents are aromatic hydrocarbons such as toluene or xylene, ethers such as tetrahydrofuran or glycol dimethyl ether, or halogenated hydrocarbons such as dichloromethane or dichloroethane.
The presence of a suitable base, for exarnple of an alkali metal hydroxide or alkaline earth metal hydroxide, such as potassium hydroxide or bariurn hydroxide, or an organic base such as triethylamine or pyridine, may be useful.
15 The reaction is usually carried out at temperatures be~veen -30 and 16ûC, preferably at room temperature.
The present invention furthermore relates to the compounds as described under 1) to 4) as pharmaceuticals, preferably for treating viral diseases, in particular diseases 20 caused by HIV.
The invention furthermore relates to pharrnaceuticals comprising at least one compound according to the invention, and to the use of the abovementioned compounds for the preparation of pharmaceuticals, preferably for the treatment of viral 25 diseases, in particular for the treatment of diseases caused by HIV.
The present invention furthermore relates to the use of compounds of the abovementioned formula I or IA in which 2 ~ 8 ~
~5 n is zero, one, two, three or four, the individual substituents R1 independentiy of one another are fluorine, chlorine, bromine, iodine, ~rifluoromethyl, trifluoromethoxy, hydroxyl, C,-C8-alkyl, Cs-C8-cycloalkyl, C1-C6-alkoxy, (C,-C6-alkoxy)-(Cl-C;4-alkXY3, C1-C6-alkylthio, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, nitro, amino, æido, C1-C6-alkylamino, di(C,-C6-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, thiomorpholino, imidazolyl, triazolyl, tetrazolyl, C1-C6-acyl, C1-C6-acyloxy, C1-C6-acylamino, cyano, carbamoyl, carboxyl, (C,-C6-alkyl)oxycarbonyl, hydroxysulfonyl, sulfamoyl 1~
or a phenyl, phenoxy, phenoxycarbonyl, phenylthio, phenylsulfinyl, phenylsulfonyl phenoxysulfonyl, phenylsulfonyloxy, anilinosulfonyl, phenylsulfonylamino, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which is substituted by up to five radicals R6 which are independent of one another, where R6 can be fluorine, chlorine, bromine, iodine, cyano, trifluoromethyl, trifluoromethoxy, nitro, amino, azido, C,-C6-alkyl, C3-C8-cycloalkyl, C1-C:6-alkoxy, C1-C6-alkylthio, C1-Cs-alkylsulfinyl, C;l-C6-alkylsulfonyl, C,-/:~6-alkylamino, di(C,-C6-alkyl)amino, (Cl-C6-alkyl)oxycarbonyl, phenyl, phenoxy, 2-, 3- or 4-pyridyl, 2~6~5 R2 and R5 are identical or different and independently of one another are hydrogen, hydroxyl, C,-C6-alkoxy, aryloxy, Cl-C6-acyloxy, cyano, amino, C,-C6-alkylamino, di(C1-C6-alkyl)amino, arylamino, C,-C~-acylamino, Cl-C8-alkyl,optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyi, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, Cl-C~-alkoxy, C,-C6-alkylamino, di(C1-C6-alkyl)amino, C,-C6-alkylthio, C,-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
C2-Ca-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C,-C6-alkyl)amino, C,-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl and carbamoyl;
C3-C~,-allenyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C3-CB-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, m0rcapto, hydroxyl, C,-Cs-acyloxy, benzoyloxy, ben7yloxy, ph~noxy, Cl-C6-alkoxy, Cl-C6-alkylamino, di(C1-C6-alkyl)amino, C,-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
C3-CB-cyClOalkyl~
optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, 2~3~
~7 Cl-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C,-C~-alkylamino, di(C,-C6-alkyl)amino, C1-C6-alkylthio, Cl-C6-alkylsulfonyl, phenylsuKonyl, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine, chiorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C;6-alkoxy, Cl-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsul~onyl, oxo,thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkyl)-(C1-C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1 C6-alkylthio, Cl-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkenyl)-(C1-C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C:1-C6-alkoxy, C,-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsuHonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
~5 C1 -C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C;6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkyiamino, 2 ~
di(C1-C6-alkyl)amino, C1~C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
C2-C8-alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl,C,-C4-alkoxy, oxo, phenyl;
(C3-C8-cycloatkyl)carbonyl, op~ionally substituted by fluorine, chlorin~ or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C8-cycloalkenyl)carbonyl, optionally substituted by fluorine~ chlorine or hydroxyl, C1-C4-alkoxy, oxo, pnenyl;
(C3-Ca-cycloalkyl)-(C1-C3-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C6-cycloalkenyl)-(Cl-C3-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C8-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(Cl-C4-alkyl)amino, C1-C4-alkylthio;
C2-Ca-alkenyloxycarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C,-C4-alkoxy, oxo, phenyl;
C2-Ca-alkynyloxycarbonyl, op~ionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C8-alkylthiocarbonyl, optionally substituted by ~luorine, chlorine, hydroxyl,C1-C4-alkoxy, oxo, phenyl;
2 ~
C2-C0-alkenylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, Cl-C4-alkoxy, oxo, phenyl;
C1-C~-alkylarnino- and di(C1-Ca-alkyl)aminocarbonyl, in each cas~ optionally substituted by fluorine, chlorine, hydroxyl, Cl-Cs-alkoxy, oxo, phenyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1-ylcarbonyl, in each case optionally substituted by C1-C4-alkyl, C2-~6-alkenyl,C,-C4-acyl, oxo, thioxo, carboxyl, or phenyl;
C2-C8-alkenylamino- and di(C1-C6-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C,,-alkoxy, oxo, phcnyl;
C1-C6-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C~-C4-alkoxy, oxo, phenyl;
C1-C6-alkenylslilfonyl, optionally substituted by fluorine, chlorine, hydroxyl, Cl-C4-alkoxy, oxo, phenyl;
or aryl, arylcarbonyl, aryl(thiocarbonyl), (arylthio)carbonyl, (arylthio)thiocarbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino)thiocarbonyl, arylalkylaminocarbonyl, arylsulfonyl, arylalkyl, arylalkenyl, arylalkynyl, arylalkyl-carbonyl, arylalkenylcarbonyl, ary1alkoxycarbonyl or aryl~alkylthio)carbonyl, each of which is substituted by up to five radioals R6 which are independent ~f one another, it being possible for the alkyl radical to contain in each case 1 to 5 carbon atoms, and R6 being as defined above, or heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkylcarbonyi or heteroarylalkenylcarbonyl, heteroaryloxycarbonyl, (het~roarylthio)carbonyl, heteroarylaminocarbonyl, heteroarylalkyloxycarbonyl, 2 ~
heteroaryl(alkylthio)carbonyl or heteroarylalkylaminocarbonyl, each of which is substituted by up to three radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms, R3 and R4 are identical or different and, independently of one another~ are hydrogen, C,-C8-alkyl which is optionally substituted by fluorine, chlorine, hydroxyl, amino, mercapto, C,-C~-acyloxy. benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C1-C4-alkylamino, di~C1-C4-alkyl)amino, Cl-C"-alkylthio, Cl-C4-alkylsulfonyl, Cl-C4-alkylsulfinyl, carboxyl or carbarnoyl;
C2-C8-alkenyl, optionaliy substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, ben~yloxy, phenoxy, Cl-C4-alkoxy, Cl-C4-alkylamino, di(Cl-C4-alkyl)amino, C1-C4-alkylthio, C,-C4-alkylsulfonyl, Cl-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-Ca-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyl, amino,mercapto, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C,-C4^
alkylamino, di(C,-C4-alkyl)amino, Cl-C4-alkylthio, C,-C4-alkylsulfonyl, C,-C4-alkylsulfinyl, carboxyl or carbamoyl C3-CB-cycloalkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C,-C~,-acyloxy, benzoyloxy, bsnzyloxy, phenoxy, C,-C4-alkoxy, C,-C,,-alkylamino, di(Cl-C4-alkyl)amino, S:~l-C4-alkylthio, Cl-C4-alkylsulfonyl, Cl-C4-alkylsulfinyl, carboxyl or carbamoyl;
aryl, arylalkyl, heteroaryl or heteroarylalkyl, each of which is substituted by u,p to five radicals R6 which are independent of one another, it being possibi~ for thealkyl radical to contain 1 to 3 carbon atoms in eaeh case, and R6 bein0 as defined above, 2 ~
R3 and R4 or R3 and R5 can furthermore aiso be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 8 carbon atoms and which can optionally be substituted by fluorine, chlorine, hydroxyl, amino, C1-C6-alkyl, C2-CB-alkenyl, C2-C6-alkynyl, C,-C6-acyloxy, benzoyloxy, C1-C6-alkoxy, oxo, thioxo, carboxyl, carbamoyl or phenyl, X is oxy~en, sulfur, selenium or substituted nitrogen N-P~2, it being possible for R2 to have the abovementioned meanings, for the preparation of pharmaceuticals ~or the treatment of viral diseases.
The compounds mentioned and elucidated above under 1)-4) are preferred for this use.
The pharmaceuticals according to the invention can be aclministered enterally (orally), parenterally (intravenously), rectally, subcutaneously, intramuscularly or locally (topically).
They can be administered in the form of solutions, powders, (tablets, capsules including microcapsules), ointments (creams or gels) or suppositories. Suitable ad~uvants for such formulations are the liquid or solid fillers and extenders, solvents, emulsifiers, glidants, flavorings, colorings and/or buffer substances which are customary in pharmacology.
0.1 - 10, pr~erably 0.2 - 8 mg/kg of body weight are administered on~e or several times daily as an expedient dosage. The dosage units used depend expediently on the specific pharmacokinetics of the substanc~ usecl, or on the pharmaceutical formulation used.
2 ~
For example, the dosage unit of the compounds according to the invantion is 1 - 1500 mg, preferably 50 - ~00 mg.
The compounds according ~o th0 invention can also be administered as a combination with other antiviral agents such as, for example, nucleoside analogs, protease inhibitors or adsorption inhibitors, immunostimulants, interferons, interleukins and colony-stimulating factors ffor example (àM-CSF, G-CSF, M-CSF).
Activity tests Test of preparations against HIV in cell culture Description of method Medium:
RMPI pH 6.8 Complete medium additionally contains 20% fetal calf serum and 40 IU/ml recombinant interleukin 2.
Cells:
Lymphocytes which have been isolated frorn fresh donor blood by means of Ficoll~gradient centrifugation are cultured for 36 hours in complete medium with an addition of 2 ,L~g/ml phytohemagglutinin ~IVellcome) at 37C under 5% of CO2. A~ter 10% of DMSO has been added, the cells are frozen at a density of 5 106 and stored in liquid nitrogen. For the test, the cells are defrosted, washed in RPMI medium and cul~ured for 3 - 4 days in the complete medium.
Mixture:
The test preparations were dissolved in DMSO at a concentration of 16.7 mg/ml and diluted in complete medium to 1 mg/ml.
0.4 ml of medium was introduced into 24-multiwell dishes. 0.1 ml of ~he dissolvsd 2~6~9~
preparation was ad~ed to the upper row of the dish, and, by transferring 0.1 ml portions, a geometric dilution series was established. Controls without preparation always contained 0.4 ml of complete medium containing 0.5% of DMSO. Lymphocyte cultures with a cell density of 5 ~ 105 cells/ml were infected by adding 1/50 volume 5 supernatant from HlV-infected Iymphocyte cultures. The titer of these culture supernatants was determined by end-point titration as 1 5 106 infectious units/ml.
After 30 minutes' incubation at 37C, the infected Iymphocytes were removed by centrifugation and taken up in an equal volume of medium. From this cell suspension, 0.6 ml aliquots were transferred into all wells of the test plate. The mixtures were 10 incubated for 3 days at 37C.
Evaluation:
The infected cell cultures were examined under the microscope for the presence of giant cells, which indicate active virus multiplication in the culture. The lowest 15 concentration of preparation where no giant cells were observed was de~ermined as inhibitory concentration against HIV. As a control, the supernatants from the culture plates were tested for the presence of HIV antigen with the aid of an HIV antigen test following the manufacturer's instructions (Organon).
20 Results:
The results from this test are shown in Table 1.
Compound ofT-cell oulture assay Examp e No. MIC (ug/ml) ~ .
IV >0,8 _ _ Vl-A 0,16 2~$~85 _ _ Compound of T-cell culture assay Example No. MIC ~ug/ml) Vl-B 20 ¦
Vl-C < 0,8 Vll < 0,16 X 0,8 Xll < 0,8 Xlll < 0,16 . . _ ^11 XIV <0,16 3-7 0,08 ~1 3-21 0,16 . 11 3-23 0,08 3-24 0,08 3-25 0,4 3-26 0,4 ._ 3-29 < 9,4 3-30 . _ 3-32 < 0,4 3-33 -- 0,4 3-36 < 2,0 3-44 ' __ 2 ~ 5 _ ~ I
Compound of T-cell culture assay ¦ Example No. MIC Cug/ml) 3-48 <0,8 3-49 0,8 3-52 >0,8 __ 1 3-53 > 0,8 3-57 < 0,8_ 3-62 ~4,0 3-64 > 0,8 3-66 > 0,08 3-67 < 0,8 3-73 > 0,4 3-75 <0,8 3-76 ~ 0,08 3-80 ~,4 ¦ 3-81 0,08 3-87 > D B
3-88 - 0,8 XX <4,0 6-1 0,4 6-16 0,3 Compound of T-cell cul~ure assay Example No. ~ MIC ~g/ml) 6-17 < 0,8 6-19 < 0,8 6-20 <0,8 6-22 > 0,8 _ 6-27 < 0,4 6-32 c 0,08 6-33 > 0,8 6-34 ` - < 0,4 ¦ 6-35 < D,08 6 33 0,8 L 6-39 0,4 6-50 < 0,01 I
XXIII 0,01 l 7-1 < 0,16 7-2 < 0,01 _ I
7-3 ~ 0,01 I
1 7-7 0,04 ¦ 7-1 D ~ 0,04 ~7 2~p~
_._ . .
Compourld of T-cell culture assay Example No. MIC ~ug/ml) 7-11 < 0,01 7-12 < 0,8 ¦
7-13 < 0,08 7-14 < 0,08 7-16 0,4 7-21 < 0,01 ... . .. . _ ~
7-22 < 0,01 ¦ 7-23 < 0,01 10-4 0,4 10^5 < 0,8 10-9 < 0,8 . .
_ . .. _ .. . . . _ 10-10 0,08 10-13 0,08 10-14 < 0,8 10-17 0,~
10-18 ~ 0,8 10-20 _ ~_0,8 ~0-2~ < 0,~ _ 10-27 0,8 2~9~
. .__ Compound of T-cell culture assay Example No. MIC Gug/ml) 10-28 < 0,8 11-1 < 0,8 11-2 > 0,8 11 4 < 0,8 ._ 11 -11 0,01 Assay of the substances for HIV reverse transcriptase inhibition The activity of reverse transcriptase (RT) was determined with the aid of a scintillation proximity assay (SPA).
The reagent kit for the RT-SPA was obtained from Amersham/Buchler (Braunschweig).
The enzyme RT (from HIV cloned in E. coli) originated from HT-Biotechnology Ltd,15 Cambridge, UK.
Mixture The assay was carried out using the manufacturer's (Amersham) protocol manual, 20 with the following modifications:
- bovine serum albumin was added to the assay buffer to give an end concentration of 0.5 mg/ml 2 9 ~
- the assay was carried out in Eppendorf reaction vessels, using 100 ~JI volume per batch - the manufacturer's RT concentrate (5000 U/ml) was diluted in Tris-HCI buffer 20 mM; pH 7.2; 30% of glycerol, to an activity of 15 U per ml - the incubation time for ~he mixtures was 60 minutes (37C) - after stopping ~he reaction and ~developing~ with the bead suspension, 130 ,ul of mixture were transferred to 4.5 ml of Tris-HCI buffer, 10 mM; pH 7.4; 0.15 M
NaCI, and the tritium activity was measured by means of a -counter.
Assay For a pre-assay for inhibitory activity, the substances were dissolved in DMSO (stock solution c = 1 mg/ml), and tested as a 101, 102, 103, etc., dilution in DMSO.
To determine IC50 values, the inhibitor stock solutions were diluted further in Tris-HCI
buffer, 50 mM, pH 8, and tested in suitable concentrations.
The concentration corresponding to a 50% enzyme inhibition was determined from aplot of RT activity versus log Cjnh.
The test results are shown in Table 1a.
.
:
2 ~
Table 1a Compound of Reverse Transcriptase Assay Example No. ICso ~u9/ml) V - ~ 7,5~
Vl-A 0,08 Vl-C 0,8 Vll 0,1 Xlll 0,04 I
XIV 0,16 3-23 0,1 -1 I _ _ _ I
3-24 0,1 - 1 3-25 0, 1 -1 I
1 3-29 0,1-1 3-30 0,025 3-32 approx. 0,1 _ _ 3-36 0,1 -1 _ _ 3-49 approx. 1 . _ _ _ _ 3-57 approx. 1 3-75 ~ -I _ 1 3-76 0,~18 ¦ 3-~1 approx. 1 . ~
2~98~
Compound ofReverse Transeriptase Assay ¦Example No.IG50 ~ug/ml) 6-1 approx. 1 I . . . .. I
6-8 0l1 -1 6-9 approx. 1 ~_ 6-16 approx. 1 6-1 7 0,1 -1 .. . .... . . ___ 6-27 approx. 1 6-35 0,1 - 1 6-50 0,01-0,1 XXIII 0,025 7-1 0,08 7-2- --~-~ 0,07 ~
7-3 0,07 _ . _ 7-7 0,1 7-10 0,1 1 7-11 0,01 . .. _ .
7-12 approx. 1 _ . e _ r 7-13 0,1 -1 _ .
7-16 appro)t. 1 10-9 _pprox.
2 ~ 5 _ ..... _ _ _ Compound of Reverse Transcriptase Assay Example No. ICso ~ug/ml) . .
10-10 approx. 1 . ............. _ 10-13 approx. 1 10-17 approx. 1 .. _ I
10-18 0,1 -1 1 0-20 0, 1 -1 . .
1 0-21 0, 1 -1 10-27 0,1 -1 10-28 0,1 - 1 11-11 0,1 - 1 10-34 0,1 -1 11-6 0,1 - 1 0,1 - 1 11-7 approx. 1 11-13 approx. 1 1 5 7-20 0, 1 -1 7-14 0,01 - 0,1 . ...
7-15 0,01 - 0,1 7-17 0,01 - 0,1 7-18 0,01 - V,1 2 ~ 8 ~ .
¦ Compound of Reverse Transcriptase Assay lExample No ICso ~ug/ml) ¦ 7-19 0,01 - 0,1 I
¦ 7-21 0,01 - 0, l I
¦ 7-22 0,01 - 0,1 I _ ¦ 7-23 0,01 - 0,1 ¦ 3-34 0, 1 -1 I
¦ 3-35 0, 1 -1 ¦ 3-37 0, 1 -1 3-7 0,08 I _ ¦ 3-127 0,01 - 0,1 3-128 0,01 - o,1 3-129 0,01 - 0,1 7-24 < 0,01 7-25 < 0,01 7-26 0,01 0,1 1 5 7-27 0, 1 -1 7-28 < 0,01 _ _ 7-29 0,01 - 0,1 7-30 < 0,01 . _ _ 7-31 ~ ~,Ot 20 ICsO = 0.08 ~ug/ml . , ~
2 ~
The examples which follow and the content of the patent claims illustrate the present invention in greater detail.
5 Example I
(3S)-6-Chloro-3-methyl-3,4-dihydroquinoxalin-2(1 H)-one A) (S)-N-(3-Chloro-6-nitrophenyl)alanine 2,4-Dichloronitrobenzene ~21.0 y, 0.109 mol) and 23.0 g (0.258 mol) of L-alanine were refluxed for 48 hours in 400 ml of 2-methoxyethanol with an addition o~ 120 rnl of 2N
sodium hydroxide solution. The mixture was subsequently concentrated in vacuo, and the residue was taken up in aqueous sodium hydrogen carbonate solution. the mixture was extracted three times using ethyl acetate, the extract was then acidified wlth 6N
15 hydrochloric acid, and the yellow product was extracted using ethyl acetate. The organic phase was washed once with saturated aqueous sodium chloride solution and dried (magnesium sulfate), and the solvent was removed under reduced pressure.
14.7 g (55%) of a yellow solid of melting point 167-169C remained (after crystallization from ethyl acetate).
1H NMR (270 MHz, d6-DMSO): ~ = 1.47 (d, J = 7 Hz, 3 tl), 4.57 (quintet, J = 7 Hz, 1 H), 6.77 (dd, J = 9, 2 Hz, 1 H), 7.11 (d, J = 2 Hz, 1 H), 8.12 (d, J = 9 Hz, 2 H), 8.41 (br. d, J = 7 Hz, 1 H), 13.2 pprn ~br., 1 H).
MS: (M + H)~ - 245 B) (3S)-6-Chloro-3-methyl-3,4-dihydroquinoxalin-~1H)-one The product of Example IA (14.0 g, 0.057 mol) was dissolved in 400 ml of methanot and hydrogenated with Raney nickel catalysis at room temperature, using 1 atm hydrogen. After the calculated amount of hydrogen had been taken up, the catalyst 30 was removed by filtration with suction, and the reaction solution was concentra~ed in 2 ~
vacuo. The residue was puri~ied by silica gel chromatography using ethyl acetate/heptane = 1:2 and 1:1 as the eluent. The yield was 6.0 g (53%) of a brownish solid of melting point 122-123C ~after reerystallization from isopropanol/heptane).
'H NMR (60 MHz, d6-DMSO): ~ = 1.23 (d, J = 11 H~, 3 H), 3.~1 (dq, J = 11, 4 Hz 1 H), 6.27 (br., 1 H), 6.3 - ~.9 (m, 3 H), 10.3 ppm (br., 1 H).
MS: (M + H)~ = 197 [~]D23 = +77.3 (c = 1, MeOH) C) ~3R)-6-Chloro-3-methyl-3,4-dihydroquinoxalin 2(1H)-on~
The compound was prepared from D-alanine by the methods described under Example IA and IB. Melting point 123-124C (after recrystallization frorn isopropanol/heptane) The NMR data agree with those of the compound described in Example IB.
[a]D23 = -81.0 (c = 1, MeOH) D) (3RS)-6-Chloro-3-methyl-3,4-dihydroquinoxalin-2(1H)-one The compound was prepared starting from D,L-alanine by the methods described in 20 Examples IA and IB. Melting point 110C (after recrystallizati~n from isopropanol/heptane) The NMR data agree with those of the compound described in Example IB.
The fsllowing compounds of the formula i were synthesized analogously using the 25 corresponding haloaromatic compounds and ~rnino acid derivatives:
2~$~
Example ll (3S)-3-Benzyl-7-chloro-3l4-dihydroquinoxalin-2(1 H)-one A) (S)-N-(4-chloro-2-nitrophenyl)-phenylalanine L-Phenylalanine (8.3 9, 0.05 mol) and 4.8 g (0.025 mol) of 2,5-dichioronitrobenzene were dissolved in 40 ml o~ anhydrous dimethyl sulfoxide (DMSO), and the stirred solution was heated to 80C under an argon atmospher Potassium tert.-butylate (4.2 9, 0.025 mol), dissolved in 30 ml of DMSO, was added dropwise in the course of 40 minutes. Stirrina was continued for 3 hours at 8û to 90C, the mixture was allowed to cool, and unreacted phenylalanine was removed by filtration with suction and washed with water. The collected alkaline filtrates were extracted twice using diethyl ether to remove unreacted dichloronitrobenzene. The mixture was then acidified using glacial acetic acid and extracted several times using cthyl acetate, and the extracts were dried over magnesium sulfate and evaporated.
The product was obtained in the form of a red oil (6.7 9, ~4%), which was further reacted without purification.
B) (3S)-3-Benzyl-7-chloro-3,4-dihydroquinoxalin-2(1H)-one The product of Example IIA (12 g) was dissolved in 300 ml of anhydrous methanol and hydrogenated at room temperature with palladium/charcoal catalysis, using 1 atm hydrogen. When the reaction had ended, solids were filtered off with su~tion, the liquid 25 was concentrated, and the concentrate was ehromatographed on silica gel usingdiisopropyl ether as the eluent. This gave 1.32 ~ of the desired product which crystallized from isopropanol, melting point 185~.
2 ~ 8 ~
1H NMR (270 Mtlz, d6-DMSO): ~ = 2.9 (m, 2 H), 4.08 (m, 1 H), 6.09 (d, 1 H), 6.7 (m, 2 H), 6.78 (m, 1 H), 7.2 (m, 5 H), 10.34 pprn (br. s, 1 H).
MS: (M + H)~ = 273, (M - 92)' = 181.
5 The compounds in Table 2 were prepared as described in the ~bove examples.
Table 2 H
I
R l n~ ~ H
. ~ ~
Nr. R~n R3 Rs M.P. C
1 ~-CI CH3 H Wax 6-CI C2Hs 120 . _ _ 6-CI -CH2cH2~O-6-CI (CH3)2CH H
_ .
6-CI ~CH3)2CH( ~H2 H Oil 6-Ci C2Hs(CH3)CH Oil 6-C;1 C6HsCH2 _ _ _156-157 2~6~9~3 - -Nr. Rln R3 Rs M.P. C
_ .__ ..
.. __ . ...... _ 11 6-CI CH2(OH) H _ .
13 7-Ci CH3 il 142 14 7-CI (CH312CH H
.. . ._ ~_ ~
_ 17 6,7-CI2 CH3 H
1E~ 7-F CH3 H 230 ~ ___ .
19 6-F CH3 H Wax 6-F CH3 C3Hs 182 21 6-F C6HsCH2 ~3Hs 23 6-CH3Oc2H4O C2Hs H 107 _ . . .
. ~, . . .
6-CI CH2-S-Bn __ 170 26 6-CI CH2-S-i.-Pr H 190 _ 27 6-CI CH2O-t.-Bu H 12E~
_ ._ 28 6-CI C,~tl9 ==-. 115 2 ~
Bn = benzyl i-Pr = isopropyl t-Bu = tert.-butyl Example lll (3S)-4-N-(Benzyloxycarbonyl)-6-chlors -3-methyl-3,~-di-hydroquinoxalin-2(1 H)-one The compound of Example IB (1.0 9, 5.1 mmol) was dissolved in 2D ml ~
dichloromethane. 10 ml of 2N aqueous sodium hydrogen carbona~e solution were added, and 0.9 ml (90%; 5.7 mmol) of benzyl chloroformate was added with ice-cooling and vigorous stirring. The two-phase system was subsequently stirred for60 hours at room temperature. After 30 hours, another 0.2 ml (1.3 mmol) of benzyl 15 chloroformate was added. When the reaction was complete, the phases wsre separated, the organic phase was washed once with water and dried (magnesium sulfate), and the solvent was rernoved in vacuo. The product was purified by silica gel chromatography with methyl tert.-butyl ether/h~ptane = 1:1 as the eluent This gave 1.65 g (98%) of a white, foam-like product.
'H NMR (270 MHz, d6-DMSO): ~ = 1.15 (d, J = 7 Hz, 3 H), 4.85 (q, J = 7 Hz, 1 H), 5.20 (d, J = 12 Hz, 1 H), 5.27 (d, J = 12 Hz, 1 H), 6.97 (d, J = 7 Hz, 1 H), 7.19 (dd, J = 8.2 Hz, 1 H), 7.3 - 7.45 (m, ~ H), 7.67 (d, J = 2 Hz, 1 H), 10.81 ppm (br- s, 1 H).
MS: (M + H)~ = 381 2~
Example IV
(3S)-4-N-(Benzyloxycarbonyl)-6-Chloro-3-methyl-8-nitro-3,4-dihydroquinoxalin-2(1 H)-one The compound of Example lll (1.5 9, 4.5 mmol) was nitrat~d in glacial ac~tic acid (15 ml). A to~al of 5 rnl (124.3 mmol) of fuming nitric acid were added dropwise in 2 ~ 8 ~
the course of 4 hours at O~C to room temperature. The mixture was subsequently poured into 100 ml of ice-water, and the product, whioh was obtained in the form of a yellow solid, was filtered off, washed thoroughly wlth water, and dried. Melting point 85C (subl.).
'H NMR (270 MHz, d6-DMSO): ~ - 1.22 (d, J = 8 Hz, 3 H3, 4.89 (q, J = 8 Hz, 1 H), 5.24 (d, J = 12 Hz, 1 H), 5.31 (d, J = 12 Hz, 1 H), 7.35 - 7.~ (m, 5 H), 7.69 (s, 1 H), 8.Q0 (s, 1 H), 11.11 ppm (br. s, 1 H).
MS: (M + H)' = 376 Example V
(3S)-8-Amino-4-N- (benzyloxycarbonyl)-6-chloro-3-methyl-3,4-dihydroquinoxalin-2(1 H)-one The compound of Example IV (1.5 g, 4.0 mmol) was dissolved in 150 ml ofmethanol and hydrogenated at room temperature with Raney nickel catalysis, using1 atm hydrogen. When the calculated amount of hydrogen had been taken up, the catalyst was r emoved by filtration with suction, and the filtrate was concentrated in 20 vacuo. The product was purified by silica gel chromatography using ethyl acetate/heptane = 2:1 as eluent. The yield was 0.68 g (49%) of brownish solid ofmelting point 152-154C.
H NMR (270 MHz, d6-DMSO): ~ = 1.11 (d, J = 8 Hz, 3 H), 4.79 (q, J - 8 Hz, 1 H), 5.15 (d, J = 12 Hz, 1 H), ~.24 (d, J = 12 Hz, 1 H), ~.38 ~br. s, 2 H), 6.42 (s, 1 H), 7.3-7.4 (m, 6 H), 19.59 ppm ~br. s, 1 H).
MS: (M + H)~ = 346 2 ~
Example Vl A) (3S)-6-Chloro-3-methyl-4-N-(3-methyl.2-buten-1-yl)-3,4-dihydroquinoxalin-2(1 H)-one The compound of Example IB (1.0 y, 5.0 mrnol) was dissolved in 20 n~l of acetonitrile and alkylated with 3-methyl-2-buten-1-yl bromide (90%; 0.92 ml, 7.0 mmol) at room temperature in the presence of ~.0 9 (7.0 mrnol) of pulverulent potassium carbonate. After 7 hours, the reaction had ended. The mixture was filtered off with suction, the filtrate was concentrated in vacus, and the product was purified by silica gel chromatography usin~ ethyi acetate/heptane = 1:2 as eluent.
The yield was 0.97 g (72%) of brownish solid of melting point 117-118C (after crystallization from methyl tert.-butyl ether/heptane).
lH NMR ~270 MHz, d6-DMSO): ~ = 1.02 ~d, J = 8 Hz, 3 I l), 1.74 (s, 6 tl), 3.69 (dd, J = 14, 8 Hz, 1 H), 3.85 - 3.9 (m, ~ H), 5.19 (m, 1 H), 6.65 - 6.8 (m, 3 H), 10.47 ppm (br. s, 1 H).
MS: (M + H)' = 265 [a]D23 = +168.0~ ~c = 1, MeOH) B~ (3R)-6-Chloro-3-methyl-4-N-(3-methyl-2-buten-1-yl)-3,4-dihydroquinoxalin-2(1 H)-one The compound was prepared by the method described in Example VIA, starting from the compound of Example IC. Melting point 115-117C (af~er reerystalli7ation from isopropanol/diethyl ether) The NMR data agreed with those of the compound deseribed in Exarnple VIA.
[a]D23 = -172 (c = 1, MeC~H) 2 ~
C) t3RS)-6-Chloro-3-methyl-4-N-(3-methyl-2-buten-1-yl)-3,4-dihydroquinoxalin-2(1 H)-one The compound was prepared by the method described in Example VIA starting with the compound of Example ID. Melting point 148-14gG (after recrystallization from isopropanol/diethyl ether) The NMR data agreed with those of the compound described in Example VIA.
Example Vll (3S)-6-Chloro-3-methyl-4-N-(2-buten-1 -yl)-3,4-dihydroquinoxalin-2(1 H~-one The substance was prepared analogously to the compound described in Example VIA, but with 2-buten-1-yl bromide as the alkylating agent. Melting point 87-88C
(after crystallization from diethyl ether/heptane) 'H NMR (270 MHz, d6-DMSO): ~ = 1.01 (d, J = 8 Hz, 3 H), 1.70 (dd, J = 8, 1 Hz, 3 H), 3.63 (dd, J = 16, 6 llz, 1 H), 3.85 -4.0 (m, 2 H), 5.47 (m, 1 H), 5.75 (m, 1 H), 6.65 - 6.8 (m, 3 H), 10.48 ppm (br. s, 1 H).
MS: (M + H)~ = 251 Example Vlll 4-N- (Isopropenyloxycarbonyl)-3,3,7-trimethyl-3,4-di-hydroquinoxalin-2(1 H)-one 3,3,7-Trimethyl-3,4-dihydroquinoxalin-2(1H)-one (0.4 g, 2.1 mmol~ were dissolved in 10 ml of anhydrous pyridine, and the stirred solution was tre~ted at ro~m temperature with 0.24 ml (2.2 mmol) of isopropenyl chloroformate. The mixture was stirred for 6 hours at room temperature and treated with water, thc precipi~ate which formed was filtered off with suction, washed with water and dried. This gave 0.4 9 (6~%) of eolorless crystals of melting point 185~G.
'H NMR (270 MHz, d,;-DMSO~: d = 1.~ (s, 6 H~1 1.9 (s, 3 H~, 2.25 ~s, 3 I l), 4.7 (m, 2 H), 6.7 - 6.9 (m, 2 H), 7.15 (d, J = 8 Hz, 1 H), 10.6 ppm (br. s, 1 H).
MS: t = 274 2 ~
Example IX
(3S)-6-Chloro-4-N- ~4-methoxyphenoxycarbonyl)-3-methyl-3,4-dihydroquinoxalin-~(1 H)-one The compound of Example IB (0.5 9, 2.5~ mmol) was dissolved in 10 ml of anhydrous N,N-dimethylformamide, and 0.41 ml (2.8 mmol) of triethylamine were added. To the stirred mixtur~ there was first added dropwise 0.4~ ml (2.8 mmol) of 4-methoxyphenyl ohloroformate and, after ~ hours, another 0.21 ml (1.9 mmol).
When ~he reaction was complete (18 hours), the solvent was stripp~d off under reduced pressure, ~he residue was taken up in ethyl acetate, and the mixture waswashed with water and dried (sodium sulfate). 0.4~ g (54%) of a whit~ solid remained after concentration. Melting point 187-19ûC (after recrystallization from isopropanol) 1H NMR (270 MHz, d6-DMSO): ~ = 1.24 (d, J = 8 Hz, 3 H), 3.77 (s, 3 H), 4.94 (q, J = 8Hz, 1 H),6.97 (dd,J = 8,2Hz, 1 H),7.03 ~d,~l = 8Hz, 1 H),7.2-7.3(m, 3 H), 7.78 (s, 1 H), 10.89 ppm (br. s, 1 H).
MS: (M + H)~ = 347 Example X
(3S)-6-Chloro-4-N-(4-fluorophenoxycarbonyl)-3-methyl-3,4-dihydroquinoxalin-2(1 H)-one The compound was prepared analogously to the compound described in Example VIA, but 4-fluorophenyl chloroformate was used as ar~lating a~ent. Melting point168-170C (after crystallization from isopropanol) 'H NMR ~270 MH~, d6-DMSO): ~ - 1.24 (d, J = 8 Hz, 3 H), 4.94 (q, J = 8 H~, 1H),7.03(d,8Hz,lH),7.2-7.5(m,5H~,7.83(d,J=2Hz,1H),10,90ppm (br. s, 1 H).
MS: (M + H)~ = 335 2 ~
Example Xl (3S)-6-Chloro~-N-(4-chlorophenoxycarbonyl)-3-methyl-3,4-dihydroquinoxaiin-2(1 H)-one The compound was prepared analogously to ~he compound described in Example VIA, but 4-chlorophenyl chloroformate was used as acylating agent. Melting point185-188C (af+er crystallization from isopropanol/diethyl ether) 'H NMR (270 MHz, d6-DMSO): ~ = 1.2~ (d, J = 8 Hz, 3 H), 4.94 (q, J ~ 8 Hz, 1 H), 7.04 (d, 8 Hz, 1 H), 7.25 (dd, J = 8, 2 Hz, 1 H), 735 - 7.6 (m, 4 11), 7.80 (s, 1 H), 10.91 ppm (br. s, 1 H).
MS: (M + H)+ = 351 Example Xll (3S)-4-N - (2-Bromoethyloxycarbonyl)-6-chloro-3-rnethyl-3,4-dihydroquinoxalin-2~1 H)-one The compound was prepared analogously to the compound described in Example VIA, but 2-bromoethyl chloroformate was used for the acylation. Melting point 133-136~C (after crystallization from isopropanol) 2û lH NMR (270 MHz, d6-DMSO): ~ = 1.16 (d, J = 8 Hz, 3 H), 3.7 - 3.8 (m, 2 H), 4.4 -4.6 (m, 2 H), 4.86 (q, J = 8 Hz), 6.99 (d, 8 Hz, 1 H), 7.21 (dd, 8, 2 Hz, 1 H), 7.74 (d, J = 2 Hz, 1 H), 10.84 ppm (br. s, 1 H).
MS: (M + H)+ = 348 Example Xlll (3S)-6-Chloro-N-~isopropenyloxycarbonyl)-3-methyl-3,4-dihydroqllinoxalin-2~1 H)-one The substance was prepared analogously to the compound described in i-~ample VIA, but isopropenyl chloroformate was used for the acylati~n. Meiting paint 2 ~
'H NMR (270 MHz, CDC13): ~ - 1.33 (d, J = 8 Hzl 3 H), 2.02 (s, 3 H), 4.79 (s, 1 H),4.83~s,1 H),5.17~q,J=8Hz,1 H),6.86(d,J=8Hz,1 H),7.12(dd, J=8,2Hz,1H),7.74(br.s,1H),9.28ppm(br.s,1H).
MS: (M + H)~ = 281 Exarnple XIV
~3S)-6-Chloro-3-methyl-4-N-(vinyloxyearbonyl)~3~4-di- hydroquinoxalin-~(1H)-one The substance was prepared analogously to the compound described in Example VIA, but vinyl chloroformate was used ~or the acylation. Melting point 177-179C'H NMR (270 MHz, CDC13): ~ = 1.33 (d, J - 8 Hz, 3 H), 4.96 (dd, J = 14, 2 Hz, 1 H), 5.20 (q, J = 8 Hz, 1 H), 6.83 (d, J = 8 Hz, 1 H), 7.12 (dd, J = 8, 2 Hz, 1 H), 7.2 - 7.3 (m, 2 H), 7.71 (br. s, 1 H), 9.42 ppm (br. s, 1 H).
MS: (M + H)~ = 267 Example X\/ and Example XVI
6-Chloro-3,4-dihydroquinoxalin-2(1H)-one was reacted with 3-methyl-2-buten-1-yl bromide analogously to the process described in Example VIA. It was possible to 20 isolate two products by silica gel chromatosraphy.
6-Chloro-4-N-(3-methyl-2-buten-1-yl)-3,4-dihydro- quinoxalin-2(1H)-one Melting point 150-151 C ~after recrystallization frorn ethyl aeetate) 'H NMR (270 MHz, d6-DMSO): ~ = 1.72 (s, 6 H), 3.ô7 (s, 2 H), 3.89 ~d, .1 = 7 Hz,2 H), 5.20 (m, 1 H), 6.7 - 6.8 (m, 3 H), 10.49 ppm (br. s, 1 H).
MS: (M ~ H)~ = 251 6-Chloro-4-N-(3-methyl-2-buten-1-yl)-3-(1 ,1 -dimethyl-2-propen-l-yl) 3,4-dihydroquinoxalin-2(1 H)-one Melting point 110-112C (after crystalli~ation from heptane) 2 ~ 5 'H NMR (270 MHz, d6-DMSO): ~ = 0.94 (s, 3 H), 0.97 (s, 3 H), 1.65 (s, 3 H), 1.66(s, 3 H), 3.77 (dd, J = ~6, 7 H7, 1 H), 4.23 (dd, J = ~6, 7 Hz, 1 H), 4.8 - 4.9 (m, 2 H), 5.02 (m, 1 H), 5.75 (dd, J = 17, 11 Hz, 1 H), 6.6 - 6.7 (m, 3 H), 10.49 ppm (br s, 1 H).
5 MS: ~M + H)~ = 319 The following compounds of the formula I were synthesize~ from the correspondingunsubstituted quinoxalinones in analogous manner and, K appropriate, derivatizedfurther:
Table 3 R n~ N
2~6~5 _ . _ __ _ _ _=
O 11~) O N 00 N N N N ~-I T ~.) O C.) ~: T ~ ~ _ ~ e oN T T
_ _ ~: I I I I I I I I I I I :C
_ _ _ _ . _ _ U~ ~ ~ ~ -~, O ~,~ ~ ~ ~.~
Z ~ N C~ ~ L~ ) ~ r- aD a) ~_ ~ r ~_ _--_ _ = _ _ _ _ :
2 ~
r _-5 U C~l t) ~ o E cl) u~ o ~ ,_ N
. N tD O 0 0 t~5 . ~) ~) cr) C~ O T-¦~ N N LL O ~ LL I~ u~ O ~ ~ ~ ~_ ~ (.) ( ) ~.) O t ) (.) O t~ N t ) t~ ~ t~) I .
tr I I I I I I I I I I I I I
_' O C) ~ O (.) O ~ O S~) O ~ (~ V
~ CD (D ~) t~ U) ~ ~J (~ ~D CD CD ~D
Z d In tD ~ ~ O) ; N N C~l N C~l ;~ N
2 ~ 5 _ _ _ _ . _ cc I u~ O t ) ~ O O 6 u~ O O ( ) o) ~ t~l N C~l O
cr: I ~ ~ ~ N t~l r~ ~q t l I
_ _ _ . _ _ CC I I I I I I I I I I I I I
tr~ T
G: CD ~D C~ ~D ~ ~ ~D CD ~D ~D ~D ~D tD
. ~ 0~ O> ~ . Cl c7) ~ U ~D ~ 00 ~
Z N C~l N cr) ~ S~ C~ C~ t~) ~ ~ ~) C') ___ _ =_ _. __ _ __ _ s ~ ~ T rl~
~ D ,_ ~ O O o co o .
tru~u~ ~u~ O O u~u~ O O , o co r~ ~ I I I N
~7 I II I I (~')NI I I
G ~ ~.) O O (..) (~) t ) O O O O t.) t.) ~: :C ~ ~ I~ L
.
~ o o ~ o ~ ~ v o ~ ~ ~) ~ ~
~ CD CD ~D tD tD tD tD tD tD ~ U~- ~0 U~
~ 1~ ~ N~ d- U ) lD I~ t~ ~) O ~ N
Z ~t ~ ~~ ~ ~ ~ ~ ~ ~ ~) Ir) Lr _ _ __ __ = _ ~ `.
2 ~
- - - ~ : ~
~ O N . N ~ N O ~ a) ~ ~ I` I~`) _ _ _ _ U7 O 1 LU~ O O ~n OU~ O 6 O
~: I I IN N t~) _ _ _ _ a: I I I I I I I I I I :C :1:
_ _ _ _ _ __ __ c O O ~ ~ ~ O O ~ ~ O ~ ~ ~
CC ~ I` ~` r- t- ~ ~ I~ r- ~ ~ I`_ ~ _ _ _ . _ _ _ Z ~ d Ll~ tD 1~ 00 cn O ~ N ~r~ ) I _ _ _ _ _--2~9~
o _ = _ ___ E ~ E 3 n CD ~ N ~ ~ ., O ~ O ~ N N N
_ _ a: ~ u~ ~ O ,0 O u~ O O ~n O O O
. _ _ ~ N
~ _ _ _ c LL IL LL IL ll~ 1~ O," T ~ O ~ t.) V
a: ~ ~D ~C) ~O t- r- ~ I~ ~D (5) Cl:~ ~1 ~
Z ~ ~D t~ ~D 1~ r` N ~ 1` 1`~ 1~ ~ 0 2~6~8~
_ _ _ ~ 1~ 1~ N tD CO ~ O ~ _ tC~ ~ ~ 1 J) B I I ¦ O
! I I I I,~, L~ I I 1: I I I I I I I I: T
I
I _ C O O O LL C~ ~ V ~ ~ ~~ ~ ~ ~
~ tD ~D tD ~ (D ~D tD ~D t.D CD ~D tD ~D
Z 1~ O 0 N 00 co 0~ 0 CO --0 O a~
~ .
2 ~ 8 ~
In__ N _ _ _ _ =_ __ _ ~_ CU N O O ~ OD 'u~ O _ O O ';t I I I I q II u~ I q I
~ __ _ __ l ~
L ~ . D ~ ~ L~ o D L o ~ _L~
2 ~
- - - = -~ N O tDa)a:~~Dtt:~ 't N 1~ O O
_ ~N _ _ ~ I ~ C .n Z L;N~ ~
~ 8 8 8 8 88 Q 8 o 8 ~ ~
_ _ _ _ ~qt"r~~rJ",I:'J ", r) N I`J
~ I II II I I I I II
~: ~ O ~ O V ~ ~ O ~ O
u I I I I I ~ I I I
~ r _c ~ ~ ~ ~ ~ ~ V ~ t~ ~ ~ ~
G U:) C~:) tD CD CD ~S) ~D CD ~ ~:1 ~D ~
_ _ . _ _ _ . In t~:) I~ :~ o) o ~ N ~) ~ Ir) C~:) ~ O O O O ~ ~ ~_ ~ ~ _- ,_ . __ _ _ --~ _ _ I ~ ~ l a '~
_ _ _ _ _ _ a: O ~ O u~ O u~ O O O O O O
a: I I I I ~ T I
~ ~ o~
Z ~ OD ~ N C~l N N N N t~J N N N
2 ~
Key: C5Hg - 3-methyl-2-buten-1-yl C4H7 = 2-butenyl CsHl1 = 3-methyl-1-butyl C6H,1 = 2,2-dimethylcyclopropyl-1-methyl sC6H11 = 4-methyl-3-penten-2-yl C3H3 = 2-propen-1-yl (CH3)2CCHCO = 3,3-dimethylacryl IPOC = isopropenyloxycarbonyl ALAC = allylaminocarbonyl ALOC = allyloxycarbonyl C4H30 = furanyl C4H3S = thienyl CsH4N = pyridyl Ph = phenyl , 2 ~
Example XVII
6,7-Dimethoxy-3-methyl-3,4-dihydroquinoxalin-2(1 H)-one 4,5-l~imethoxy-1,2-dinitrabenzene (34.2 g, Q.15 mol) was hydrogenated in 500 ml of 5 methanol with Raney nickel catalysis using 1 atm hydrogen. After the calculated amount of hydrogen had been taken up, the process was stopped, the catalyst was removed by filtration with suction, and the solvent was stripped off in vacuo.
To remove the water completely, the mixture was taken up hNice in methanol and reconcentrated. 4,5-Dimethoxy-1,2-phenylenediamine (24.0 g), which remained as abrown oil, was refluxed for 48 hours in 200 ml of ethanol (96%) together with 17.1 ml (0.15 mol) of methyl 2-chloropropionate, with an addition of 21.0 ml (0.15 mol) of triethylamine. The solution, which was very dark, was concentrated, the concentrate was taken up in ethyl acetate, the mixture was washed twice withwater and dried (sodium sulfate), and the solvent was stripped off in vacuo.
15 The crude product was crystallized by stirring with diethyl ether (6.2 g, 19%). A
analytically pure sample of melting point 151 C was obtained by silica gel chromatography using ethyl acetate as the eluent.
H NMR (60 MHz, d6-DMSO): ~ = 1.22 (d, J = 7 Hz, 3 H), 3.63 (s, 3 H), 3.67 (s, 1 H), 3.6 - 3.7 (m, 1 H), 5.62 (br. s, 1 H), 6.40 (s, 1 H), 6.45 (s, 1H), 9.90 ppm 20 (br s, 1 H).
MS: Mt = 222 The following compounds of the formula I were synthesized in analogous manner and, if appropriate, derivatized further:
.
2 ~ 6 Table 4 H
g~
N~H
R
Nr. R1n R3 Rs X M.P. C
. _ _ 16,7-(CH30)2 CH3 IPOC O '133 26,7-(CH30)2 CH3 IPOC S
36-C6HsS CH3 C5H9 O 115 .
47-C6HsS CH3 C5Hg O 107 I _ 56-C6HsS CH3 H O
I
67-C6HsS CH3 H O
76,7(CH30)2 CH3 H O 151 Key: CsHg = 3-methyl-2-buten-1-yl IPOC = isopropenyloxycarbonyl Example XVIII
(3RS)-6-Chloro-4-N-(cyclopropyl)-3-methyl-3,4-dihydroquinoxalin-2(1 H)-one A) (2RS)-N-(4~Chloro-2-cyclopropylaminophenyl)-(2-brornopropionamide) 4-Chloro-2-cyclopropylaminonitrobenzene (2.10 9, 0.01 mol) was hydrogenated in 100 ml of methanol with Raney nickel catalysis, using 1 atm hydrogen. After the calculated amount of hydrogen had been taken up, the process was stopped, the catalyst was removed by filtration with suction, and the solvent was stripped off i 2~6~
acuo. To remove water completely, the mixture was taken up ~vice in methanol and reconcentrated 4-Chloro-2-cyclopropylaminoaniline (1.80 g), which r~mained in the form of a brown oil, was dissolved in 50 ml of anhydrous 1,2-dimethoxyethaneand cooled to -60C, with stirring. A solution of 1.1 ml (0.01 mol) of 2-bromopropionyl chloride in 5 ml of anhydrous 1,2-dime~hoxyethane was slowly added dropwise, and stirring of the reaction mixture was continued ~or 2 hours at -60 - -70C. The mixture was then allowed to warm ~o approx. -20C and poured into 150 ml of ice-cold, saturated aqueous sodium hydrogen carbonate soiution.
The mixture was extracted twice usir~g ethyl acetate, and the organic phase was washed once with water, dried (sodium sul~ale) and concentrated in vacuo. After crystallization with diethyl ether/pentane, 2.51 9 (79%) of the desired product of melting point 130C remained.
'H NMR (270 MHz, d6-DMSO): ~ = 0.4 - 0.5 (m, 2 H), 0.7 - 0.8 tm, 2 H), 1.75 (d, J = 7Hz,3H),2.39(m,1 H),4.72(q,J =7Hz,1 H),5.6(br.s,1 H),6.66(dd, J = 8, 2 Hz, 1 H), 6.96 ~d, J = 2 Hz, 1 H), 7,21 (d, J = 8 Hz, 1 H), 9.36 ppm (br.
s, 1 H).
MS: (M + H)+ = 319, 317 B) (3RS~-6-Chloro-4-N- (cyclopropyl)-3-methyl-3,4-dihydroquinoxalin-2 ~1 H)-one The compound of Example XVIIIA (318 mg, 1.0 mmol) was dissolved in 20 rnl of ethanol (96/o), 0.28 ml (2.0 mmol) of triethylamine were added, and the mixturewas reflux~d for 18 hours. The solvent was removed under reduced pressure, and the reaction product was purified by silica gei chromatography using ethyl acetate/heptane = 1 :2 as eluent. The yield was 200 mg ~85%~ of white crystals of melting point 167C (after crystallization from pentane).
1H NMR (270 MHz, d6-DMSO): ~ = 0.40 (m, 1 H~, 0.63 (m, 1 H), 0.76 (m, 1 tl), 0.98 ~m, 1 H), 1.12 (d, J = 7 Hz, 3 H), 2.47 (m, 1 H~, 3.87 ~q, J = 7 ~z, 1 H), 6.78 (s, 2 H), 7.0 (sl 1 H), 10.46 ppm (br. s, 1 H~.
MS: (M ~ H)~ = 237 2 ~
The following compounds of the formula I were synthesized analogously to the procedure described in Example XVIII using the correspondingly substituted ortho-nitroanilines and 2-halo carboxylic acid derivatives and, if appropriate, derivatized further:
Table 5 H
R 1 n~ N\I(~ R 3 R
Nr. Rln R3 R4- - R5 XM.P.C
~ I
1 6-CI CH3 H C6Hs O 191 2 6-CI CH3 CH3 ~3Hs O
_ 3 6-CI CH3 CH3 C3Hs S
. _ 4 6-CI CH3 CH3 C3Hs __ 6-CI CH3 CH3 C3Hs S
Key: C3Hs = cyclopropyl C6Hs = phenyl 92 2 ~ 5 Example XIX
7-Chloro-1-N-(cyclopropyl)-3,3-dimethyl-3,4-dihydroquinoxalin-2(1 H)-one 4-Chloro-2-cyclopropylaminonjtrobenzene (2.0 g, 9.4 mmol) was hydrogenated as described in Example XVIIIA. The resulting 4-chloro-2-cyclopropylaminoaniline (1.70 g) was taken up in 20 ml of dichloromethane. 1.~ ml (2.01 mmol) of chloroform, 1.8 ml (2.45 mmol) of acetone and 0.10 g (0.4 mmol) of benzyltriethylammoniurn chloride were added, and the reaction solution was cooled to 10C. 4 ml of 50% strength sodium hydroxide solution were slowly added dropwise with vigorous stirring, during which process the reaction temperature should not exceed ~0C. After stirring for 5 hours at 10DC, the phases were diluted and separated. The organic phase was washed once with water, dried (magnesium sulfate) and evaporated in vacuo. The crude product was purified by silica gel chromatography using ethyl acetate/heptane = 1:2 as the eluent. the yield was 1.0 g (42%) of white crystals of melting point 132-133C (after recrystallization from toluene/heptane) .
'H NMR (270 MHz, d6-DMSO): ~ = 0.45 - 0.55 (m, 2 H), 1.05 -1.1 (m, 2 H), 1.19 (s,6H),2.71(m,1H),6.09(br.s,1H),6.71(d,J=8Hz,lH),6.88(dd,J=8, 2 Hz, 1 H), 7.19 ppm (d, J = 2 Hz, 1 H).
MS: (M ~ H)~ = 251 The following compounds of the formula I were synthesized in analogous manner and, if appropriate, derivatized further:
2 ~
Table 6:
R 1 --t~ ~
1~1 R5 _ _ _ Nr. R'n R3 R4 R5 M.P.C
I _ _ 1 6-CI CH3 CH3 CsHs 179 I
L~ 7-CI CH3 CH3 CsHs 171 3 6,7-(CH30)2 CH3 CH3 H
4 6,7-(CH3O)2 CH3 CH3 CsHs _ CH3 CH3 SC6H1l 113 __ ~ C6Hs CH3 H .
7 C~Hs CH3 C5H9 _ 9 7-CI C:;H3 CH3 IPOC 169 _ _ , _ 7-~H3 CH3 CH3 CsH~ 168 . , _ . _ _ 2~ 12 6-CH3C) CH, CH~, _ 138 13 6/7-COOH CH3 CH3 H > 240 2 ~
- ._ Nr. R' R3 R4 Rs M.P. ~C
14 6/7-COOH CH3 CH3 CsH9 180 . .
16 ~-CH3 CH3 CH3 CsHs 160 18 6/7-CH3 C2Hs C2Hs H 160 _ 19 6-CH3 C2Hs C2Hs CsHs 100 ~ _ _ ._ 7-CH3 C2Hs C2Hs CsHs 110 _ 22 7-F CH3 CH3 CsHg 155 23 7-C2tlsO CH3 CH3 H i55 _ 24 7-C2HsO CH3 CH3 CsHs 123 6-COOH CH3 CH3 GsHs 245 _ 26 7,8-(CH3)2 CH3 CH3 H 196 I _ _ _ 27 7,8-(CH3)2 CH3 CH3 CsHs 155 I
28 6,7-(CH3)2 CH3 CH3 H 248 I
29 6,7-(CH3)2 CH3 ~ 3 G5Hg 200 _ _ _ _ 6-CI,7- CH3 C:H3 H 211 (2,3-CI2C6H30) _ .
31 6-CI,7- C:H3 CH3 C5Hg 205 (2~3-cl2c6H3o) _ , .
I _ . _ 33 7-C2H,O CH CH3 IPOC 150 2 ~
~5 Nr.Rln R3 R4 Rs M.P. C
357,8-(CH3)2 CH3 CH3 IPOC 147 _ 366,7-(CH3)2 CH3 CH3 IPOC 161 377-C6H5 CH~ CH~ ~ H 167 ¦ 387-C6H50 CH3 CH3 C5Hg 138 I
¦ 416-CH30, CH3 CH3 H > 240 7-(4-Pyridyl) 426-CI, CH3 CH3 219 7-Piperidino .
l 436/7-CI,7/6- CH3 CH3 H 236 Morpholino (mixture) 446/7-(N-Methyl- CH3 CH3 H > 240 l piperazin-1 -yl) I
456/7-CI,7/6- CH3 CH3 H 147 (N-Methyl-piperazin- 1 -yl) _ L~ 7-CI CH3 CH3 _ ¦ 48 6-CICH3 CH3 ALOC 128-129 I _ Nr. R' R3 - R4 Rs M.P. C
sO 6-CI CHD CH3 COOCH(CH3)2 118 51 7-CI CH3 CH3 COOCH(CH3)2 171 52 7-(4-F-Ph-SO20) CH3 ~H3 H
._ _ 537-(4-F-Ph-S02C)) CH3 CH3 IPOC 204 _ 546-CI,7-Piperidino CH3 CH3 IPOC 152 6-CI,7- CH3 CH3 IPOC 11 3 Morpholino _ 56 6-CI,7-(N- CH3 CH3 IPOC 168 Methyl-piperazin-1 -yl) ~
~57 6-CI,7-NEt2 CH3 CH3 141 58 6-CI,7-NEt2 CH3 CH, IPOC C)il 10 59 6,7-CI2 CH3 CH3 H 232 6,7-CI2 CH3 CH3 IPOC 171 :
61 7-(N-Methyl- CH3 CH3 H 198 piperazinyl-1 -yl) 62 7-(N-Methyl- CH3 CH3 IPOC 123 piperazinyl-1 -yl) _ _ 63 6-C;H30 CH3Ctl3 IPOC 128 ~ __ - ___ . .. - --. _ ., _ 15 1~ 7-CI -(CH2)3- IPOC 172 7-CI -(CH2)~,- iPOC 181 66 6-CI -(CH2~3- IPOC 157-158 I
67 6-CI - (CH2)4- I POC 179- 180 2 ~ 3 5 _ __ Nr. R' R3 R4 Rs M.P. CC ¦
_ _ I
68 6-Clq CH3 CH3 cOOC2H5 137 I _ ~ _ Key: c5~3 = 3-methyl-2-buten-1-yl sC6H'1 = 4-methyl-3-penten-2-yl IPOC = isopropenyioxycarbonyl Example XX
3,3-Dimethyl-4-N-(3-methyl-2-buten-1-yl)-3,4-dihydroquinoxalin-2(1 H)-one The compound was prepared analogously to the compound described in Example VIA, starting from 3,3-dimethyl-3,4-dihydroquinoxalin-2(1H~-one (J. T. Lai, Synthesis 1982, 71). Melting point 146-147C (after crystallization ~rom methyl tert.-butyl 1 5 ether/heptane) 'H NMR (270 MHz, d6-DMSO): ~ = 1.27 (s, 3 H), 1.68 (s, 3 H), 1.72 (s, 3 I l), 3.88 (d, J = 7 Hz, 1 H), 5.15 (m, 1 H), 6.60 td, J = 7 Hz, 1 H), 6.67 (t, J = 7 H2l 1 H), 6.78 (d, J = 7 Hz, 1 H), 6.87 (t, J = 7 Hz, 1 tl), 1û.33 ppm (br. s, 1 H).
MS: (M + H)' = 245 Example XXI
4-N-(3-Methyl-2-buten-1 -yl)-3,4-dihydroquinoxalin-2(1 H)-one-3-spiro-1 '-cyclohexane The compouncl was prepared analogously to the compound described in Example VIA, starting from spiroEcyclohexane-1,3'-(3',4'-dihydroquinoxalin-(1'H)-one)] (J. T.
Lai, Synthesis 1982, 71). Melting point 82-83C ~a~ter crystallization from h~ptane) H NMR (270 MHz, d6-DMSO): ~ = 1.25~1.75 (rn, 1D H~, 3.75 (d, J = 6 tlz, 2 H), 5.07 (m, 1 H), 6.7 - 7.U (m, 4 H), 10.15 pprn (br. s, 1 H).
MS: (M + H)t = 285 2 ~ 5 Example X)(ll 4-N-(3-Methyl-2-buten-1-yl)-3,4-dihydroquinoxaline-2(1 H)-thione-3-spiro-1 '-cyclohexane 5 The compound of Example XXI (50~ mg, 1.~ mmol) was refluxed for 1.5 hours under argon together with 370 mg (0.9 mmol3 of ~,4-bis-(4-methoxyphenyl)-1~3-dithia-2~4-diphosphetane 2,~-disulfide (Lawesson~s reagent) in 10 ml of anhydrous toluene. The mixture was subsequently ~oncentrated in vacuo, and the products were isolated by silica gel chrornatography using methyl tert.-butyl ether/heptane = 10:1 as eluent. The yield was 50 mg (9%) of yellow crystals of melting point 125C.
'H NMR (270 MHz, d6-DMSO): ~ = 1.1 1.9 ~m, 16 H), 3.64 (d, J = 7 Hz, 2 H), 4.99 (m, 1 H), 6.95 - 7.1 (m, 3 H), 7.18 (d, J = 7 H~, 1 H), 12.2 ppm (br. s, 1 H).
MS: (M + H)+ = 301 3,4-Dihydroquinoxaline-2(1H)-thione-3-spiro-1'-cyclohexane was isolated as a further product in a yield of 110 mg (26%); yellow crystals of melting point 178C.
~H NMR (270 MHz, cDC13 ~ = 1.25 - 2.2 (m, 10 H), 4.18 (br. s, 1 H), 6.7 - 6.8 (m, 3 H), 6.97 (m, 1 H~, 9.42 ppm (br. s, 1 H).
MS: (M + H)~ = 233.
Example XXIII
(3S)-6-Chloro-4-N- (isopropenyloxycarbonyl)-3-methyl-3,4-dihydroquinoxaline-2(1 H)-thione The cornpound of Example Xlll (0.5 ~, 1.78 mmol), dissolved in îO ml of anhydrous pyridine, was refluxed for 4 hours together with 0.47 g ~2.12 mmol) of phosphorus pentasulfide. The mixture was concentrated in vacuo, and lhe residue was chromatographed on silica gel using ethyl acetate/heptane = 1:1 2S eluent. This gave 0.25 g (47%) of a yellow crystalline solid of rnelting point 148-150C (after recrystallization from ethyl acetate/heptane).
2 ~
H NMR (270 MHz, d6-DMSO): ~ = 1.24 (d, J = 7 Hz, 3 H), 1.96 (s, 3 H), 4.8 - 4.9 (m,2H),5.28(q,J=7Hz,1H),7.22(d,J=8Hz,1H),7.30(dd,J=8,2Hz, 1 H), 7.72 (br. s, 1 H), 12.84 ppm (br. s, 1 H).
MS: (M + H)~ = 297.
The following compounds of the formula I were ~ynthesized in analogous rnanner ~rom the corresponding 3,4-dihydroquinoxalin-2(1H)-ones:
Table 7 H
I
R ~ ~ -- R 3 .
Nr. R'n R3 R4 Rs M.P.C
1 CH3 H C5Hg 119 2 6-CI CH3 H CsHg 109- 110 _ .
. _ .. . , . _ _ 6 C6Hs CH3C5H~
_ _ 7 6-CI CH3 CH3CsH5 157 _ 8 7-CI CH3 CH3C5Hg 160 _ .
2~6~9~
~oo _ _ I
Description 5 Quinoxalines, processes for their preparation, and their use The present invention relates to quinoxalines, to processes for their preparation, and to their use.
Quinoxalines are a well-known class of compound (O. Hinsberg, J. Liebi~s Ann.
Chem. 237, 327 (1986)).
Quinoxaline derivatives have been described in the patent literature for use in various applications in medicine.
Austrian Patent 284,848 (19.12.67) mentions 1-N-dialkylaminoalkyl-3,4-dihydroquinoxalin-2(1H)-ones as spasmolytic agents. A series of patent applications by the Japanese company Sumitomo Chem. Co. Ltd. describe 4-N-aroyl-, arylacyl- and arylsulfonyl-3,4-dihydroquinoxalin-2(1H)-ones which have an antiinflammatory action (JA 17,137t69 (11.4.66), JA 17,136/69 (8.4.66), ~IA 7,008/422 (9.8.66), BE 706,623 (16.11.66)). 3,4-Dihydroquinoxalin-2(1H)-one-3-carboxamides ars contained in US Patent US 3,654,275 (4.4.72). They, too, have an antiinflamma~ory action. In US Applications US 4,203,987 (21.5.79) and 4,032,639 (22.3.76), pyridinyl-alkyltetrahydropyrazino[1,2-a]quinoxalinone derivatives are described by Am0rican Horne Prod. Corp. as antihypertensive and antisecretory reagents. A European Patent Application by Pfizer Inc. (EP 266,102 A (30.10.86)) includes 4-N-benzenesulfonyl-3,4-dihydroquinoxalin-2(1H)-one-1-alkylcarboxylic acids as aldose reductase inhibitors.
However, an antiviral activity has not been demonstrated to date.
Surprisingly, it has now been found that quinoxalines of the formulae I and la 2 2 ~ 8 ~
I
R 1 ~N~R 3 ( I ) and their tautomeric forms of the formula la N X
R ~ R 2 ( I a ) ~N/~
R
and physiologically acceptable salts or prodrugs thereof have an antiviral action, in particular against retroviruses, for example against the human immunodeficiency virus (H IV) .
20 In the compounds of the formula I or la according to the invention, 1) n is ~ero, one, twl three or four, the individual substituents R' independently of ons another are fluorine, chlorine, bromine, iodine, trifluoromethyl, trifluoromethoxy~ hydroxyl, C1-C8-alkyl, C5-C8-cycloalkyl, C1-C~-alkoxy, (C:1-C6-alkoxy)-(C1-C4-alkoxy3, 2~g8~
C,-C6-alkylthio, C,-C6-alkylsulfinyl, C,-C6-alkylsulfonyl, ni~ro, amino, azido, C,-C6-alkylamino, di(C,-C6-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, thiomorpholino, irnidazolyl, triazolyl, tetrazolyl, C,-C6-acyl, C,-C6-acyloxy, C,-C6-acylamino, cyano, carbamoyl, carbo~
(C,-C6-alkyl)oxycarbonyl, hydroxysulfonyl, sulfamoyl or a phenyl, phenoxy, phenoxycarbonyl, phenylthio, phenylsulfinyl, phenylsulfonyl, phenoxysulfonyl, phenylsulfonyloxy, anilinosulfonyl, phenylsulfonylamino, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which is substituted by up to five radicals R6 which are independent o~ one another, where R6 can be t5 fluorine, chlorine, bromine, iodine, cyano, trifluoromethyl, trifluoromethoxy, nitro, amino, azido, C1-C6-alkyl, C3-C9-cycloalkyl, C1-C6-alkoxy, C,-C6-alkylthio, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-alkylamino, di(C,-C6-alkyl)amino, (C1-C6-alkyl)oxycarbonyl, phenyl, phenoxy, 2-, 3- or 4-pyridyl, R2 is hydrogen, C,-C6-alkoxy, hydroxyl, picolyl, cyclopropyl or isopropenyloxycarbonyl and R5 is hydrogen, hydroxyl, C1-C6-alkoxy, aryloxy, C,-C6-acyloxy, cyano, amino, 2~ C,-C6-alkylamino, di(C,-C6-alkyl~amino, arylamino, Ct-C6-acylamino, I:~,-C8-alkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C6-alkoxy, C,-C6-alkylamino, di(C1-(::6-alkyl~amino, C,-C6-alkylthio, C,-C:6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
2~9~
C2-C~-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C,-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C6-alkoxy, C1-C6-alkylamino, di~Cl-C8-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl and carbamoyl;
C3-Ca-allenyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C3-CB-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, Cl-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C8-alkoxy, C,-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, Cl-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-G6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C,-C6-alkylthio, C,-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbarnoyl;
C3-CB-cycloalkenyl, 2~ optionally ~ubstituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, Cl-C6-alkoxy, C,-C6-alkylamino, di~Cl-C6-alkyl)amino, Cl-C6-alkylthio, C,-S:~6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
2 ~ 8 ~
(C3-C8-cycloalkyl~-(C,-C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, Cl-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, Cl-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkenyl)-(C, -C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, rnercapto, hydroxyl, C,-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C,-C6-alkylamino, di(C1-C6-alkyl)amino, C,-C6-alkylthio, C,-C6 alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
1 5 C,-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C6-alkoxy, C,-C6-alkylamino, di(C1-C6-alkyl)amino, C,-C6-alkylthio, C,-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
C2-C8-alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl,C1-C4-alkoxy, oxo, phenyl;
2~ (C3-C6-cycloalkyl)carbonyl, optionally substituted by fluorine, chlorine or hya'roxyl, C,-C4-alkoxy, oxo, phenyl;
(C5-C~-cycloalkenyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C,-C4-alkoxy, oxo, phenyl;
- :
2~6~
(C3-C~-cycloalkyl)-(C1-C~-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-aikoxy, oxo, phenyl;
(C5-C6-cycloalkenyl)-(Cl-c3-alkyl)carbonyl~ optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C,-C8-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, Cl-C4-alkylarnino, di(Cl-C4-alkyl)amino, C1-C4-alkylthio;
C2-C8-alkenyloxycarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, ph~nyl;
C2-C5-alkynyloxycarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-CB-alkylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl,Cl-C4-alkoxy, oxo, phenyl;
C2-C~-alkenylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-CB-alkylamino- and di(C1-C5-alkyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydro)~yl, Cl-C4-alkoxy, oxo, phenyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperæinyl-, w 4-methylpiperazin-1-ylcarbonyl, in each case optionally substituted by ~1-C4-alkyl, C2-C6-alkenyl,C1-C4-acyl, oxo, thioxo, carboxyi, or phenyl;
C2-C5-alkenylamino- and di(C,-C6-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
2 ~ 8 5 C1-C6-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C:1-C4-alkoxy, oxo, phenyl;
C1-C6-alkenylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
or aryl, arylcarbonyl, aryl(thiocarbonyl), (arylthio)carbonyl, (arylthio~thiocarbonyl, aryloxycarbonyl, arylaminocarbonyl, ~arylamino)thiocarbonyl, arylalkylaminocarbonyl, arylsulfonyl, arylalkyl, arylalk~nyl, arylalkynyl, arylalkyl-carbonyl, arylalkenylcarbonyl, arylalkoxycarbonyl or aryl(alkylthio)carbonyl, each of which is substituted by up to five radicals R5 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 5 carbon atoms, and R6 being as defined above, or heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkylcarbonyl or heteroarylalkenylcarbonyl, heteroaryloxycarbonyl, (heteroarylthio)carbonyl, heteroarylaminocarbonyl, heteroarylalkyloxycarbonyl, heteroaryl(alkylthio)carbonyl or heteroarylalkylaminocarbonyl, each of which is substituted by up to three radicals R6 which are independent of one another, it being possible for the alkyl raclical to contain in each case 1 to 3 carbon atoms, R3 and R4 are identical or different and, independently of one another, are hydrogen, C1-C8-alkyl which is optionally substituted by fluorine, chlorine, hydroxyl, amino, mercapto, Cl-C:4-acyloxy, b~nzoyloxy, benzyloxy, phenoxy, G1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl~amino, C1-C4-alkylthio, C1-C4-alkylsulFonyl, Cl-C4-alkylsulfinyl, carboxyl or carbamoyl;
C2-C8-alkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, Gl-C"-alkoxy, C1-C4-.
2 ~ 9 3 ~
alkylamino, di(C1-C4-alkyl)amino, C1-C4 alkylthio, C,-C4-alkylsulfonyl, C;1-C4-alkylsulfinyl, carboxyi or carbamoyl;
C3-CE,-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyl, amino, mercapto, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C"-alkoxy, C,-C4-alkylamino, di(C1-C4-alkyl)amino, C,-C,-alkylthio, C1-C4-alkyisulfonyl, C,-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-~4-alkoxy, C1-C4-alkylamino, di(C,-C4-alkyl)amino, C,-C4-alkylthio, C,-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
aryl, arylalkyl, heteroaryl or heteroarylalkyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for thealkyl radical to contain 1 to 3 carbon atoms in each case, and R6 being as defined above, R3 and R4 can furthermore also be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 8 carbon atoms and which can optionally be substituted by fluorine, chlorine, hydroxyl, amino, C,-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-acyloxy, benzoyloxy, C1-C6-alkoxy, oxo, thioxo, carboxyl, carbamoyl or phenyl, ?5 X is oxygen, sulfur~ selenium or substituted nitrogen N-R2, it being possible for R2 to have the abovementioned meanings, with the exception of those compounds in which R3 and R4 are both hydrogen, and compounds in wnich R2 and R5 are hydrogen and R3 and/or R4 are/is arylalkyl, andcompounds in which X is oxygen and R2 and Rs are hydrogen.
2 ~
In a preferred group of compounds of the formula I or la, 2) n is zero, one, two or three, the individual substituents R1 independently of one another are fluorine, chlorine, bromine, trifluoromethyl, trifluoromethoxy, hydroxyl, Cl-C4-alkyl, C5-C6-cycloalkyl, C1-C4-alkoxy, (C1-C4-alkoxy)-(C1-C4-ali~o~ C~ 4-alkylthio, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonyl, nitro, amino, C1-C4-alkylamino, di(C1-C4-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpip~razinyl, thiomorpholino, imidazolyl, C1-C4-acyl, C,-C4-acyloxy, C1-C4-acylamino, cyano, carbamoyl, carboxyl, (C1-C4-alkyl)oxycarbonyl, hydroxysulfonyl or sulfamoyl or a phenyl, phenoxy, phenoxycarbonyl, phenylthio, phenylsulfinyl, phenylsulfonyl, phenoxysulfonyl, phenylsulfonyloxy, anilinosulfonyl, phenylsulfonylamino, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which is substituted by up to two radicals R6 which are independent of one another, where R6 can be fluorine, chlorine, bromine, cyano, trifluoromethyl, nltro, amino, C1-C4-alkyl, C3-C7-cycloalkyi, Cl-C4-alkoxy, C,-C4-alkylthio, Cl-C4-alkylsulfinyl, C,-C4-alkylsulfonyl, C,-C4-alkylamino, di(C,-C4-alkyl)amino, ~C:l-C4-alkyl)oxycarbonyl, phenyl or phenoxy, 2~9~ ~
R2 is hydrogen and R5 is hydrogen, hydroxyl, cyano, amino, C,-C6-alkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, rnercapto, hydroxyl, C:l-C4 acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C~-alkoxy, C,-C4-alkylamino, di(C,-C4-alkyl)amino, C,-C4-alkylthio, oxo, thioxo, oarboxyl or carbamoyl;
C2-C8-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C,-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
t5 C3-Ca-allenyl, C3-C8-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C,-C4-alkylamino, di(C,-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-CB-cycloalkyl, optiorlally subs~ituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C,-C4-alkylamino, di(C,-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, ~yano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
(C3-C~-cycloalkyl)-(C1-C2-alkyl) optionaliy substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1~C4-alkoxy, Cl-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
(C3-C~-cycloalkenyl)-(C,-C2-alkyl), optionally substituted by fiuorine, chlor;ne, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C~-C4-alkylamino, di(C,-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C1-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C~,-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C2-C6^alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl,C,-C4-alkoxy, oxo, phenyl;
~C3-C6-cycloalkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C6-cycloalkenyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
g ~ 5 ~C3-C6-cycloalkyl)-(C,-C2-alkyl)carbonyl, optionally substituted by fiuorine, chlorine or hydroxyl, Cl-C4-alkoxy, oxo, phenyl;
(C5-C6-cycloalkenyl)-(C,-C2-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkyloxycarbonyl, optionally substituted by fluorine, chlorin~, bromine, hydroxyl, C1 C4-alkoxy, C1-C~,-alkylamino, di(Cl-C4-alkyl)amino, C,-C4-alkylthio;
C2-C6-alkenyloxycarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C2-C6-alkynyloxycarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
~5 C1-C6-alkylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl,C1-C4-alkoxy, oxo, phenyl;
C2-C6-alkenylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkylamino- and di(C1-C6-alkyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1-ylcarbonyl;
C2-C6-alkenylamino- and di(C1-C5-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
~ ~ 6 ~
C1-C4-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C,-C4-alkoxy, oxo, phenyl;
C1-C4-alkenylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C,-C4-alkoxy, oxo, phenyl;
or aryl, arylcarbonyl, aryl(thiocarbonyl), (arylthio)carbonyl, (arylthio)thiocarbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino)thiocarbonyl, arylalkylaminocarbonyl, arylsulfonyl, arylalkyl, arylalkenyl, arylalkynyl, arylalkyl-carbonyl, arylalkenylcarbonyl, aryl(alkyl~hio)carbonyl or arylalkoxycarbonyl, each of which îs substituted by up to three radicals R6 which are independsnt of one another, it being possible for the alkyl radical to contain in each case 1 to 5 carbon atoms and R6 being as defined above, or 1- or 2-naphthylmethyl, 2-, 3- or 4-picolyl, 2- or 3-furylmethyl, 2- or 3-thienylmethyl, 2- or 3-pyrrolylmethyl, 2-, 3- or 4-pyridylcarbonyl, 2- or 3-furylcarbonyl, 2- or 3-thienylcarbonyl, 2- or 3-thienylacetyl, 2-, 3- or 4-picolyloxycarbonyl, 2- or 3-furylmethyloxycarbonyl, 2- or 3-thienylrnethyl-oxycarbonyl, each of which is substituted by up to two radicals R6 which are independent of one another, and R3 and R4 are identical or different and independently of 2~ one another are hydrogen, C1-C6-alkyl, optionally substituted by fluorine, chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, ben7yloxy, phenoxy, C1-C4-aikoxy, C,-C4-~lkylamino, 2 ~
di(C1-C4-alkyl)amino, C,-54-alkylthio, C1-C4-alkylsulfonyl, C,-C4-alkylsulfinyl,carboxyl or carbamoyl;
C2-Ca-alkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C,-C4-alkylamino, di(C1-C4-alkyl~amino, Cl-C4-alkylthio, C,-C4-alkylsulfonyl, C,-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-Ca-cycloalkyl, optionally substituted by fluorine, ch!orine, hydroxyl, arnino, mercapto, Cl-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C1-C4-alkylamino, di(C,-C4-alkyl)amino, C,-C4-alkylthio, C,-C4-alkylsulfonyl, C l-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-Ca-cycloalkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, Cl-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C,-C4-alkylthio, C,-C4-alkylsulfonyl, C,-C4-alkylsulfinyl, carboxyl or carbamoyl;
aryl, arylalkyl, heteroaryl or heteroarylalkyl, each of which is substituted by up to three radicals R~ which are independent o~ one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms and R6 being as defined above, R3 and R4 can furthermore also be par~ of a saturated or unsaturated carbo- or heterocyclic ring which has 3 tQ 7 carbon atoms and which can optionally be substitut~d by fluorine, chlorine, hydroxyl, amino, C1-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-acyloxy, benzoyloxy, C1-C4-alkoxy, oxo, thioxo, carboxyl, carbamoyl or phenyl, and X is oxygen, sulfur or selenium.
2~6~85 In a yet more preferred group of compounds of the formula I or la, 3) n is zero, one or two, the individual substituents R' independently of one another are fluorine, chlorine, bromine, trifluoromethyl, hydroxyl, C1-C4-alkyl, C,-C4-alkoxy, (C1-C4-alkoxy)-(C1-C4-alkoxy), C1-C4-alkylthio, nitro, amino, C1-C4-alkylamino, di(C,-C4-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, Cl-C4-acyl, C1-C4-acyloxy, Cl-C4-acylamino, cyano, carbamoyl, carboxyl, (C1-C4-alkyl)oxycarbonyl, hydroxysulfonyl or sulfamoyl, or a phenyl, phenoxy, phenylthio, phenylsulfonyl, phenoxysulfonyl, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which is substituted by up to two radicals R6 which are independent of one another, where R6 can be fluorine, chlorine, bromine, cyano, trifluoromethyl, nitro, amino, C1-C4-alkyl, C1-C4-alkoxy, (C1-C4-alkyl)oxycarbonyl, phenyl or phenoxy, R2 is hydrogen and R5 is C1-C6-alkyl, optionally substituted by fluorine, chlorlne, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzylo~y, phenoxy, :
2 ~
C1-C4-alkoxy, C1-C4-alkylamino, di(C,-C4-alkyl)amino, Cl-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C2-C6-alkenyl, optionally substituted by fluorine, chlorine, hydroxyl, Cl-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C,-C4-aikylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-t:~B-allenyl, C3-C8-alkynyl, optionally substituted by fluorine, chlorine, hydroxyl, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C,-C4-alkylamino, di(C,-C4-alkyl)amino, C,-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-Ca-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyl, C,-C4-alkyl, C,-C4-acyloxy, benzoyloxy, benzyloxy,phenoxy, C,-C4-alkoxy, C,-C4-alkylamino, di(C,-C4-alkyl)amino, C,-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine, chlorine, hydroxyl, C,-C4-alkyl, C;,-C4-acyloxy, ben7oyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C,-C4-alkylamino, di(C,-C4-alkyl)amino, C,-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
2~98~
(C3-Cs-cycloalkyl)-(C1-C2-alkyl~, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-acyloxy, benzoyloxy, benzyloxy,phenoxy, C1-C4-alkoxy, C1-C"-alkylamino, di~C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
(C3-C6-cycloalkenyl)-(C,-C2-alkyl), optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-acyloxy, benzoyloxy, benzyloxy,phenoxy, C1-C4-alkoxy, C1-C~-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkyithio, oxo, thioxo, carboxyl or carbamoyl;
C1 -C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-acyloxy, benzoyloxy, benzyloxy,pheroxy, C1-C4-alkoxy, C1-C4-alkylamino, C,-C4-alkenylamino, di(C1-C4-alkyl)amino, 1-pyrrolidinyl, piperidino, morpholino, 4-methylpiperazin-1-yl, Cl-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C2-C6-alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl;
(C3-C6-cycloalkyl)carbonyl, (C5-C6-cycloalkenyl)carbonyl, (C3-C6-cycloalkyl)-(C1-C2-alkyl)carbonyl, (Cs-C6-cycloalkenyl)-(C,-C2-alkyl)carbonyl, C1-C6-alkyloxycarbonyl, optionally substituted by flvorine, ehiorine, bromine, hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl~amino or C1-C4-alkylthio;
2~6~9~
C2-C6-alkenyloxycarbonyl, optionally substituted by flusrine, chlorine, hydroxyl, C,-C4-alkoxy;
C2-C6-alkynyloxycarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, Cl-C4-alkoxy;
Cl-C6-alkylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, Cl-C4-alkoxy;
C2-C6-alkenylthiocarbnnyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy;
C1-C6-alkylamino- and di(C1-C6-alkyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, Cl-G4-alkoxy;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1 -ylcarbonyl;
C2-C6-alkenylamino- and di(C1-C~-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, Cl-C4-alkoxy;
Cl-C4-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy;
C1-C4-alkenylsulfonyl;
or aryl, arylcarbonyl, (arSlthio)carbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino~thiocarbonyl, arylsulfonyl, arylalkylaminocarbonyl, arylalkyl, arylalkenyl, arylalkylcarbonyl, arylalkoxycarbonyl or aryl(alkylthio)carbonyl, each of which is substituted by up to two radicals R6 which are independent of one 2 ~
another, it being possible for the alkyl radical to contain in each oase 1 to 3 carbon atoms, and R6 being as defined above, or 1- or 2-naphthylmethyl, 2-, 3- or 4-picolyl, 2- or 3-furylmethyl, 2- or 3-thienylmethyl, 2- or 3-pyrrolylmethyl, 2-, 3- or 4-pyridylcarbonyl, 2- or 3-furylcarbonyl, 2- or 3-thienylcarbonyl, 2- or 3-thienylacetyl, 2-, 3- or 4-picolyloxycarbonyl, 2- or 3-furylmethyloxycarbonyl or 2- or 3-thienylmethyloxycarbonyl, sach of which is substituted by up to two radicals R6 which are independent of one another, and R3 and R4 are identical or different and independently of one another are hydrogen, C1-C4-alkyl, optionally substitu~ed by fluorine, chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, phenoxy, Cl-C4-alkoxy, Cl-C4-alkylamino, di(Cl-C4-alkyl)amino, Cl-C4-alkylthio, Cl-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C2-C6-alkenyl, optionally substituted by fluorine or chlorine;
C3-C6-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyi, amino,mercapto, Cl-C4-acyloxy, benzoylo~y, benzyloxy, phenoxy, C1-C4-alkoxy, Cl-C4-alkylamino, di~C,-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C~-C4-alkylsulfinyl, carboxyl or carbamoyl;
~5 C3-Ca-cycloalkenyl, optionally substituted by fluorine or chlorine;
- aryl, benzyl, heteroaryl or heteroarylmethyl, each of which is su~stituted by up to two radicals R~ which are independent of one another, 2 ~ 5 2û
R3 and R4 can furthermore also be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 6 carbon atoms and which can optionally be substituted by fluorine, chlorine, hydroxyl, amino, C1-C4-acytoxy, benzoyloxy, C,-C"-alkoxy, oxo, thioxo, carboxyl or carbamoyl, and X is oxygen or sulfur.
In a yet again preferred group of compounds of the formula I or la, 4) n is zero, one or two, the individual substituents R' independently of one another are fluorine, chlorine, bromine, trifluoromethyl, hydroxyl, C1-C4-alkyt, C1-C4-alkoxy, (C1-C4-alkoxy)-(C1-C2-alkoxy), C1-C4-alkylthio, nitro, amino, C1-C4-alkylamino, di(C,-C4-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, C1-C4-acyl, C1-C4-acyloxy, C,-C4-acylamino, cyano, carbamoyl, carboxyl, (C1-C4-alkyl)oxycarbonyl, hydroxysulfonyl or sulfamoyl or a phenyl, phenoxy, phenylthio, phenylsulfonyl, phenoxysulfonyl, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical, each of whk:h is substituted by up to two radicals R6 which are independent of one anoth0r, where R6 can be ~ ~ .
2 ~
fluorine, chlorine, bromine, cyano, trifluoromethyl, nitro, amino, C1-C"-alkyl, C1-C4-alkoxy, (C1-C4-alkyl)o~carbonyl, pheny~ or phenoxy, R2 is hydrogen and R5 is C1-C6-alkyl, optionally substituted by C1-C"-alkoxy or C1-C"-alkylthio;
C2-C6-alkenyl, optionally substituted by oxo;
C3-C6-allenyl;
C3-CB-alkynyl, in particular 2-butynyl;
C3-C6-cycloalkyl;
Cs-C6-cycloalkenyl;
(C3-C6-cycloalkyl)-(C1-C2-alkyl), in particular cyclopropyimethyl, optionally substituted by C1-C4-alkyl;
(C3-C6-cycloalkenyl)-(C,-C2-alkyl), in particular cyclohexenylmethyl;
C1-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, benzyloxy, phenoxy, C,-C4-alkoxy, C1-e;4-alkylamino, C1-C4-alkenylamino, di(C1-C4-alkyl)amino, 1-pyrrolidinyl, piperidino, morpholino, 4-methylpiperazin-1-yl or C1-C4-alkylthio;
22 2 ~ 8 C2-C6-alkenylcarbonyl;
Cl-C6-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, Ct-C4-alkylamino, di(C1-C4-alkyl)amino or C1-C4-alkylthio;
C2-C6-aikenyloxycarbonyl, in particular vinyloxycarbonyl, allyloxycarbonyl, isoprnpenyloxycarbonyl, butenyloxycarbonyl or pentenyloxycarbonyl;
C2-C6-alkynyloxycarbonyl, in particular propynyloxycarbonyl or butynyloxycarbonyl;
C1 -C6-alkylthiocarbonyl;
C2-C6-alkenylthiocarbonyl, in particular allylthiocarbonyl;
C,-C6-alkylamino- and di(C1-C6-alkyl)aminocarbonyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1-ylcarbonyl;
C2-C6-alkenylamino- and di(C,-C6-alkenyl)aminocarbonyl;
C1 -C4-alkylsulfonyl;
~5 C,-C4-alkenylsulfonyl;
or aryl which is substituted by up to two radicals R6 which are inciependent of one another, in particular phenyl, aryicarbonyl, in parSicular benzoyl, (arylthio)carbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino~thiocarbonyl,arylalkylaminocarbonyl, arylsulfonyl, arylalkyi, in particular benzyl, phenylethyl, ~$~
arylalkenyl, arylalkylcarbonyl, arylalkoxycarbonyl or aryl(alkylthio)carbonyl, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atomsand R6 being as defined above, or 1- or 2-naphthylmethyl, 2-, 3- or 4-picolyl, ~- or 3-furylmethyl, 2- or 3-thienylmethyl, 2- or 3-pyrrolylmethyl, 2-, 3- or 4-pyridylcarbonyl, 2- or 3-furylcarbonyl, 2- or 3-thienylcarbonyl, 2- or 3-thienylacetyl, 2-, 3- or 4-picolyloxycarbonyl, 2- or 3-furylmethyloxycarbonyl, or 2- or 3-thienyl-methyloxycarbonyl, each of which is substituted by up to two radicals R6 which are independent of one another, and R3 and R4 are identical or different and independently of one another are hydrogen, Cl-C4-alkyl, optionally substituted by hydroxyl, mercapto, C1-C4-alkoxy, C1-C4-alkylthio, C,-C4-alkylsulfonyl, C,-C4-alkylsulfinyl, carboxyl or carbarnoyl;
C2-C6-alkenyl, aryl, benzyl, thienyl or thienylmethyl, each of which is substituted by up to two radicals R6 which are independent of one another, R6 beinç3 as defined above, R3 and R4 can also be part o~ a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 6 carbon atoms and can optionally be substituted by oxo or thioxo, an~
2 ~ 8 ~
X is oxygen or suifur.
Compounds of the formula I or la as defined above wherein the substituents mentioned have the following meanings are very particularly important:
n is zero or one, the individual substituents R' independently of one another are fluorine, chlorine, bromine, C1-C2-alkyl, C,-C2-alkoxy, C2-C4-acyl or cyano, R2 is hydrogen and Rs is 1 5 C2-C6-alkenyl, C3-C8-alkynyl, in particular 2-butynyl;
(C3-C6-cycloalkyl)-(C1-C2-alkyl), in particular cyclopropylmethyl, optionally substituted by C1-C4-alkyl;
(C3-C6-cycloalkenyl)-(C1-C2-alkyl), in particular cyclohexenylmethyl;
C2-C6-alkylcarbonyl, C2-C6-alkenylcarbonyi;
C1 -C6-alkyloxycarbonyl;
2 ~ 5 C2-C6-alkenyloxycarbonyl, in particular vinyloxycarbonyl, allyloxycarbonyl, isopropenyloxycarbonyl, butenyloxycarbonyl or pentenyloxycarbonyl;
C~-C6-alkynyloxycarbonyl, in particular propynyloxycarbonyl or butynyloxycarbonyl;
C2-C6-alkenylthiocarbonyl, in particular allylthiocarbonyl;
Cl-C4-alkylsulfonyl;
C1 -C4-alkenylsuHonyl;
or arylalkyl, in particu!ar benzyl or arylalkenyl, which is substituted by up to two radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms and for the alkenyl radical to contain 2-3 carbon atoms, or 1-naphthylmethyl, 2- or 3-picolyl, 2-furylme~hyl or 2- or 3-thienylmethyl, each of which is substituted by up to two radicals R6 which are independent of one another, where R6 is fluorine, chlorine, bromine, cyano, C1-C2-alkyl or C1-C2-alkoxy, ~5 and R3 and R4 are identical or different and independently of one another are 2 ~
hydrogen, C1-C4-alkyl, optionally substituted by hydroxyl, mercapto, C,-C4-alkoxy. C1-C2-aikylthio, and 5 X is oxygen or sulfur.
The alkyl groups in the above definitions can be straight-chain or branched. Unless otherwise defined, they preferably contain 1-8, particularly preferably 1-6, in particular 1-4, carbon atoms. Examples are the methyl, ethyl, propyl, 1-methylethyl, butyl,10 1-methylpropyl, 2-methylpropyl and 1,1-dimethylethyl ~roup, and similar groups.
The alkenyl groups mentioned in the above definitions can be strai~ht-chain or branched and contain 1 to 3 double bonds. Unless otherwise defined, these groupspreferably contain 2-8, in particular 2-6, carbon atoms. Examples are the 2-propenyl, 1-methylethenyl, 2-butenyl, 3-butenyl, 2-methyl-2-propenyl, 3-methyl-2-butenyl, 2,3-dimethyl-2-butenyl, 3,3-dichloro-2-propenyl and pentadienyl groups and similar groups.
The alkynyl groups mentioned in the above definitions can be straight-chain or 20 branched and contain 1 to 3 triple bonds. Unless otherwise defined, they contain preferably 2-8, particularly preferably 3-6, carbon atoms. Examples are the 2-propynyl and 3-butynyl group and similar groups.
Unless otherwise defined, the cycloalkyl and cycloalkenyl groups mentioned in the 25 above definitions contain ,orefsrably 3-8, particularly preferably 4-6, carbon atoms.
Examples are the cyclopropyl, cyclobutyl, cyclopentyl, cyclopentenyl, cyclohexyl or cyclohexenyl group.
The acyl groups mentioned in the above definitions can be aliphatic, cycloaliphatic or 30 aromatic. Unless otherwise defined, they preferably contain 1-8, particularly preferably 2 ~ 5 2-7, carbon atoms. Examples of acyl ~roups are the formyl, acetyl, chloroacetyl,trifiuoroacetyl, hydroxyacetyl, propisnyl, butyryl, isobutyryl, pivaloyl, cyclohexanoyl or benzoyl group.
5 The aryl groups mentioned in the above definitions are preferably aromatic groups having 6-14 carbon atoms, in particular 6-10 carbon atoms, for example phenyl ornaphthyl.
Suitable hetero atoms in the abovementioned heterocyclic rings Dr heteroaryi groups 10 are, in particular, oxygen, sulfur and nitrogen, where, in the case of a nitrogen-containing ring which is saturated in this position, a structure N-Z is present in which Z
is H or R5 w1th the individual above-described definitions.
Unless otherwise defined, the heterocyclic rings preferably have 1-13 carbon atoms and 1-6 hetero atoms, in particular 3-9 carbon atoms and 1-4 hetero atoms.
Suitable radicals for the heteroaryl groups mentioned in the above definitions are, for example, heteroaromatic radicals such as 2- or 3-thienyl, 2- or 3-furyl, 2-, 3- or 4-pyridyl, pyrimidyl, indolyl, quinolyl or isoquinolyl.
Examples of the aralkyl groups mentioned in the above definitions are benzyl, phenylethyl, naphthylmethyl or styryl.
The abovementioned substituents R1 to Rs are preferably trisubstituted, particularly 25 preferably disubstituted, in particular monosubstituted, by the particular substituents mentioned.
In the case of the particular definitions of composite substituents (such as, for example, arylalkoxycarbonyl~, the ranges which have been described above as being 30 preferred for the individual substituents are also preferred.
2 ~ 6 ~ 9 8 ~
Depending on the various substituents, compounds of the formulae I and la can have several asymmetric carbon atoms. The invention therefore relates both to the pure stereoisomers and to mixtures thereof such as, for example, the corresponding racemate.
The pure stereoisomers of the compounds of the formulae I and la can be prepareddirectly by known methods or analogously to known methods, or they can be resolved later.
The compounds of the formulae I and la can be prepared by known methods or 10 modifications thereof (seel for example, Rodd's Chemistry of Carbon Compounds, S.
Coffey, M. F. Anse!l (Editor); Elsevier, Amsterdam, 1989; Vol. IV Part IJ, p. 301-311.
Heterocyclic Compounds. R. C. Elderfield (Editor); Wiley, New York, 1957; Vol. 6, p.
491-495)-The present invention furthermore includes a process for the preparation of 15 compounds of the formulae I and la as explained in 1) - 4) above, which comprises A) for preparing compounds of the formula I where X is oxy~en and the radicals R1, R2, R3, R4 and R5 are as defined under 1) - 4), reacting a compound of the formula ll H
I
R n~N~R 3 ( I I ) with the definitions mentioned under 1) - 4) applying to R1, R3 and R4, with a compound of the ~ormula lll R-Z
;
2 ~
where R has the meanings for R5 and R2 which have been mentioned above under 1) -4) with the exception of hydrogen, hydroxyl, Cl-C6-alkoxy, aryloxy, C1-C8-acyloxy, amino, C,-C6-alkylamino, di(C1-C;6-alkyl)amino, arylamino and C,-C6-acylamino, and Z is a leaving group, 5 or B) preparing compounds of ~he formula I where X is sulfur and R1, R2, R3, R4 and R5 are as defined under 1) - ~) by reacting a compound of the formula I where X is oxygen and the definitions mentioned under 1) - 4) apply ~o R1, R2, R3, R4 and Rs, with a sulfurizing reagent, 10 or C) preparing compounds of the formula la where X and the radicals R1 to Rs are as defined under 1) - 4), by reacting a compound of the formula IV
H
I
R ~ ~N~R 3 ( I V
20 or R 1 n~N~ ( I V ~ ) where the definitions mentioned under 1) - 4) apply to R1, R3, R4 and R5, with acompound of the tormula lll 2~3 R2 z (111) where the definitions described under 1) - 4) for formula I and la apply to R2, with the exception of hydrogen, hydroxyl, C1-C8-alkoxy, aryloxy, C1-C6-acyloxy, amino, 5 C,-C6-alkylamino, di(C1-C6-alkyl)amino, arylamino or C1-C6-acylamino, and Z is a leaving group, or D) preparing compounds of the formula I where X is oxygsn and the radicals R' to Rs are as defined under 1) - 4) by cyclizing a compound of the formula V
I
R n ~ J~R 3 V
R
where R' to Rs are as defined under 1) - 4) and Y is hydroxyl, C1-C4-alkoxy, optionally halogenated C,-C4-acyloxy, chlorine, bromine or iodine, or 20 E) preparing compounds of the formula i where X is oxygen, R4 and R5 are hydrogen and the definitions mentioned under 1) - 4) apply to R1 to R3, from the quinoxalinones of the formula Xl 25 R ~N~R 3 X I
where R1 to R3 are as defined under 1) - 4), by addition of hydrogen on the C=N
30 bond, 2 ~
or F) preparing compounds of the formuia I where X is oxygen and Rl to R5 are as defined under 1) - 4), from compounds of the formula Vl R 1 ~N H V I
N H
where R1, R2 and R5 are as defined under 1) - 4), by reacting them with chloroform or bromoform and a carbonyl cornpound of the formula Xlll R3-Co-R4 Q(lll) where R3 and R4 are as defined under 1) - 4), or with a-(trihalomethyl)alkanols of the formula XIV
Hal3C-C(OH)-R3R4 (XIV) where Hal is Cl, Br or 1, in which R3 and R4 are as defined under 1) - 4), 25 or G) praparing compounds of the formula I where X is oxygen and R', R2, R3, R4 and R5 are as defined under 1) - 4), by reacting a compound of the formula I where X isoxygen and the definitions mentioned und0r 1) - 4) apply to Rl, R2, ~5 and to R3 and R4, with the exception that at least one of the radicals R3 or R4 is hydrogen; ~ith an 30 alkylating reagent of the formula XV
2 ~
R'-Z (XV) where R' has the meanings mentioned above for R3 and R4 with the exception of hydrogen and Z is a leaving group, or H) preparing compounds of the formula I where X is oxygen, Rl, R2, R3 and R4 are as defined under 1) - ~) and R5 is C1-C8-alkyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, pheno)~y, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl, carbamoyl, C3-C8-alkenyl, optionally substitut~d by fluorine, chlorine, bromine, iodine, hydroxyl, Cl-C6-acyloxy, benzoyloxy, phenoxy, C:l-C6-alkoxy, C,-C6-alkylamino, di(C1-C6-alkyl)amino, Cl-C6-alkylthio, cyano, carboxyl or carbamoyl, C3-C8-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylarrlino, di(Cl-C6-alkyl)amino, C1-C6-alkyi-1~ thio, cyano, carboxyl or carbamoyl, C4-Ca-cycloalkyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, Cl-C6-alkoxy, C1-C6-alkylamino, di(Cl-C6-alkyl)amino, C,-C6-alkylthio, cyano, carboxyl or carbamoyl, Cs-C6-cycloalkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, Cl-C6-alkoxy, C,-C;6-alkylamino, C1-C6-dialkylamino, Cl-C6-alkylthio, cyano, carboxyl or carbamoyl, (C1-C6-alkoxy)-(C1-C6-alkyl), di(C1-C6-alkylamino)-(C1-C6-alkyl) or (C3-C6-cycloalkyl)alkyl, (C6-C8-cyclo-alkenyl)alkyl, or arylalkyl, naphthylalkyl or heteroarylalkyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 oarbon atoms, by reductive alkylation of a compound of the formula I where R5 is hydrogen and X is oxygen and the definitions mentioned under 1) - 4) ~pply to R1, F~2, R3 and R4, with a carbonyl compound of the formula XVI, 2~5~5 R''-C(=O)-R''' (XVI) whsre R" and R~" are identical or different and independently of one another arehydrogen, C,-C7-alkyl, optionally substituted by fluorine, chlnrine, bromine, iodine, hydroxyl, C,-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, Cl-C6-alkylamino, ditC.-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl, C3-C7-alkenyl, optionally substituted by fluorine, chlorin~, bromine, iodine, hydroxyl, C,-C6-acyloxy, benzoyloxy, phenoxy, C,-C6-alkoxy, Cl-C5-alkylamino, di(C,-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbarnoyl, C3-C7-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C,-C;6-acyloxy, benzoyloxy, phenoxy, C,-C6-alkoxy, C,-C6-alkylamino, di(C,-C6-alkyl)amino, C,-C6-alkylthio, cyano, carboxyl or carbamoyl, C4-C8-cycloalkyl, optionally substituted by fluorine, chlorine, brornine, iodine, hydroxyl, C1-C6-acyloxy, benzoyioxy, phenoxy, C,-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)arnino, C,-C6-alkylthio, cyano, carboxyl or carbamoyl, C6-cycloalkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C,-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, Cl-C6-alkylamino, di(C,-C5-alkyl)amino, Cl-C6-alkylthio, cyano, carboxyl or carbamoyl, (C,-C6-alkoxy)-(C,-C5-alkyl), [di(C1-C6-alkyl)aminol-(C1-Cs-alkyl) or (C4-C6-cycloalkyl)alkyl, (C6-cyeloalkenyl)alkyl, or arylalkyl, naphthylalkyl or heteroarylalkyl, each of which is substituted by up to five radicals R5 which are independent of one another, it being possible for the alkyl radical to contain in each case 0 to 2 carbon atoms, and where R" and R"' can be linked to each other to form a 4- to 8-membered ring, or 1) preparing compounds of the formula I where X is oxygen and R1, R2, R3 and R4 are as defined under 1) - 4) and R5 is Cl-C8-alkyloxycarbonyl, C1-C8-alkylthiocarbonyl, C2-C~-alkenyloxycarbonyl, C2-C8-alkenylthiocarbonyl, C2-C8-alkynyloxycarbonyl, Cl-C6-alkylaminocarbonyl, C3-C6-alkenylaminocarbonyl, di(C,-C6-alkyl)aminocarbonyi, pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, 4-methylpiperæin-1-ylcarbonyl, optionally substituted by fluorine, chlorine, bromine3 iodine, cyano, amino, mercapto, 30 hydroxyl, C1-C6-acyloxy, ben~oyloxy, benzyloxy, phenoxy, C1-G6-alkoxy, .
2 ~
C1-C6-alkylamino, di(Cl-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsul-fonyl, oxo, thioxo, carboxyl or carbamoyl;
or aryloxycarbonyl, arylthio(carbonyl), arylaminocarbonyl, heteroaryloxycarbonyl, heteroary!thiocarbonyl, hateroarylaminocarbonyl, arylalkyloxycarbonyl, (aryl-5 alkylthio)carbonyl, arylalkylaminocarbonyl, heteroalkyloxycarbonyl, (heteroalkylthio)carbonyl or heteroalkylaminocarbonyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms, by reacting a compound of the formula X\/ll n ~ ~R 3 )( V I I
to ( C H 2 ) n where the definitions mentioned under 1~ - 4) apply to R1, p~2, R3 and R4, n is 0, 1, 2 or 2a 3, X is oxygen and U is a leaving group, with a compound of the formula XVIII
Nu-H ~NIII) where Nu is Cl-C8-alkoxy, C2-Ca-alkenyloxy, C2-C~-alkynyloxy, C,-CB-alkylthio, C2-C8-alkenylthio, Cl-C8-alkylamino- and di(C,-Ca-alkyl)amino, C2-C8-alkenylamino- and di(C1-C6-alkyl)amino, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C,-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C,-C4-alkylthio, pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl- or 4-methylpipera~in-1-ylcarbonyl, optionally substituted by C,-C4-alkyl, C2-C~-alkenyl, C,-C4-acyl, oxo, thioxo, carboxyl or phenyl, or aryloxy, arylthio, arylamino, arylalkyloxy, arylalkylthio, arylalkylamino, 2 ~
heteroaryloxy, heteroarylthio, heteroarylamino, heteroarylalkyloxy, heteroarylalkylthio or heteroarylalkylamino, each of which is ~ubstituted by up to five radicals R6 (R6 is as defined at the outset) which are independent of one another, it being possible for the alkyl radical to contain in aach oase 1 to 3 carbon atoms.
The abovementioned method A preferably proceeds under the following conditions:
The substituent Z in formula lll is a suitable leaving group such as, for example, chlorine, bromine or iodine, a suitable radical of sulfuric acid, an aliphatic or aromatic 10 sulfonate, or optionally halogenated acyloxy.
The reaction is expediently carried out in an inert sol\lent. Suitable solvents are, for example, aromatic hydrocarbons such as toluene or xylene, lower alcohols such asmethanol, ethanol or 1-butanol, ethers such as tetrahydrofuran or glycol dimethyl 15 ether, dipolar aprotic solvents such as N,N-dimethylforrnamide, N-methyl-2-pyrro-lidone, acetonitrile, nitrobenzene, dimethyl sulfoxide, or mixtures of these solvents.
Two-phase systems with aqueous solutions of bases in the presence of a phase transfer catalyst such as, for example, benzyltriethylammonium chlorid~, are also possible.
The presence of a suitable base, for example of an alkali metal carbonate, alkali metal hydrogen carbonate, alkaline earth mstal carbonate or alkaline earth rnetal hydrogen carbonate such as sodium carbonate, calcium carbonate or sodium bicarbonate, of an alkali metal nydroxide or alkaline earth metal hydroxide such as potassium hydroxide 25 or barium hydroxide, an alcoholate such as sodium ethanolate or potassium tert.-butylate, an organolithium compound such as butyllithiurn or lithiumdiisopropylamine, an alkali metal hydride or alkaline earth rnetal hydride such as sodium hydride or calcium hydride, an alkali metal fluoride such as potassium fluoride, or an organic base such as triethylamine or pyridine for scavenging the acid which is liberated 30 during tne reaction, may be expedient.
2 ~
In some cases, the addition of an iodide, for example potassium iodide, is expedicnt.
The reaction is generally carried out at temperaturss between -10 and 160C, preferably at room ternperature.
5 To carry out this reaction, any nucleophilic substihJents such as, ~or example, hydroxyl, mercapto or amino groups, with the exGeption o~ the 1- and/or 4-position in compounds of the formula ll or lll, must, before the reaction is carried out, bederivatized in a suitable manner or provided with conventional protective groups such as, for example, acetyl or benzyl, which can then be eliminated.
The sulfurizing reagent which is preferably used for the reaction as described above under B) is 2,4-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphetane 2,4-disulfide (Lawesson's reagent), bis(tricyclohexyltin) sulfide, bis(tri-n-butyltin) sulfide, bis(triphenyltin) sulfide, bis(trimethylsilyl) sulfide or phosphorus pentasulfide. The 15 reaction is carried out expediently in an organic solvent or in a solvent mixture, at room temperature or above, preferably at the boiling point of the reaction mixture, and, if possible, under anhydrous conditions. Suitable substances are, for example, carbon disulfide, toluene, xylene, pyridine and 1,2-dichloroethane. If the tin sulfides or silyl sulfides which have been mentioned are used, it is advisable to carry out the 20 sulfurization reaction in the presence of a Lewis acid, such as boron trichloride.
In the presence of other carbonyl groups in a compound of the formula 1, for example in a compound where X is oxygen and one or more radicals p~1 to R6 are acyl, thecarbonyl is to be protected by known methods prior to the sulfurization reaction by a 25 suitable protective group, for example by acetalization; subsequent elimination of the protective groups results in the desired compound.
For the reaction described above under C, the substituent Z is a suitable leaving group, preferably chlorine, bromine or iodine, a suitable radical o~ sulfuric acid, an 30 aliphatic or aromatic sulfonate, or optionally halogenated acyloxy.
2~$~
The reaction conditions for this reaction correspond to those of method A.
The cyclization described under D) is effec~ed in a suitabie solvent such as rnethanol, ethanol, N,N-dimethylformamide or N-methylpyrrolidone, in the pres~nce of a base;
S suitable bases are alkali metal carbonates, alkali nnetal hydrogen carbonates, alkaline earth metal carbonates or alkaline earth metal hydrogen carbonates such as sodium carbonate, calcium carbonate or sodium bicarbonate, alkali metal hydroxides or alkaline earth metal hydroxides such as potassium hydroxide or bariu~ hydroxide,alcoholates such as sodium ethanolate or potassium tert.-butylate, organolithium10 compounds such as butyllithiurn or lithium diisopropyiamine, aikali metal hydrides or alkaline earth metal hydrides such as sodium hydride or calcium hydride, or an organic base such as triethylamine or pyridine - the latter substances can also be used as solvents, or organic or mineral acids such as glacial acetic acid, trifluoroacetic acid, hydrochloric acid or phosphoric acid. The reaction is preferably earried out at temperatures between 20 and 120C, particularly preferably at room temperature.
The compounds of the formula V, where R1 to R5 and Y are as defined under 1) - 5), can be obtained from compounds of the formula Vl R n~N H V I
where R', R2 and R5 are as defined under 1) - 4), by alkylation with a compound of the formula Vll ~.
.
2~$~
C O - Y
kR3 V I I
5 where R3, R4 and Y are as defined under 1) - 5) and Z is as defined undar A). The reaction conditions for this alkylation correspond to those given in method A.
Simultaneous cyclization to give the dihydroquinoxaline of the formula I takes place under suitable conditions.
10 Compounds of the formula V in which R', R3 to R5 and Y are as defined under 1) - 5) and R2 is hydrogen can also be prepared from compounds of the formula Vlll R 1 ~XN/~ ( V I I I ) where R', R3 to Rs and Y are as defined under 1) - 5) by reducing ~he nitro group by known processes to the amino group.
Simultaneous cyclization to give the dihydroquinoxaline of the formula I takes place under suitable conditions, for example by carrying out the reduction in the presence of an acid.
The reduction is carried out by standard methods (see, for example, Methoden derOrganischen Chemie [Methods in Organic Chemistry3 (Houben-Weyi), E. Muller (Editor); G. Thieme Verlag, Stuttgart, 1957; Vol. Xl/1, p. 360-490), for example using tin(ll) chloride in glacial acetic acid, TIC13 in hydrochloric acid, or by catalytic hydrogenation, the choice of reagent being determined by the chemical stability of the various substituents R1 and R3 to R5; if, for example, one of the radicals is alkenyl, the first method will be selected to obtain the double bond.
;
The phenylenediamines of the formula Vl which are required as startin0 materials for the syntheses described are known from the literature or commercially available or can be synthesized by methods known from the literature.
5 N-ortho-nitrophenylamino acid derivatives of the formula Vlll, where Rln and R3 to Rs are as defined under 1) - 4) and Y is oR7, where R7 is hydrogen, C,-C6-alkyl, optionally in each case for example halo~en-substituted phenyl, benzyl or 9-fiuorenylmethyl, can be obtained for example by amination of ortho-halonitro aromatic substances of the formula IX
,~N 2 R n~ t ll I x ~w where R' is as defined under 1) - 4) and W is fluorine, chlorine, bromine or iodine, with 15 amino acids or their esters of the formula X
~R~ X
R S
where R3, R4, Rs and R7 are as defined under 1) - 5). The reaction can be carried out in the presence of an inorganic or organic auxiliary base such as, for exampie, sodium carbonate, potassium carbonate, sodium hydroxide or triethylamine. It is advantageous to use an inert solvent at temperatures between 0 and 150C, preferably at reflux temperature. Suitable solvents are open-chain or cyclic ethers, for example tetrahydrofuran or glycol dimethyl ether, aromatic hydrocarbons, for example toluene or chlorobenzene, alcohols, for example ethanol, isopropanol or glycol monomethyl ether, dipolar aprotic solvents, for ~xample N,N-dimethylformamide, N-methyl-2-pyrrolidone or 1,3-dimethyl-tetrahydro-2~1H)-pyrimidinone.
2 ~
The N-ortho-nitrophenylamino acids of the formula Vlll where Y is hydroxyl can, if desired or necessary, be converted by well-known standard methods into the acid derivatives of the formula Vlll where Y is hydroxyl, C:1-C4-alkoxy, optionally halogenated C,-C4-acylo)ty, chlorine, bromine or iodine.
Ortho-halonitroaromatic compounds of the formula IX and amino acids of the formula X are known from the literature and comrnercially available or can be prepared by methods known from the literature.
The reaction described above under E) is preferably effected by means of catalytic hydrogenation (using hydrogen) or hydrosilylation (using alkylsilanes, for example diphenylsilane) in the presence of a hydrogenation ca~alyst, for example Raney nickel or palladium-on-charcoal, at a hydrogen pressure of 1 to 5 bar, or by means of areducing agent from the class of the complex metal hydrides such as sodium borohydride or sodium cyanoborohydride, or using metals, or metal salts, and acid such as, for example, zinc/glacial acetic acid or SnCI2/HCI. It is advantageous to carry out the reaction in an inert solvent such as lower aicohols, for example methanol or isopropanol, ethers such as tetrahydrofuran or glycol dimethyl ether, dipolar aprotic solvents such as N,N-dimethylformamide, aromatic hydrocarbons such as toluene orxylene, or mixtures of these solvents, at temperatures between -20 and 100C, preferably at room temperature.
If a chiral hydrogenation catalyst, for example di-/u-chloro-bis[(cycloocta-1c,5c-diene~-rhodium(l)]/(~) or (-)-4,5-bis-(diphenylphosphinomethyl)-2,2-dimethyl-1,3-dioxolane, or a chiral complex metal hydride, for example sodium tris-lN-benzyloxycarbonyl-L-prolinoyloxy)-borohydride, are used in the above-described reaction, the individual enantiomers can be prepared selectively.
If, in compounds of the formula Xl, substituents are present which can be hydrogenated or reduced under the above-described conditions, for example oxo, it is 2 ~
necessary to use an intermediate of the formula Xl with substituents which are not attacked, but which can be derivatized to give the ~roup raquired, for example hydroxyl. The substituents can also be provided with a customary protective group, for example an acetal protective group, which can then be removed after th~ above-des-5 cribed reaction.
Quinoxalinones of the formula Xl where R1 to R3 are as defined uncler 1) - 4) can be obtained by known processes by condensing a phenylenediamine of the formula Vl, where R' and R2 are as defined under 1) - 43 and Rs is hydrogen, with an alpha-10 ketocarboxylic acid of the formula Xll R3-Co-CooH (Xll) where R3 is as defined under 1) - 4).
15 The reaction is expediently carried out in an inert solvent in a temperature range of between 0 and 150C; examples of suitable solvents are alcohols, for exampls ethanol or isopropanol, open-chain or cyclic ethers, for example glycol dimethyl ether or tetrahydrofuran, or dipolar aprotic solvents, for example N,N-dimethylformamide or acetonitrile.
2~
The reaction described above under F) is expediently carried out in a two-phase system cornposed of an organic solvent or solvent mixture which is not miscible with water, composed of, for example, halogenated hydrocarbons, for example dichlorornethane or 1,2-dichloroethane, or aromatic hydrocarbons, for example toluene 25 or xylene, and a concentrated aqueous solution of an alkali metal hydroxide or alkaline earth metal hydroxide, for example sodium hydroxide or barium hydroxide. The presence of a phase transfer catalyst such as, for example, benzyltriethylammonium chloride or tetrabutylammonium ~romide, is advantageous.
The reaction is usuaily carried out at temperatures be~ween 0 and ~0C, preferably at 30 room temperatur~.
2 ~
Substituents in compounds of th~ ~ormulae Vl and Xlll, or XIV, which arc not stable under the reaction conditions must be replaced by those which can be derivatized to the required group. The substituents can also be provided with a customary protective group which can then ~e removed a~ter the above-described reaction.
In the reaction described above under G), Z in formula XV is a suitabl~ leaving group such as, for example, chlorine, bromine or iodine, a suitable sulfuric acid radical, an aliphatic or aromatic sulfonate, or optionally halogenated acyioxy.
10 The reaction conditions for this reaction correspond to those in method A.
The reaction described under H) is preferably effected by catalytic hydrog0nation (using hydrogen) in the presence o~ a hydrogena~ion catalyst, for example palladium-on-charcoal, at a hydrogen pressure of 1 to 5 bar, or by means of a reducing agent 15 from the class of the complex metal hydrides, such as sodium borohydride, sodium triacetoxyb¢rohydride or sodium cyanoborohydride.
The reaction is expediently carried out in an inert solvent, sur,h as lower alcohols, for example methanol or isopropanol, ethers, for example tetrahydrofuran or glycol 20 dimethyl ether, halogenated hydrocarbons, ~or example dichloromethane or dichloroethane, at temperatures between -20 and 100C, preferably at room tempera-ture. The presence of an acid such as, for example, acetic acid or trifluoroacetic acid, or of a Lewis acid such as, for example, titanium tetrachloride, is advantageous. If, in compounds of the formulae I and XVIJ substituents are pres~nt which can be 25 hydrogenated or reduced under the above-described conditions, for example oxo, the use of an intermediate of the formulae I and XVI with substituents which are notattacked but which can be derivatized to the required group, for example hydroxyl, is necessary. Acid-labile groups such as, for example, acetals, or groups which react under the reaction conditions, such as, ~or exarnple, primary amines, are also ~o be 30 avoided or to be provided with a customary protective group.
2 ~
The reaction described under 1) is expediently carried ou~ in an inert solvent. Examples of suitable solvents are aromatic hydrocarbons such as toluene or xylene, lower alcohols such as methanol, sthanol or 1-butanol, ethers such as tetrahydrofuran or glycol dirnethyl ether, dipolar aprotic solvents such as N,N-dimethylformamide, N-methyl-2-pyrrolidone, acetonitrile, nitrobenzene, dimethyl suHoxid~, or mixtures of these solvents. Two-phase systems wlth aqueous solutions of bases in the presence of a phase transfer catalyst such as, for example, benzyltriethylamrnonium chloride, are also possible.
The presence of a suitable base, for example an alkali metal hydroxide or alkaline earth metal hydroxide such as potassium hydroxide or barium hydroxide, of an alcoholate such as sodium ethanolate or potassium tert~-butylate, an or~anolithium compound such as butyllithium or lithium diisopropylamide, an alkali metal hydride or alkaline earth metal hydride such as sodium hydride or calciurn hydride, an alkali metal fluoride such as potassium fluoride, or an organic base such as triethylamine orpyridine, may be useful. The reaction is usually carried out at temperatures between -10 and 160C, preferably at room temperature.
To carry out this reaction, any nucleophilic ~ubstituents in compounds XVII and XVIII
which do not participate in the reaction, such as, for example, hydroxyl, mercapto or arnino groups, are to be derivatized in a suitable manner or to be provided withcustomary protective groups such as, for example, acetyl or benzyl, which can then be eliminated.
The compounds XVII which are required for the abovementioned reaction and in which the definitions described under 1) - 4) apply to R', p~2, R3 and R4, n is 0, 1, 2 or 3, X is oxygen and U is a suitable leaving group, halogen ~uch as, for example, chlorine, bromine, iodine, a halogenated aliphatic or aromatic alcoholate such as, for example, 2,2,2-trichloroethoxy, chlorophenoxy, or ~ heterocycle which is linked via nitro~en such as, for example, imidazolyl, tria~olyl or benzotri~olyl, are prepared by reac~ing a compound of the formula I where Rs is hydrogen and X is oxygen, and the definitions 2 ~ 8 ~
~4 described under 1) - 4) apply to R', R2, R3 and R4, with a suitable carbonic acid derivative, for exarnple phosgene, diphosgene, triphosgene, trichloroethyl chloroformate or carbonyldiimidazole, or with a suitable halo carbonyl halide, for example bromoacetyl chloride.
The reaction is expediently carried out in an inert solvent. Examples of suitable solvents are aromatic hydrocarbons such as toluene or xylene, ethers such as tetrahydrofuran or glycol dimethyl ether, or halogenated hydrocarbons such as dichloromethane or dichloroethane.
The presence of a suitable base, for exarnple of an alkali metal hydroxide or alkaline earth metal hydroxide, such as potassium hydroxide or bariurn hydroxide, or an organic base such as triethylamine or pyridine, may be useful.
15 The reaction is usually carried out at temperatures be~veen -30 and 16ûC, preferably at room temperature.
The present invention furthermore relates to the compounds as described under 1) to 4) as pharmaceuticals, preferably for treating viral diseases, in particular diseases 20 caused by HIV.
The invention furthermore relates to pharrnaceuticals comprising at least one compound according to the invention, and to the use of the abovementioned compounds for the preparation of pharmaceuticals, preferably for the treatment of viral 25 diseases, in particular for the treatment of diseases caused by HIV.
The present invention furthermore relates to the use of compounds of the abovementioned formula I or IA in which 2 ~ 8 ~
~5 n is zero, one, two, three or four, the individual substituents R1 independentiy of one another are fluorine, chlorine, bromine, iodine, ~rifluoromethyl, trifluoromethoxy, hydroxyl, C,-C8-alkyl, Cs-C8-cycloalkyl, C1-C6-alkoxy, (C,-C6-alkoxy)-(Cl-C;4-alkXY3, C1-C6-alkylthio, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, nitro, amino, æido, C1-C6-alkylamino, di(C,-C6-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, thiomorpholino, imidazolyl, triazolyl, tetrazolyl, C1-C6-acyl, C1-C6-acyloxy, C1-C6-acylamino, cyano, carbamoyl, carboxyl, (C,-C6-alkyl)oxycarbonyl, hydroxysulfonyl, sulfamoyl 1~
or a phenyl, phenoxy, phenoxycarbonyl, phenylthio, phenylsulfinyl, phenylsulfonyl phenoxysulfonyl, phenylsulfonyloxy, anilinosulfonyl, phenylsulfonylamino, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which is substituted by up to five radicals R6 which are independent of one another, where R6 can be fluorine, chlorine, bromine, iodine, cyano, trifluoromethyl, trifluoromethoxy, nitro, amino, azido, C,-C6-alkyl, C3-C8-cycloalkyl, C1-C:6-alkoxy, C1-C6-alkylthio, C1-Cs-alkylsulfinyl, C;l-C6-alkylsulfonyl, C,-/:~6-alkylamino, di(C,-C6-alkyl)amino, (Cl-C6-alkyl)oxycarbonyl, phenyl, phenoxy, 2-, 3- or 4-pyridyl, 2~6~5 R2 and R5 are identical or different and independently of one another are hydrogen, hydroxyl, C,-C6-alkoxy, aryloxy, Cl-C6-acyloxy, cyano, amino, C,-C6-alkylamino, di(C1-C6-alkyl)amino, arylamino, C,-C~-acylamino, Cl-C8-alkyl,optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyi, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, Cl-C~-alkoxy, C,-C6-alkylamino, di(C1-C6-alkyl)amino, C,-C6-alkylthio, C,-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
C2-Ca-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C,-C6-alkyl)amino, C,-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl and carbamoyl;
C3-C~,-allenyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C3-CB-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, m0rcapto, hydroxyl, C,-Cs-acyloxy, benzoyloxy, ben7yloxy, ph~noxy, Cl-C6-alkoxy, Cl-C6-alkylamino, di(C1-C6-alkyl)amino, C,-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
C3-CB-cyClOalkyl~
optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, 2~3~
~7 Cl-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C,-C~-alkylamino, di(C,-C6-alkyl)amino, C1-C6-alkylthio, Cl-C6-alkylsulfonyl, phenylsuKonyl, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine, chiorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C;6-alkoxy, Cl-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsul~onyl, oxo,thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkyl)-(C1-C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1 C6-alkylthio, Cl-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkenyl)-(C1-C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C:1-C6-alkoxy, C,-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsuHonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
~5 C1 -C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C;6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkyiamino, 2 ~
di(C1-C6-alkyl)amino, C1~C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo,thioxo, carboxyl or carbamoyl;
C2-C8-alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl,C,-C4-alkoxy, oxo, phenyl;
(C3-C8-cycloatkyl)carbonyl, op~ionally substituted by fluorine, chlorin~ or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C8-cycloalkenyl)carbonyl, optionally substituted by fluorine~ chlorine or hydroxyl, C1-C4-alkoxy, oxo, pnenyl;
(C3-Ca-cycloalkyl)-(C1-C3-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C6-cycloalkenyl)-(Cl-C3-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C8-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(Cl-C4-alkyl)amino, C1-C4-alkylthio;
C2-Ca-alkenyloxycarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C,-C4-alkoxy, oxo, phenyl;
C2-Ca-alkynyloxycarbonyl, op~ionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C8-alkylthiocarbonyl, optionally substituted by ~luorine, chlorine, hydroxyl,C1-C4-alkoxy, oxo, phenyl;
2 ~
C2-C0-alkenylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, Cl-C4-alkoxy, oxo, phenyl;
C1-C~-alkylarnino- and di(C1-Ca-alkyl)aminocarbonyl, in each cas~ optionally substituted by fluorine, chlorine, hydroxyl, Cl-Cs-alkoxy, oxo, phenyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1-ylcarbonyl, in each case optionally substituted by C1-C4-alkyl, C2-~6-alkenyl,C,-C4-acyl, oxo, thioxo, carboxyl, or phenyl;
C2-C8-alkenylamino- and di(C1-C6-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C,,-alkoxy, oxo, phcnyl;
C1-C6-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C~-C4-alkoxy, oxo, phenyl;
C1-C6-alkenylslilfonyl, optionally substituted by fluorine, chlorine, hydroxyl, Cl-C4-alkoxy, oxo, phenyl;
or aryl, arylcarbonyl, aryl(thiocarbonyl), (arylthio)carbonyl, (arylthio)thiocarbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino)thiocarbonyl, arylalkylaminocarbonyl, arylsulfonyl, arylalkyl, arylalkenyl, arylalkynyl, arylalkyl-carbonyl, arylalkenylcarbonyl, ary1alkoxycarbonyl or aryl~alkylthio)carbonyl, each of which is substituted by up to five radioals R6 which are independent ~f one another, it being possible for the alkyl radical to contain in each case 1 to 5 carbon atoms, and R6 being as defined above, or heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkylcarbonyi or heteroarylalkenylcarbonyl, heteroaryloxycarbonyl, (het~roarylthio)carbonyl, heteroarylaminocarbonyl, heteroarylalkyloxycarbonyl, 2 ~
heteroaryl(alkylthio)carbonyl or heteroarylalkylaminocarbonyl, each of which is substituted by up to three radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms, R3 and R4 are identical or different and, independently of one another~ are hydrogen, C,-C8-alkyl which is optionally substituted by fluorine, chlorine, hydroxyl, amino, mercapto, C,-C~-acyloxy. benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C1-C4-alkylamino, di~C1-C4-alkyl)amino, Cl-C"-alkylthio, Cl-C4-alkylsulfonyl, Cl-C4-alkylsulfinyl, carboxyl or carbarnoyl;
C2-C8-alkenyl, optionaliy substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, ben~yloxy, phenoxy, Cl-C4-alkoxy, Cl-C4-alkylamino, di(Cl-C4-alkyl)amino, C1-C4-alkylthio, C,-C4-alkylsulfonyl, Cl-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-Ca-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyl, amino,mercapto, C,-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C,-C4-alkoxy, C,-C4^
alkylamino, di(C,-C4-alkyl)amino, Cl-C4-alkylthio, C,-C4-alkylsulfonyl, C,-C4-alkylsulfinyl, carboxyl or carbamoyl C3-CB-cycloalkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C,-C~,-acyloxy, benzoyloxy, bsnzyloxy, phenoxy, C,-C4-alkoxy, C,-C,,-alkylamino, di(Cl-C4-alkyl)amino, S:~l-C4-alkylthio, Cl-C4-alkylsulfonyl, Cl-C4-alkylsulfinyl, carboxyl or carbamoyl;
aryl, arylalkyl, heteroaryl or heteroarylalkyl, each of which is substituted by u,p to five radicals R6 which are independent of one another, it being possibi~ for thealkyl radical to contain 1 to 3 carbon atoms in eaeh case, and R6 bein0 as defined above, 2 ~
R3 and R4 or R3 and R5 can furthermore aiso be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 8 carbon atoms and which can optionally be substituted by fluorine, chlorine, hydroxyl, amino, C1-C6-alkyl, C2-CB-alkenyl, C2-C6-alkynyl, C,-C6-acyloxy, benzoyloxy, C1-C6-alkoxy, oxo, thioxo, carboxyl, carbamoyl or phenyl, X is oxy~en, sulfur, selenium or substituted nitrogen N-P~2, it being possible for R2 to have the abovementioned meanings, for the preparation of pharmaceuticals ~or the treatment of viral diseases.
The compounds mentioned and elucidated above under 1)-4) are preferred for this use.
The pharmaceuticals according to the invention can be aclministered enterally (orally), parenterally (intravenously), rectally, subcutaneously, intramuscularly or locally (topically).
They can be administered in the form of solutions, powders, (tablets, capsules including microcapsules), ointments (creams or gels) or suppositories. Suitable ad~uvants for such formulations are the liquid or solid fillers and extenders, solvents, emulsifiers, glidants, flavorings, colorings and/or buffer substances which are customary in pharmacology.
0.1 - 10, pr~erably 0.2 - 8 mg/kg of body weight are administered on~e or several times daily as an expedient dosage. The dosage units used depend expediently on the specific pharmacokinetics of the substanc~ usecl, or on the pharmaceutical formulation used.
2 ~
For example, the dosage unit of the compounds according to the invantion is 1 - 1500 mg, preferably 50 - ~00 mg.
The compounds according ~o th0 invention can also be administered as a combination with other antiviral agents such as, for example, nucleoside analogs, protease inhibitors or adsorption inhibitors, immunostimulants, interferons, interleukins and colony-stimulating factors ffor example (àM-CSF, G-CSF, M-CSF).
Activity tests Test of preparations against HIV in cell culture Description of method Medium:
RMPI pH 6.8 Complete medium additionally contains 20% fetal calf serum and 40 IU/ml recombinant interleukin 2.
Cells:
Lymphocytes which have been isolated frorn fresh donor blood by means of Ficoll~gradient centrifugation are cultured for 36 hours in complete medium with an addition of 2 ,L~g/ml phytohemagglutinin ~IVellcome) at 37C under 5% of CO2. A~ter 10% of DMSO has been added, the cells are frozen at a density of 5 106 and stored in liquid nitrogen. For the test, the cells are defrosted, washed in RPMI medium and cul~ured for 3 - 4 days in the complete medium.
Mixture:
The test preparations were dissolved in DMSO at a concentration of 16.7 mg/ml and diluted in complete medium to 1 mg/ml.
0.4 ml of medium was introduced into 24-multiwell dishes. 0.1 ml of ~he dissolvsd 2~6~9~
preparation was ad~ed to the upper row of the dish, and, by transferring 0.1 ml portions, a geometric dilution series was established. Controls without preparation always contained 0.4 ml of complete medium containing 0.5% of DMSO. Lymphocyte cultures with a cell density of 5 ~ 105 cells/ml were infected by adding 1/50 volume 5 supernatant from HlV-infected Iymphocyte cultures. The titer of these culture supernatants was determined by end-point titration as 1 5 106 infectious units/ml.
After 30 minutes' incubation at 37C, the infected Iymphocytes were removed by centrifugation and taken up in an equal volume of medium. From this cell suspension, 0.6 ml aliquots were transferred into all wells of the test plate. The mixtures were 10 incubated for 3 days at 37C.
Evaluation:
The infected cell cultures were examined under the microscope for the presence of giant cells, which indicate active virus multiplication in the culture. The lowest 15 concentration of preparation where no giant cells were observed was de~ermined as inhibitory concentration against HIV. As a control, the supernatants from the culture plates were tested for the presence of HIV antigen with the aid of an HIV antigen test following the manufacturer's instructions (Organon).
20 Results:
The results from this test are shown in Table 1.
Compound ofT-cell oulture assay Examp e No. MIC (ug/ml) ~ .
IV >0,8 _ _ Vl-A 0,16 2~$~85 _ _ Compound of T-cell culture assay Example No. MIC ~ug/ml) Vl-B 20 ¦
Vl-C < 0,8 Vll < 0,16 X 0,8 Xll < 0,8 Xlll < 0,16 . . _ ^11 XIV <0,16 3-7 0,08 ~1 3-21 0,16 . 11 3-23 0,08 3-24 0,08 3-25 0,4 3-26 0,4 ._ 3-29 < 9,4 3-30 . _ 3-32 < 0,4 3-33 -- 0,4 3-36 < 2,0 3-44 ' __ 2 ~ 5 _ ~ I
Compound of T-cell culture assay ¦ Example No. MIC Cug/ml) 3-48 <0,8 3-49 0,8 3-52 >0,8 __ 1 3-53 > 0,8 3-57 < 0,8_ 3-62 ~4,0 3-64 > 0,8 3-66 > 0,08 3-67 < 0,8 3-73 > 0,4 3-75 <0,8 3-76 ~ 0,08 3-80 ~,4 ¦ 3-81 0,08 3-87 > D B
3-88 - 0,8 XX <4,0 6-1 0,4 6-16 0,3 Compound of T-cell cul~ure assay Example No. ~ MIC ~g/ml) 6-17 < 0,8 6-19 < 0,8 6-20 <0,8 6-22 > 0,8 _ 6-27 < 0,4 6-32 c 0,08 6-33 > 0,8 6-34 ` - < 0,4 ¦ 6-35 < D,08 6 33 0,8 L 6-39 0,4 6-50 < 0,01 I
XXIII 0,01 l 7-1 < 0,16 7-2 < 0,01 _ I
7-3 ~ 0,01 I
1 7-7 0,04 ¦ 7-1 D ~ 0,04 ~7 2~p~
_._ . .
Compourld of T-cell culture assay Example No. MIC ~ug/ml) 7-11 < 0,01 7-12 < 0,8 ¦
7-13 < 0,08 7-14 < 0,08 7-16 0,4 7-21 < 0,01 ... . .. . _ ~
7-22 < 0,01 ¦ 7-23 < 0,01 10-4 0,4 10^5 < 0,8 10-9 < 0,8 . .
_ . .. _ .. . . . _ 10-10 0,08 10-13 0,08 10-14 < 0,8 10-17 0,~
10-18 ~ 0,8 10-20 _ ~_0,8 ~0-2~ < 0,~ _ 10-27 0,8 2~9~
. .__ Compound of T-cell culture assay Example No. MIC Gug/ml) 10-28 < 0,8 11-1 < 0,8 11-2 > 0,8 11 4 < 0,8 ._ 11 -11 0,01 Assay of the substances for HIV reverse transcriptase inhibition The activity of reverse transcriptase (RT) was determined with the aid of a scintillation proximity assay (SPA).
The reagent kit for the RT-SPA was obtained from Amersham/Buchler (Braunschweig).
The enzyme RT (from HIV cloned in E. coli) originated from HT-Biotechnology Ltd,15 Cambridge, UK.
Mixture The assay was carried out using the manufacturer's (Amersham) protocol manual, 20 with the following modifications:
- bovine serum albumin was added to the assay buffer to give an end concentration of 0.5 mg/ml 2 9 ~
- the assay was carried out in Eppendorf reaction vessels, using 100 ~JI volume per batch - the manufacturer's RT concentrate (5000 U/ml) was diluted in Tris-HCI buffer 20 mM; pH 7.2; 30% of glycerol, to an activity of 15 U per ml - the incubation time for ~he mixtures was 60 minutes (37C) - after stopping ~he reaction and ~developing~ with the bead suspension, 130 ,ul of mixture were transferred to 4.5 ml of Tris-HCI buffer, 10 mM; pH 7.4; 0.15 M
NaCI, and the tritium activity was measured by means of a -counter.
Assay For a pre-assay for inhibitory activity, the substances were dissolved in DMSO (stock solution c = 1 mg/ml), and tested as a 101, 102, 103, etc., dilution in DMSO.
To determine IC50 values, the inhibitor stock solutions were diluted further in Tris-HCI
buffer, 50 mM, pH 8, and tested in suitable concentrations.
The concentration corresponding to a 50% enzyme inhibition was determined from aplot of RT activity versus log Cjnh.
The test results are shown in Table 1a.
.
:
2 ~
Table 1a Compound of Reverse Transcriptase Assay Example No. ICso ~u9/ml) V - ~ 7,5~
Vl-A 0,08 Vl-C 0,8 Vll 0,1 Xlll 0,04 I
XIV 0,16 3-23 0,1 -1 I _ _ _ I
3-24 0,1 - 1 3-25 0, 1 -1 I
1 3-29 0,1-1 3-30 0,025 3-32 approx. 0,1 _ _ 3-36 0,1 -1 _ _ 3-49 approx. 1 . _ _ _ _ 3-57 approx. 1 3-75 ~ -I _ 1 3-76 0,~18 ¦ 3-~1 approx. 1 . ~
2~98~
Compound ofReverse Transeriptase Assay ¦Example No.IG50 ~ug/ml) 6-1 approx. 1 I . . . .. I
6-8 0l1 -1 6-9 approx. 1 ~_ 6-16 approx. 1 6-1 7 0,1 -1 .. . .... . . ___ 6-27 approx. 1 6-35 0,1 - 1 6-50 0,01-0,1 XXIII 0,025 7-1 0,08 7-2- --~-~ 0,07 ~
7-3 0,07 _ . _ 7-7 0,1 7-10 0,1 1 7-11 0,01 . .. _ .
7-12 approx. 1 _ . e _ r 7-13 0,1 -1 _ .
7-16 appro)t. 1 10-9 _pprox.
2 ~ 5 _ ..... _ _ _ Compound of Reverse Transcriptase Assay Example No. ICso ~ug/ml) . .
10-10 approx. 1 . ............. _ 10-13 approx. 1 10-17 approx. 1 .. _ I
10-18 0,1 -1 1 0-20 0, 1 -1 . .
1 0-21 0, 1 -1 10-27 0,1 -1 10-28 0,1 - 1 11-11 0,1 - 1 10-34 0,1 -1 11-6 0,1 - 1 0,1 - 1 11-7 approx. 1 11-13 approx. 1 1 5 7-20 0, 1 -1 7-14 0,01 - 0,1 . ...
7-15 0,01 - 0,1 7-17 0,01 - 0,1 7-18 0,01 - V,1 2 ~ 8 ~ .
¦ Compound of Reverse Transcriptase Assay lExample No ICso ~ug/ml) ¦ 7-19 0,01 - 0,1 I
¦ 7-21 0,01 - 0, l I
¦ 7-22 0,01 - 0,1 I _ ¦ 7-23 0,01 - 0,1 ¦ 3-34 0, 1 -1 I
¦ 3-35 0, 1 -1 ¦ 3-37 0, 1 -1 3-7 0,08 I _ ¦ 3-127 0,01 - 0,1 3-128 0,01 - o,1 3-129 0,01 - 0,1 7-24 < 0,01 7-25 < 0,01 7-26 0,01 0,1 1 5 7-27 0, 1 -1 7-28 < 0,01 _ _ 7-29 0,01 - 0,1 7-30 < 0,01 . _ _ 7-31 ~ ~,Ot 20 ICsO = 0.08 ~ug/ml . , ~
2 ~
The examples which follow and the content of the patent claims illustrate the present invention in greater detail.
5 Example I
(3S)-6-Chloro-3-methyl-3,4-dihydroquinoxalin-2(1 H)-one A) (S)-N-(3-Chloro-6-nitrophenyl)alanine 2,4-Dichloronitrobenzene ~21.0 y, 0.109 mol) and 23.0 g (0.258 mol) of L-alanine were refluxed for 48 hours in 400 ml of 2-methoxyethanol with an addition o~ 120 rnl of 2N
sodium hydroxide solution. The mixture was subsequently concentrated in vacuo, and the residue was taken up in aqueous sodium hydrogen carbonate solution. the mixture was extracted three times using ethyl acetate, the extract was then acidified wlth 6N
15 hydrochloric acid, and the yellow product was extracted using ethyl acetate. The organic phase was washed once with saturated aqueous sodium chloride solution and dried (magnesium sulfate), and the solvent was removed under reduced pressure.
14.7 g (55%) of a yellow solid of melting point 167-169C remained (after crystallization from ethyl acetate).
1H NMR (270 MHz, d6-DMSO): ~ = 1.47 (d, J = 7 Hz, 3 tl), 4.57 (quintet, J = 7 Hz, 1 H), 6.77 (dd, J = 9, 2 Hz, 1 H), 7.11 (d, J = 2 Hz, 1 H), 8.12 (d, J = 9 Hz, 2 H), 8.41 (br. d, J = 7 Hz, 1 H), 13.2 pprn ~br., 1 H).
MS: (M + H)~ - 245 B) (3S)-6-Chloro-3-methyl-3,4-dihydroquinoxalin-~1H)-one The product of Example IA (14.0 g, 0.057 mol) was dissolved in 400 ml of methanot and hydrogenated with Raney nickel catalysis at room temperature, using 1 atm hydrogen. After the calculated amount of hydrogen had been taken up, the catalyst 30 was removed by filtration with suction, and the reaction solution was concentra~ed in 2 ~
vacuo. The residue was puri~ied by silica gel chromatography using ethyl acetate/heptane = 1:2 and 1:1 as the eluent. The yield was 6.0 g (53%) of a brownish solid of melting point 122-123C ~after reerystallization from isopropanol/heptane).
'H NMR (60 MHz, d6-DMSO): ~ = 1.23 (d, J = 11 H~, 3 H), 3.~1 (dq, J = 11, 4 Hz 1 H), 6.27 (br., 1 H), 6.3 - ~.9 (m, 3 H), 10.3 ppm (br., 1 H).
MS: (M + H)~ = 197 [~]D23 = +77.3 (c = 1, MeOH) C) ~3R)-6-Chloro-3-methyl-3,4-dihydroquinoxalin 2(1H)-on~
The compound was prepared from D-alanine by the methods described under Example IA and IB. Melting point 123-124C (after recrystallization frorn isopropanol/heptane) The NMR data agree with those of the compound described in Example IB.
[a]D23 = -81.0 (c = 1, MeOH) D) (3RS)-6-Chloro-3-methyl-3,4-dihydroquinoxalin-2(1H)-one The compound was prepared starting from D,L-alanine by the methods described in 20 Examples IA and IB. Melting point 110C (after recrystallizati~n from isopropanol/heptane) The NMR data agree with those of the compound described in Example IB.
The fsllowing compounds of the formula i were synthesized analogously using the 25 corresponding haloaromatic compounds and ~rnino acid derivatives:
2~$~
Example ll (3S)-3-Benzyl-7-chloro-3l4-dihydroquinoxalin-2(1 H)-one A) (S)-N-(4-chloro-2-nitrophenyl)-phenylalanine L-Phenylalanine (8.3 9, 0.05 mol) and 4.8 g (0.025 mol) of 2,5-dichioronitrobenzene were dissolved in 40 ml o~ anhydrous dimethyl sulfoxide (DMSO), and the stirred solution was heated to 80C under an argon atmospher Potassium tert.-butylate (4.2 9, 0.025 mol), dissolved in 30 ml of DMSO, was added dropwise in the course of 40 minutes. Stirrina was continued for 3 hours at 8û to 90C, the mixture was allowed to cool, and unreacted phenylalanine was removed by filtration with suction and washed with water. The collected alkaline filtrates were extracted twice using diethyl ether to remove unreacted dichloronitrobenzene. The mixture was then acidified using glacial acetic acid and extracted several times using cthyl acetate, and the extracts were dried over magnesium sulfate and evaporated.
The product was obtained in the form of a red oil (6.7 9, ~4%), which was further reacted without purification.
B) (3S)-3-Benzyl-7-chloro-3,4-dihydroquinoxalin-2(1H)-one The product of Example IIA (12 g) was dissolved in 300 ml of anhydrous methanol and hydrogenated at room temperature with palladium/charcoal catalysis, using 1 atm hydrogen. When the reaction had ended, solids were filtered off with su~tion, the liquid 25 was concentrated, and the concentrate was ehromatographed on silica gel usingdiisopropyl ether as the eluent. This gave 1.32 ~ of the desired product which crystallized from isopropanol, melting point 185~.
2 ~ 8 ~
1H NMR (270 Mtlz, d6-DMSO): ~ = 2.9 (m, 2 H), 4.08 (m, 1 H), 6.09 (d, 1 H), 6.7 (m, 2 H), 6.78 (m, 1 H), 7.2 (m, 5 H), 10.34 pprn (br. s, 1 H).
MS: (M + H)~ = 273, (M - 92)' = 181.
5 The compounds in Table 2 were prepared as described in the ~bove examples.
Table 2 H
I
R l n~ ~ H
. ~ ~
Nr. R~n R3 Rs M.P. C
1 ~-CI CH3 H Wax 6-CI C2Hs 120 . _ _ 6-CI -CH2cH2~O-6-CI (CH3)2CH H
_ .
6-CI ~CH3)2CH( ~H2 H Oil 6-Ci C2Hs(CH3)CH Oil 6-C;1 C6HsCH2 _ _ _156-157 2~6~9~3 - -Nr. Rln R3 Rs M.P. C
_ .__ ..
.. __ . ...... _ 11 6-CI CH2(OH) H _ .
13 7-Ci CH3 il 142 14 7-CI (CH312CH H
.. . ._ ~_ ~
_ 17 6,7-CI2 CH3 H
1E~ 7-F CH3 H 230 ~ ___ .
19 6-F CH3 H Wax 6-F CH3 C3Hs 182 21 6-F C6HsCH2 ~3Hs 23 6-CH3Oc2H4O C2Hs H 107 _ . . .
. ~, . . .
6-CI CH2-S-Bn __ 170 26 6-CI CH2-S-i.-Pr H 190 _ 27 6-CI CH2O-t.-Bu H 12E~
_ ._ 28 6-CI C,~tl9 ==-. 115 2 ~
Bn = benzyl i-Pr = isopropyl t-Bu = tert.-butyl Example lll (3S)-4-N-(Benzyloxycarbonyl)-6-chlors -3-methyl-3,~-di-hydroquinoxalin-2(1 H)-one The compound of Example IB (1.0 9, 5.1 mmol) was dissolved in 2D ml ~
dichloromethane. 10 ml of 2N aqueous sodium hydrogen carbona~e solution were added, and 0.9 ml (90%; 5.7 mmol) of benzyl chloroformate was added with ice-cooling and vigorous stirring. The two-phase system was subsequently stirred for60 hours at room temperature. After 30 hours, another 0.2 ml (1.3 mmol) of benzyl 15 chloroformate was added. When the reaction was complete, the phases wsre separated, the organic phase was washed once with water and dried (magnesium sulfate), and the solvent was rernoved in vacuo. The product was purified by silica gel chromatography with methyl tert.-butyl ether/h~ptane = 1:1 as the eluent This gave 1.65 g (98%) of a white, foam-like product.
'H NMR (270 MHz, d6-DMSO): ~ = 1.15 (d, J = 7 Hz, 3 H), 4.85 (q, J = 7 Hz, 1 H), 5.20 (d, J = 12 Hz, 1 H), 5.27 (d, J = 12 Hz, 1 H), 6.97 (d, J = 7 Hz, 1 H), 7.19 (dd, J = 8.2 Hz, 1 H), 7.3 - 7.45 (m, ~ H), 7.67 (d, J = 2 Hz, 1 H), 10.81 ppm (br- s, 1 H).
MS: (M + H)~ = 381 2~
Example IV
(3S)-4-N-(Benzyloxycarbonyl)-6-Chloro-3-methyl-8-nitro-3,4-dihydroquinoxalin-2(1 H)-one The compound of Example lll (1.5 9, 4.5 mmol) was nitrat~d in glacial ac~tic acid (15 ml). A to~al of 5 rnl (124.3 mmol) of fuming nitric acid were added dropwise in 2 ~ 8 ~
the course of 4 hours at O~C to room temperature. The mixture was subsequently poured into 100 ml of ice-water, and the product, whioh was obtained in the form of a yellow solid, was filtered off, washed thoroughly wlth water, and dried. Melting point 85C (subl.).
'H NMR (270 MHz, d6-DMSO): ~ - 1.22 (d, J = 8 Hz, 3 H3, 4.89 (q, J = 8 Hz, 1 H), 5.24 (d, J = 12 Hz, 1 H), 5.31 (d, J = 12 Hz, 1 H), 7.35 - 7.~ (m, 5 H), 7.69 (s, 1 H), 8.Q0 (s, 1 H), 11.11 ppm (br. s, 1 H).
MS: (M + H)' = 376 Example V
(3S)-8-Amino-4-N- (benzyloxycarbonyl)-6-chloro-3-methyl-3,4-dihydroquinoxalin-2(1 H)-one The compound of Example IV (1.5 g, 4.0 mmol) was dissolved in 150 ml ofmethanol and hydrogenated at room temperature with Raney nickel catalysis, using1 atm hydrogen. When the calculated amount of hydrogen had been taken up, the catalyst was r emoved by filtration with suction, and the filtrate was concentrated in 20 vacuo. The product was purified by silica gel chromatography using ethyl acetate/heptane = 2:1 as eluent. The yield was 0.68 g (49%) of brownish solid ofmelting point 152-154C.
H NMR (270 MHz, d6-DMSO): ~ = 1.11 (d, J = 8 Hz, 3 H), 4.79 (q, J - 8 Hz, 1 H), 5.15 (d, J = 12 Hz, 1 H), ~.24 (d, J = 12 Hz, 1 H), ~.38 ~br. s, 2 H), 6.42 (s, 1 H), 7.3-7.4 (m, 6 H), 19.59 ppm ~br. s, 1 H).
MS: (M + H)~ = 346 2 ~
Example Vl A) (3S)-6-Chloro-3-methyl-4-N-(3-methyl.2-buten-1-yl)-3,4-dihydroquinoxalin-2(1 H)-one The compound of Example IB (1.0 y, 5.0 mrnol) was dissolved in 20 n~l of acetonitrile and alkylated with 3-methyl-2-buten-1-yl bromide (90%; 0.92 ml, 7.0 mmol) at room temperature in the presence of ~.0 9 (7.0 mrnol) of pulverulent potassium carbonate. After 7 hours, the reaction had ended. The mixture was filtered off with suction, the filtrate was concentrated in vacus, and the product was purified by silica gel chromatography usin~ ethyi acetate/heptane = 1:2 as eluent.
The yield was 0.97 g (72%) of brownish solid of melting point 117-118C (after crystallization from methyl tert.-butyl ether/heptane).
lH NMR ~270 MHz, d6-DMSO): ~ = 1.02 ~d, J = 8 Hz, 3 I l), 1.74 (s, 6 tl), 3.69 (dd, J = 14, 8 Hz, 1 H), 3.85 - 3.9 (m, ~ H), 5.19 (m, 1 H), 6.65 - 6.8 (m, 3 H), 10.47 ppm (br. s, 1 H).
MS: (M + H)' = 265 [a]D23 = +168.0~ ~c = 1, MeOH) B~ (3R)-6-Chloro-3-methyl-4-N-(3-methyl-2-buten-1-yl)-3,4-dihydroquinoxalin-2(1 H)-one The compound was prepared by the method described in Example VIA, starting from the compound of Example IC. Melting point 115-117C (af~er reerystalli7ation from isopropanol/diethyl ether) The NMR data agreed with those of the compound deseribed in Exarnple VIA.
[a]D23 = -172 (c = 1, MeC~H) 2 ~
C) t3RS)-6-Chloro-3-methyl-4-N-(3-methyl-2-buten-1-yl)-3,4-dihydroquinoxalin-2(1 H)-one The compound was prepared by the method described in Example VIA starting with the compound of Example ID. Melting point 148-14gG (after recrystallization from isopropanol/diethyl ether) The NMR data agreed with those of the compound described in Example VIA.
Example Vll (3S)-6-Chloro-3-methyl-4-N-(2-buten-1 -yl)-3,4-dihydroquinoxalin-2(1 H~-one The substance was prepared analogously to the compound described in Example VIA, but with 2-buten-1-yl bromide as the alkylating agent. Melting point 87-88C
(after crystallization from diethyl ether/heptane) 'H NMR (270 MHz, d6-DMSO): ~ = 1.01 (d, J = 8 Hz, 3 H), 1.70 (dd, J = 8, 1 Hz, 3 H), 3.63 (dd, J = 16, 6 llz, 1 H), 3.85 -4.0 (m, 2 H), 5.47 (m, 1 H), 5.75 (m, 1 H), 6.65 - 6.8 (m, 3 H), 10.48 ppm (br. s, 1 H).
MS: (M + H)~ = 251 Example Vlll 4-N- (Isopropenyloxycarbonyl)-3,3,7-trimethyl-3,4-di-hydroquinoxalin-2(1 H)-one 3,3,7-Trimethyl-3,4-dihydroquinoxalin-2(1H)-one (0.4 g, 2.1 mmol~ were dissolved in 10 ml of anhydrous pyridine, and the stirred solution was tre~ted at ro~m temperature with 0.24 ml (2.2 mmol) of isopropenyl chloroformate. The mixture was stirred for 6 hours at room temperature and treated with water, thc precipi~ate which formed was filtered off with suction, washed with water and dried. This gave 0.4 9 (6~%) of eolorless crystals of melting point 185~G.
'H NMR (270 MHz, d,;-DMSO~: d = 1.~ (s, 6 H~1 1.9 (s, 3 H~, 2.25 ~s, 3 I l), 4.7 (m, 2 H), 6.7 - 6.9 (m, 2 H), 7.15 (d, J = 8 Hz, 1 H), 10.6 ppm (br. s, 1 H).
MS: t = 274 2 ~
Example IX
(3S)-6-Chloro-4-N- ~4-methoxyphenoxycarbonyl)-3-methyl-3,4-dihydroquinoxalin-~(1 H)-one The compound of Example IB (0.5 9, 2.5~ mmol) was dissolved in 10 ml of anhydrous N,N-dimethylformamide, and 0.41 ml (2.8 mmol) of triethylamine were added. To the stirred mixtur~ there was first added dropwise 0.4~ ml (2.8 mmol) of 4-methoxyphenyl ohloroformate and, after ~ hours, another 0.21 ml (1.9 mmol).
When ~he reaction was complete (18 hours), the solvent was stripp~d off under reduced pressure, ~he residue was taken up in ethyl acetate, and the mixture waswashed with water and dried (sodium sulfate). 0.4~ g (54%) of a whit~ solid remained after concentration. Melting point 187-19ûC (after recrystallization from isopropanol) 1H NMR (270 MHz, d6-DMSO): ~ = 1.24 (d, J = 8 Hz, 3 H), 3.77 (s, 3 H), 4.94 (q, J = 8Hz, 1 H),6.97 (dd,J = 8,2Hz, 1 H),7.03 ~d,~l = 8Hz, 1 H),7.2-7.3(m, 3 H), 7.78 (s, 1 H), 10.89 ppm (br. s, 1 H).
MS: (M + H)~ = 347 Example X
(3S)-6-Chloro-4-N-(4-fluorophenoxycarbonyl)-3-methyl-3,4-dihydroquinoxalin-2(1 H)-one The compound was prepared analogously to the compound described in Example VIA, but 4-fluorophenyl chloroformate was used as ar~lating a~ent. Melting point168-170C (after crystallization from isopropanol) 'H NMR ~270 MH~, d6-DMSO): ~ - 1.24 (d, J = 8 Hz, 3 H), 4.94 (q, J = 8 H~, 1H),7.03(d,8Hz,lH),7.2-7.5(m,5H~,7.83(d,J=2Hz,1H),10,90ppm (br. s, 1 H).
MS: (M + H)~ = 335 2 ~
Example Xl (3S)-6-Chloro~-N-(4-chlorophenoxycarbonyl)-3-methyl-3,4-dihydroquinoxaiin-2(1 H)-one The compound was prepared analogously to ~he compound described in Example VIA, but 4-chlorophenyl chloroformate was used as acylating agent. Melting point185-188C (af+er crystallization from isopropanol/diethyl ether) 'H NMR (270 MHz, d6-DMSO): ~ = 1.2~ (d, J = 8 Hz, 3 H), 4.94 (q, J ~ 8 Hz, 1 H), 7.04 (d, 8 Hz, 1 H), 7.25 (dd, J = 8, 2 Hz, 1 H), 735 - 7.6 (m, 4 11), 7.80 (s, 1 H), 10.91 ppm (br. s, 1 H).
MS: (M + H)+ = 351 Example Xll (3S)-4-N - (2-Bromoethyloxycarbonyl)-6-chloro-3-rnethyl-3,4-dihydroquinoxalin-2~1 H)-one The compound was prepared analogously to the compound described in Example VIA, but 2-bromoethyl chloroformate was used for the acylation. Melting point 133-136~C (after crystallization from isopropanol) 2û lH NMR (270 MHz, d6-DMSO): ~ = 1.16 (d, J = 8 Hz, 3 H), 3.7 - 3.8 (m, 2 H), 4.4 -4.6 (m, 2 H), 4.86 (q, J = 8 Hz), 6.99 (d, 8 Hz, 1 H), 7.21 (dd, 8, 2 Hz, 1 H), 7.74 (d, J = 2 Hz, 1 H), 10.84 ppm (br. s, 1 H).
MS: (M + H)+ = 348 Example Xlll (3S)-6-Chloro-N-~isopropenyloxycarbonyl)-3-methyl-3,4-dihydroqllinoxalin-2~1 H)-one The substance was prepared analogously to the compound described in i-~ample VIA, but isopropenyl chloroformate was used for the acylati~n. Meiting paint 2 ~
'H NMR (270 MHz, CDC13): ~ - 1.33 (d, J = 8 Hzl 3 H), 2.02 (s, 3 H), 4.79 (s, 1 H),4.83~s,1 H),5.17~q,J=8Hz,1 H),6.86(d,J=8Hz,1 H),7.12(dd, J=8,2Hz,1H),7.74(br.s,1H),9.28ppm(br.s,1H).
MS: (M + H)~ = 281 Exarnple XIV
~3S)-6-Chloro-3-methyl-4-N-(vinyloxyearbonyl)~3~4-di- hydroquinoxalin-~(1H)-one The substance was prepared analogously to the compound described in Example VIA, but vinyl chloroformate was used ~or the acylation. Melting point 177-179C'H NMR (270 MHz, CDC13): ~ = 1.33 (d, J - 8 Hz, 3 H), 4.96 (dd, J = 14, 2 Hz, 1 H), 5.20 (q, J = 8 Hz, 1 H), 6.83 (d, J = 8 Hz, 1 H), 7.12 (dd, J = 8, 2 Hz, 1 H), 7.2 - 7.3 (m, 2 H), 7.71 (br. s, 1 H), 9.42 ppm (br. s, 1 H).
MS: (M + H)~ = 267 Example X\/ and Example XVI
6-Chloro-3,4-dihydroquinoxalin-2(1H)-one was reacted with 3-methyl-2-buten-1-yl bromide analogously to the process described in Example VIA. It was possible to 20 isolate two products by silica gel chromatosraphy.
6-Chloro-4-N-(3-methyl-2-buten-1-yl)-3,4-dihydro- quinoxalin-2(1H)-one Melting point 150-151 C ~after recrystallization frorn ethyl aeetate) 'H NMR (270 MHz, d6-DMSO): ~ = 1.72 (s, 6 H), 3.ô7 (s, 2 H), 3.89 ~d, .1 = 7 Hz,2 H), 5.20 (m, 1 H), 6.7 - 6.8 (m, 3 H), 10.49 ppm (br. s, 1 H).
MS: (M ~ H)~ = 251 6-Chloro-4-N-(3-methyl-2-buten-1-yl)-3-(1 ,1 -dimethyl-2-propen-l-yl) 3,4-dihydroquinoxalin-2(1 H)-one Melting point 110-112C (after crystalli~ation from heptane) 2 ~ 5 'H NMR (270 MHz, d6-DMSO): ~ = 0.94 (s, 3 H), 0.97 (s, 3 H), 1.65 (s, 3 H), 1.66(s, 3 H), 3.77 (dd, J = ~6, 7 H7, 1 H), 4.23 (dd, J = ~6, 7 Hz, 1 H), 4.8 - 4.9 (m, 2 H), 5.02 (m, 1 H), 5.75 (dd, J = 17, 11 Hz, 1 H), 6.6 - 6.7 (m, 3 H), 10.49 ppm (br s, 1 H).
5 MS: ~M + H)~ = 319 The following compounds of the formula I were synthesize~ from the correspondingunsubstituted quinoxalinones in analogous manner and, K appropriate, derivatizedfurther:
Table 3 R n~ N
2~6~5 _ . _ __ _ _ _=
O 11~) O N 00 N N N N ~-I T ~.) O C.) ~: T ~ ~ _ ~ e oN T T
_ _ ~: I I I I I I I I I I I :C
_ _ _ _ . _ _ U~ ~ ~ ~ -~, O ~,~ ~ ~ ~.~
Z ~ N C~ ~ L~ ) ~ r- aD a) ~_ ~ r ~_ _--_ _ = _ _ _ _ :
2 ~
r _-5 U C~l t) ~ o E cl) u~ o ~ ,_ N
. N tD O 0 0 t~5 . ~) ~) cr) C~ O T-¦~ N N LL O ~ LL I~ u~ O ~ ~ ~ ~_ ~ (.) ( ) ~.) O t ) (.) O t~ N t ) t~ ~ t~) I .
tr I I I I I I I I I I I I I
_' O C) ~ O (.) O ~ O S~) O ~ (~ V
~ CD (D ~) t~ U) ~ ~J (~ ~D CD CD ~D
Z d In tD ~ ~ O) ; N N C~l N C~l ;~ N
2 ~ 5 _ _ _ _ . _ cc I u~ O t ) ~ O O 6 u~ O O ( ) o) ~ t~l N C~l O
cr: I ~ ~ ~ N t~l r~ ~q t l I
_ _ _ . _ _ CC I I I I I I I I I I I I I
tr~ T
G: CD ~D C~ ~D ~ ~ ~D CD ~D ~D ~D ~D tD
. ~ 0~ O> ~ . Cl c7) ~ U ~D ~ 00 ~
Z N C~l N cr) ~ S~ C~ C~ t~) ~ ~ ~) C') ___ _ =_ _. __ _ __ _ s ~ ~ T rl~
~ D ,_ ~ O O o co o .
tru~u~ ~u~ O O u~u~ O O , o co r~ ~ I I I N
~7 I II I I (~')NI I I
G ~ ~.) O O (..) (~) t ) O O O O t.) t.) ~: :C ~ ~ I~ L
.
~ o o ~ o ~ ~ v o ~ ~ ~) ~ ~
~ CD CD ~D tD tD tD tD tD tD ~ U~- ~0 U~
~ 1~ ~ N~ d- U ) lD I~ t~ ~) O ~ N
Z ~t ~ ~~ ~ ~ ~ ~ ~ ~ ~) Ir) Lr _ _ __ __ = _ ~ `.
2 ~
- - - ~ : ~
~ O N . N ~ N O ~ a) ~ ~ I` I~`) _ _ _ _ U7 O 1 LU~ O O ~n OU~ O 6 O
~: I I IN N t~) _ _ _ _ a: I I I I I I I I I I :C :1:
_ _ _ _ _ __ __ c O O ~ ~ ~ O O ~ ~ O ~ ~ ~
CC ~ I` ~` r- t- ~ ~ I~ r- ~ ~ I`_ ~ _ _ _ . _ _ _ Z ~ d Ll~ tD 1~ 00 cn O ~ N ~r~ ) I _ _ _ _ _--2~9~
o _ = _ ___ E ~ E 3 n CD ~ N ~ ~ ., O ~ O ~ N N N
_ _ a: ~ u~ ~ O ,0 O u~ O O ~n O O O
. _ _ ~ N
~ _ _ _ c LL IL LL IL ll~ 1~ O," T ~ O ~ t.) V
a: ~ ~D ~C) ~O t- r- ~ I~ ~D (5) Cl:~ ~1 ~
Z ~ ~D t~ ~D 1~ r` N ~ 1` 1`~ 1~ ~ 0 2~6~8~
_ _ _ ~ 1~ 1~ N tD CO ~ O ~ _ tC~ ~ ~ 1 J) B I I ¦ O
! I I I I,~, L~ I I 1: I I I I I I I I: T
I
I _ C O O O LL C~ ~ V ~ ~ ~~ ~ ~ ~
~ tD ~D tD ~ (D ~D tD ~D t.D CD ~D tD ~D
Z 1~ O 0 N 00 co 0~ 0 CO --0 O a~
~ .
2 ~ 8 ~
In__ N _ _ _ _ =_ __ _ ~_ CU N O O ~ OD 'u~ O _ O O ';t I I I I q II u~ I q I
~ __ _ __ l ~
L ~ . D ~ ~ L~ o D L o ~ _L~
2 ~
- - - = -~ N O tDa)a:~~Dtt:~ 't N 1~ O O
_ ~N _ _ ~ I ~ C .n Z L;N~ ~
~ 8 8 8 8 88 Q 8 o 8 ~ ~
_ _ _ _ ~qt"r~~rJ",I:'J ", r) N I`J
~ I II II I I I I II
~: ~ O ~ O V ~ ~ O ~ O
u I I I I I ~ I I I
~ r _c ~ ~ ~ ~ ~ ~ V ~ t~ ~ ~ ~
G U:) C~:) tD CD CD ~S) ~D CD ~ ~:1 ~D ~
_ _ . _ _ _ . In t~:) I~ :~ o) o ~ N ~) ~ Ir) C~:) ~ O O O O ~ ~ ~_ ~ ~ _- ,_ . __ _ _ --~ _ _ I ~ ~ l a '~
_ _ _ _ _ _ a: O ~ O u~ O u~ O O O O O O
a: I I I I ~ T I
~ ~ o~
Z ~ OD ~ N C~l N N N N t~J N N N
2 ~
Key: C5Hg - 3-methyl-2-buten-1-yl C4H7 = 2-butenyl CsHl1 = 3-methyl-1-butyl C6H,1 = 2,2-dimethylcyclopropyl-1-methyl sC6H11 = 4-methyl-3-penten-2-yl C3H3 = 2-propen-1-yl (CH3)2CCHCO = 3,3-dimethylacryl IPOC = isopropenyloxycarbonyl ALAC = allylaminocarbonyl ALOC = allyloxycarbonyl C4H30 = furanyl C4H3S = thienyl CsH4N = pyridyl Ph = phenyl , 2 ~
Example XVII
6,7-Dimethoxy-3-methyl-3,4-dihydroquinoxalin-2(1 H)-one 4,5-l~imethoxy-1,2-dinitrabenzene (34.2 g, Q.15 mol) was hydrogenated in 500 ml of 5 methanol with Raney nickel catalysis using 1 atm hydrogen. After the calculated amount of hydrogen had been taken up, the process was stopped, the catalyst was removed by filtration with suction, and the solvent was stripped off in vacuo.
To remove the water completely, the mixture was taken up hNice in methanol and reconcentrated. 4,5-Dimethoxy-1,2-phenylenediamine (24.0 g), which remained as abrown oil, was refluxed for 48 hours in 200 ml of ethanol (96%) together with 17.1 ml (0.15 mol) of methyl 2-chloropropionate, with an addition of 21.0 ml (0.15 mol) of triethylamine. The solution, which was very dark, was concentrated, the concentrate was taken up in ethyl acetate, the mixture was washed twice withwater and dried (sodium sulfate), and the solvent was stripped off in vacuo.
15 The crude product was crystallized by stirring with diethyl ether (6.2 g, 19%). A
analytically pure sample of melting point 151 C was obtained by silica gel chromatography using ethyl acetate as the eluent.
H NMR (60 MHz, d6-DMSO): ~ = 1.22 (d, J = 7 Hz, 3 H), 3.63 (s, 3 H), 3.67 (s, 1 H), 3.6 - 3.7 (m, 1 H), 5.62 (br. s, 1 H), 6.40 (s, 1 H), 6.45 (s, 1H), 9.90 ppm 20 (br s, 1 H).
MS: Mt = 222 The following compounds of the formula I were synthesized in analogous manner and, if appropriate, derivatized further:
.
2 ~ 6 Table 4 H
g~
N~H
R
Nr. R1n R3 Rs X M.P. C
. _ _ 16,7-(CH30)2 CH3 IPOC O '133 26,7-(CH30)2 CH3 IPOC S
36-C6HsS CH3 C5H9 O 115 .
47-C6HsS CH3 C5Hg O 107 I _ 56-C6HsS CH3 H O
I
67-C6HsS CH3 H O
76,7(CH30)2 CH3 H O 151 Key: CsHg = 3-methyl-2-buten-1-yl IPOC = isopropenyloxycarbonyl Example XVIII
(3RS)-6-Chloro-4-N-(cyclopropyl)-3-methyl-3,4-dihydroquinoxalin-2(1 H)-one A) (2RS)-N-(4~Chloro-2-cyclopropylaminophenyl)-(2-brornopropionamide) 4-Chloro-2-cyclopropylaminonitrobenzene (2.10 9, 0.01 mol) was hydrogenated in 100 ml of methanol with Raney nickel catalysis, using 1 atm hydrogen. After the calculated amount of hydrogen had been taken up, the process was stopped, the catalyst was removed by filtration with suction, and the solvent was stripped off i 2~6~
acuo. To remove water completely, the mixture was taken up ~vice in methanol and reconcentrated 4-Chloro-2-cyclopropylaminoaniline (1.80 g), which r~mained in the form of a brown oil, was dissolved in 50 ml of anhydrous 1,2-dimethoxyethaneand cooled to -60C, with stirring. A solution of 1.1 ml (0.01 mol) of 2-bromopropionyl chloride in 5 ml of anhydrous 1,2-dime~hoxyethane was slowly added dropwise, and stirring of the reaction mixture was continued ~or 2 hours at -60 - -70C. The mixture was then allowed to warm ~o approx. -20C and poured into 150 ml of ice-cold, saturated aqueous sodium hydrogen carbonate soiution.
The mixture was extracted twice usir~g ethyl acetate, and the organic phase was washed once with water, dried (sodium sul~ale) and concentrated in vacuo. After crystallization with diethyl ether/pentane, 2.51 9 (79%) of the desired product of melting point 130C remained.
'H NMR (270 MHz, d6-DMSO): ~ = 0.4 - 0.5 (m, 2 H), 0.7 - 0.8 tm, 2 H), 1.75 (d, J = 7Hz,3H),2.39(m,1 H),4.72(q,J =7Hz,1 H),5.6(br.s,1 H),6.66(dd, J = 8, 2 Hz, 1 H), 6.96 ~d, J = 2 Hz, 1 H), 7,21 (d, J = 8 Hz, 1 H), 9.36 ppm (br.
s, 1 H).
MS: (M + H)+ = 319, 317 B) (3RS~-6-Chloro-4-N- (cyclopropyl)-3-methyl-3,4-dihydroquinoxalin-2 ~1 H)-one The compound of Example XVIIIA (318 mg, 1.0 mmol) was dissolved in 20 rnl of ethanol (96/o), 0.28 ml (2.0 mmol) of triethylamine were added, and the mixturewas reflux~d for 18 hours. The solvent was removed under reduced pressure, and the reaction product was purified by silica gei chromatography using ethyl acetate/heptane = 1 :2 as eluent. The yield was 200 mg ~85%~ of white crystals of melting point 167C (after crystallization from pentane).
1H NMR (270 MHz, d6-DMSO): ~ = 0.40 (m, 1 H~, 0.63 (m, 1 H), 0.76 (m, 1 tl), 0.98 ~m, 1 H), 1.12 (d, J = 7 Hz, 3 H), 2.47 (m, 1 H~, 3.87 ~q, J = 7 ~z, 1 H), 6.78 (s, 2 H), 7.0 (sl 1 H), 10.46 ppm (br. s, 1 H~.
MS: (M ~ H)~ = 237 2 ~
The following compounds of the formula I were synthesized analogously to the procedure described in Example XVIII using the correspondingly substituted ortho-nitroanilines and 2-halo carboxylic acid derivatives and, if appropriate, derivatized further:
Table 5 H
R 1 n~ N\I(~ R 3 R
Nr. Rln R3 R4- - R5 XM.P.C
~ I
1 6-CI CH3 H C6Hs O 191 2 6-CI CH3 CH3 ~3Hs O
_ 3 6-CI CH3 CH3 C3Hs S
. _ 4 6-CI CH3 CH3 C3Hs __ 6-CI CH3 CH3 C3Hs S
Key: C3Hs = cyclopropyl C6Hs = phenyl 92 2 ~ 5 Example XIX
7-Chloro-1-N-(cyclopropyl)-3,3-dimethyl-3,4-dihydroquinoxalin-2(1 H)-one 4-Chloro-2-cyclopropylaminonjtrobenzene (2.0 g, 9.4 mmol) was hydrogenated as described in Example XVIIIA. The resulting 4-chloro-2-cyclopropylaminoaniline (1.70 g) was taken up in 20 ml of dichloromethane. 1.~ ml (2.01 mmol) of chloroform, 1.8 ml (2.45 mmol) of acetone and 0.10 g (0.4 mmol) of benzyltriethylammoniurn chloride were added, and the reaction solution was cooled to 10C. 4 ml of 50% strength sodium hydroxide solution were slowly added dropwise with vigorous stirring, during which process the reaction temperature should not exceed ~0C. After stirring for 5 hours at 10DC, the phases were diluted and separated. The organic phase was washed once with water, dried (magnesium sulfate) and evaporated in vacuo. The crude product was purified by silica gel chromatography using ethyl acetate/heptane = 1:2 as the eluent. the yield was 1.0 g (42%) of white crystals of melting point 132-133C (after recrystallization from toluene/heptane) .
'H NMR (270 MHz, d6-DMSO): ~ = 0.45 - 0.55 (m, 2 H), 1.05 -1.1 (m, 2 H), 1.19 (s,6H),2.71(m,1H),6.09(br.s,1H),6.71(d,J=8Hz,lH),6.88(dd,J=8, 2 Hz, 1 H), 7.19 ppm (d, J = 2 Hz, 1 H).
MS: (M ~ H)~ = 251 The following compounds of the formula I were synthesized in analogous manner and, if appropriate, derivatized further:
2 ~
Table 6:
R 1 --t~ ~
1~1 R5 _ _ _ Nr. R'n R3 R4 R5 M.P.C
I _ _ 1 6-CI CH3 CH3 CsHs 179 I
L~ 7-CI CH3 CH3 CsHs 171 3 6,7-(CH30)2 CH3 CH3 H
4 6,7-(CH3O)2 CH3 CH3 CsHs _ CH3 CH3 SC6H1l 113 __ ~ C6Hs CH3 H .
7 C~Hs CH3 C5H9 _ 9 7-CI C:;H3 CH3 IPOC 169 _ _ , _ 7-~H3 CH3 CH3 CsH~ 168 . , _ . _ _ 2~ 12 6-CH3C) CH, CH~, _ 138 13 6/7-COOH CH3 CH3 H > 240 2 ~
- ._ Nr. R' R3 R4 Rs M.P. ~C
14 6/7-COOH CH3 CH3 CsH9 180 . .
16 ~-CH3 CH3 CH3 CsHs 160 18 6/7-CH3 C2Hs C2Hs H 160 _ 19 6-CH3 C2Hs C2Hs CsHs 100 ~ _ _ ._ 7-CH3 C2Hs C2Hs CsHs 110 _ 22 7-F CH3 CH3 CsHg 155 23 7-C2tlsO CH3 CH3 H i55 _ 24 7-C2HsO CH3 CH3 CsHs 123 6-COOH CH3 CH3 GsHs 245 _ 26 7,8-(CH3)2 CH3 CH3 H 196 I _ _ _ 27 7,8-(CH3)2 CH3 CH3 CsHs 155 I
28 6,7-(CH3)2 CH3 CH3 H 248 I
29 6,7-(CH3)2 CH3 ~ 3 G5Hg 200 _ _ _ _ 6-CI,7- CH3 C:H3 H 211 (2,3-CI2C6H30) _ .
31 6-CI,7- C:H3 CH3 C5Hg 205 (2~3-cl2c6H3o) _ , .
I _ . _ 33 7-C2H,O CH CH3 IPOC 150 2 ~
~5 Nr.Rln R3 R4 Rs M.P. C
357,8-(CH3)2 CH3 CH3 IPOC 147 _ 366,7-(CH3)2 CH3 CH3 IPOC 161 377-C6H5 CH~ CH~ ~ H 167 ¦ 387-C6H50 CH3 CH3 C5Hg 138 I
¦ 416-CH30, CH3 CH3 H > 240 7-(4-Pyridyl) 426-CI, CH3 CH3 219 7-Piperidino .
l 436/7-CI,7/6- CH3 CH3 H 236 Morpholino (mixture) 446/7-(N-Methyl- CH3 CH3 H > 240 l piperazin-1 -yl) I
456/7-CI,7/6- CH3 CH3 H 147 (N-Methyl-piperazin- 1 -yl) _ L~ 7-CI CH3 CH3 _ ¦ 48 6-CICH3 CH3 ALOC 128-129 I _ Nr. R' R3 - R4 Rs M.P. C
sO 6-CI CHD CH3 COOCH(CH3)2 118 51 7-CI CH3 CH3 COOCH(CH3)2 171 52 7-(4-F-Ph-SO20) CH3 ~H3 H
._ _ 537-(4-F-Ph-S02C)) CH3 CH3 IPOC 204 _ 546-CI,7-Piperidino CH3 CH3 IPOC 152 6-CI,7- CH3 CH3 IPOC 11 3 Morpholino _ 56 6-CI,7-(N- CH3 CH3 IPOC 168 Methyl-piperazin-1 -yl) ~
~57 6-CI,7-NEt2 CH3 CH3 141 58 6-CI,7-NEt2 CH3 CH, IPOC C)il 10 59 6,7-CI2 CH3 CH3 H 232 6,7-CI2 CH3 CH3 IPOC 171 :
61 7-(N-Methyl- CH3 CH3 H 198 piperazinyl-1 -yl) 62 7-(N-Methyl- CH3 CH3 IPOC 123 piperazinyl-1 -yl) _ _ 63 6-C;H30 CH3Ctl3 IPOC 128 ~ __ - ___ . .. - --. _ ., _ 15 1~ 7-CI -(CH2)3- IPOC 172 7-CI -(CH2)~,- iPOC 181 66 6-CI -(CH2~3- IPOC 157-158 I
67 6-CI - (CH2)4- I POC 179- 180 2 ~ 3 5 _ __ Nr. R' R3 R4 Rs M.P. CC ¦
_ _ I
68 6-Clq CH3 CH3 cOOC2H5 137 I _ ~ _ Key: c5~3 = 3-methyl-2-buten-1-yl sC6H'1 = 4-methyl-3-penten-2-yl IPOC = isopropenyioxycarbonyl Example XX
3,3-Dimethyl-4-N-(3-methyl-2-buten-1-yl)-3,4-dihydroquinoxalin-2(1 H)-one The compound was prepared analogously to the compound described in Example VIA, starting from 3,3-dimethyl-3,4-dihydroquinoxalin-2(1H~-one (J. T. Lai, Synthesis 1982, 71). Melting point 146-147C (after crystallization ~rom methyl tert.-butyl 1 5 ether/heptane) 'H NMR (270 MHz, d6-DMSO): ~ = 1.27 (s, 3 H), 1.68 (s, 3 H), 1.72 (s, 3 I l), 3.88 (d, J = 7 Hz, 1 H), 5.15 (m, 1 H), 6.60 td, J = 7 Hz, 1 H), 6.67 (t, J = 7 H2l 1 H), 6.78 (d, J = 7 Hz, 1 H), 6.87 (t, J = 7 Hz, 1 tl), 1û.33 ppm (br. s, 1 H).
MS: (M + H)' = 245 Example XXI
4-N-(3-Methyl-2-buten-1 -yl)-3,4-dihydroquinoxalin-2(1 H)-one-3-spiro-1 '-cyclohexane The compouncl was prepared analogously to the compound described in Example VIA, starting from spiroEcyclohexane-1,3'-(3',4'-dihydroquinoxalin-(1'H)-one)] (J. T.
Lai, Synthesis 1982, 71). Melting point 82-83C ~a~ter crystallization from h~ptane) H NMR (270 MHz, d6-DMSO): ~ = 1.25~1.75 (rn, 1D H~, 3.75 (d, J = 6 tlz, 2 H), 5.07 (m, 1 H), 6.7 - 7.U (m, 4 H), 10.15 pprn (br. s, 1 H).
MS: (M + H)t = 285 2 ~ 5 Example X)(ll 4-N-(3-Methyl-2-buten-1-yl)-3,4-dihydroquinoxaline-2(1 H)-thione-3-spiro-1 '-cyclohexane 5 The compound of Example XXI (50~ mg, 1.~ mmol) was refluxed for 1.5 hours under argon together with 370 mg (0.9 mmol3 of ~,4-bis-(4-methoxyphenyl)-1~3-dithia-2~4-diphosphetane 2,~-disulfide (Lawesson~s reagent) in 10 ml of anhydrous toluene. The mixture was subsequently ~oncentrated in vacuo, and the products were isolated by silica gel chrornatography using methyl tert.-butyl ether/heptane = 10:1 as eluent. The yield was 50 mg (9%) of yellow crystals of melting point 125C.
'H NMR (270 MHz, d6-DMSO): ~ = 1.1 1.9 ~m, 16 H), 3.64 (d, J = 7 Hz, 2 H), 4.99 (m, 1 H), 6.95 - 7.1 (m, 3 H), 7.18 (d, J = 7 H~, 1 H), 12.2 ppm (br. s, 1 H).
MS: (M + H)+ = 301 3,4-Dihydroquinoxaline-2(1H)-thione-3-spiro-1'-cyclohexane was isolated as a further product in a yield of 110 mg (26%); yellow crystals of melting point 178C.
~H NMR (270 MHz, cDC13 ~ = 1.25 - 2.2 (m, 10 H), 4.18 (br. s, 1 H), 6.7 - 6.8 (m, 3 H), 6.97 (m, 1 H~, 9.42 ppm (br. s, 1 H).
MS: (M + H)~ = 233.
Example XXIII
(3S)-6-Chloro-4-N- (isopropenyloxycarbonyl)-3-methyl-3,4-dihydroquinoxaline-2(1 H)-thione The cornpound of Example Xlll (0.5 ~, 1.78 mmol), dissolved in îO ml of anhydrous pyridine, was refluxed for 4 hours together with 0.47 g ~2.12 mmol) of phosphorus pentasulfide. The mixture was concentrated in vacuo, and lhe residue was chromatographed on silica gel using ethyl acetate/heptane = 1:1 2S eluent. This gave 0.25 g (47%) of a yellow crystalline solid of rnelting point 148-150C (after recrystallization from ethyl acetate/heptane).
2 ~
H NMR (270 MHz, d6-DMSO): ~ = 1.24 (d, J = 7 Hz, 3 H), 1.96 (s, 3 H), 4.8 - 4.9 (m,2H),5.28(q,J=7Hz,1H),7.22(d,J=8Hz,1H),7.30(dd,J=8,2Hz, 1 H), 7.72 (br. s, 1 H), 12.84 ppm (br. s, 1 H).
MS: (M + H)~ = 297.
The following compounds of the formula I were ~ynthesized in analogous rnanner ~rom the corresponding 3,4-dihydroquinoxalin-2(1H)-ones:
Table 7 H
I
R ~ ~ -- R 3 .
Nr. R'n R3 R4 Rs M.P.C
1 CH3 H C5Hg 119 2 6-CI CH3 H CsHg 109- 110 _ .
. _ .. . , . _ _ 6 C6Hs CH3C5H~
_ _ 7 6-CI CH3 CH3CsH5 157 _ 8 7-CI CH3 CH3C5Hg 160 _ .
2~6~9~
~oo _ _ I
12 7-CI CH3 CH3 IPOC 174 l _ I
l 14 6-CI C2Hs H IPOC 176-1.77 6-CI C2Hs H ALOC 159-161 l I
166,7-(CH3)2 CH3 CH3 CsH9 173 17 6-CI C3H7 H IPOC 154-1~5 l _ ~ I
_ l 19 6-CI CH3 (2-csH4N)-cH2 175-178 6-CI CH3 H (3-C5H4N)-CH2 77 I _ 22 6-CI CH3 CH3 COOCH(CH3)2 151 l 23 6-CI CH2SCH3 H IPOC 128 l 24 6-CI H3 CH3 COOC2Hs 163 l 25 6-CI CH3 CH3 COOC3H7 164 l _ .
26 6-CI C2Hs H (2-csH4N)-cH2 162-164 27 6-CI C4Hg H IPOC 132 I _ ~ _ l 28 6-CI CH2SCH3 HCOOCH(Ctl3)2 124 l 29 6-CI CH2SCH3 J (2-csH4N)-cH2 1~9 I .
¦ 30 6-CH30 CH2S~H3 H IPOC _ 31 6-CH30 CH2SCH3 HCOC)CH(CH3)2 163 2 ~
, r-32 6-CI ¦ CH2SCH3 H ¦ C~H2C6H4-2-CI __=
Key; CsHg = 3-methyl-2-buten-1-yl IPOC = isopropenyloxycarbsnyl 5ALOC = allyloxycarbonyl CsH4N = pyridyl Example X)(IV
(3RS)-3-Methyl-4-N-(3-methyl-2-buten-1-yl)-2-methylthio-3,4-dihydroquinoxaline (3RS)-3-Methyl-4-N-(3-methyl-2-buten-1-yl)-3,4-dihydroquinoxaline-2(1 H)-thione (Table 7, No. 1) (0.49 g, 2.0 mmol) was dissolved in 20 ml of ethanol (96%), andthe solution was treated with 5.1 ml (2.2 rnmol) of a 1% strength sodium ethanolate 1~ solution. After the mixture had been stirred for 15 minutes at room temperature, û.14 ml (2.2 mmol) of methyl iodide was added dropwise, and the mixture was stirred for a further 2 hours at room temperature. The reaction solution was concentrated, and the residue was chromatographed on silica gel. 500 mg (96%) ofa yellow oil were isolated using ethyl acetate/heptane ~ 1:6.
1H NMR d6-DMSO): ~ = 0.96 (d, J = 7 Hz, 3 H), 1.72 (s, 6 H), 2.44 (s, 3 H), 3.71(dd, J = 15, 6 Hz, 1 H), 3.89 (dd, J = 15, 6 Hz, 1 H), 4.00 (q, J = 7 llz, 1 H), 5.20 (m, 1 H), 6.65 - 6.75 (m, 2 H), 7.02 (t, J = B Hz, 1 H), 7.11 ppm (d, J = 8 Hz, 1 H).
MS: (M ~ H)~ - 261 The following compound of the formula i was synthesized in the same manner:
4-lsopropenyloxycarbonyl-2-(isopropenylOXyCarbOnyl)-thiO-3,~,7,8-tetramethyl-3,4-dihydroquinoxaline.
Melting point: 11~C
2~6~
Example XXV
~3Rs)-3-Methyl-4-N-(3-methyl-2-buten-l-yl)-3l4-dihydroquinoxalirl-2(1 H)-one (3RS)-3-Methyl-3,4-dihydroquinoxalin-2(1~)-on0 (4.86 g, 0.03 mol) dissolved in 50 ml of N,N-dimethylformamide was alkylated with 4.2 ml ~0.033 mol) of 3-methyl2-buten-1-yl bromide (90%) in the presence of 4.60 9 (0.033 mol) of pulverulent potassium carbonate. The reaction mixture was stirred at room temperature until reaction of the educt was complete. The solvent was th~n stripped off in vacuo, the residue was taken up in ethyl acetate and water, the phases were separated, the aqueous phase was extracted twioe with ethyl acetate, and the combined organic extracts were washed twice with water. Dryin~ over sodium sulfa~e, concentration in vacuo and crystatlization from pentane gave 5.80 9 (84%) of white crystalline product of melting point 92-93C.
lH NMR (270 MHz, d6-DMSO): ~ = 0.99 (d, J = 7 Hz, 3 H), 1.72 (s, 6 H), 3.67 (dd,J = 15, 7 Hz, 1 H), 3.86 (q, J = 7 Hz, 1 H), 3.88 (dd, J = t5, 7 Hz, 1 H), 5.21 (m, 1 H), 6.65 - 6.9 (m, 4 H), 10.31 ppm (br. s, 1 H).
MS: (M + H)+ = 231 Example XXVI
3,3a-Dihydropyrrolo[1,2-a]quinoxaline-1,4(2H,5H)-dione 2-Fluoronitrobenzene (14.1 9, 0.1 mol) and L-glutamic acid (45.0 9, 0.3 mol) were heated in 100 ml of 2-rnethoxyethanol at 95C, with stirring, and 300 ml of 2N
sodium hydroxide solution were added dropwise. Stirring was then continued for 25 another 3 hours at this temperature. After cooling, the solution was treated with 400 ml of methanol and hydrogenated under atmospheric pressure with Raney nickel as catalyst.
When the uptake of hydrogen had ended, the catalyst was removed by filtration with suction, and the solution was concentrated under reduced pressure.
30 The residue was acidified with 250 ml of 2N hydrochloric acid and heatecl in a steam bath for approx. 30 minutes. The precipitate which resulted in this process 2~6~8~
was filtered off with suction, washed with water and alcohol and subsequently dried, melting point 255C, decomposition.
'H NMR (60 MHz, d6-DMSO): ~ = 1.9 - 2.7 ~m, 4 H), 4.5 (t, J = 8 Hz, 1 H~, 6.8 - 7.3 (m, 3 H), 7.8 - 8.2 (m, 1 H), 10.7 ppm (br. s, 1 H).
MS: (M + H)+ = 202 Example XXVII
7-Phenoxysulfonyl-3,3a-dihydropyrrolo[1 ,2-a~iquinoxaline-1 ,4~2H,5H~-dione The compound was obtained in analo~ous manner by r0acting phenyl 4-chloro 3-nitrobenzenesulfonate with L-glutamic acid, melting point 140C: (decomp.).
1H NMR (60 MHz, d6-DMSO): ~ = 1.6 - 2.5 (m, 4 H), 4.07 (t, J = 6 Hz, 1 H), 6.7 - 7.6 (m, 8 H), 10.57 ppm (br. s, 1 H).
MS: (M + H)~ = 358 Example XXVIII
3-Carboxymethyl-3,4-dihydroquinoxalin-2(1 H)-one 2-Fluoronitrobenzene (14.1 g, 0.1 mol) and L-aspartic acid (40.0 g, 0.3 mol) were heated to 95C in 100 ml of 2-rnethoxyethanol, with stirring, and 300 rnl of 2N
sodium hydroxide solution were added dropwise. Stirring was then continued for 1hour at this temperature. After the solution had cooled, it was treated with 500 ml of methanol and hydrogenated under atmospheric pressure with Raney nickel as catalyst.
When the uptake of hydrogen had ended, the catalyst was removed by filtration with suction, and the solution was concentrated under reduced pressure.
The residue was acidified with 500 ml of 2N hydrochloric acid, the mixture was subsequently concentrated, neutralized with sodium acetate anci extracted with ethyl acetate. The mixture was dried with sodium suifate, the solvent was stripped off, and the residue was then obtained which was first oily and crystailized upon stirring with water, melting point 152-154t::.
2~6~
'H NMR (60 MHz, d6-DMSO): ~ = 2.5 - 2.7 (dd partly concealed, 2 H), 4.1 (td, J = 6, 2 Hz, 1 H), 5.98 (br. s, 1 H), 6.5 - 6.9 (m, 4 H), 10.30 (br. s, 1 H), 12.37 ppm (br. s, 1 H).
MS: M+ = 206 CHN analysis: calculated C 58.2; H 4.8; N 13.6%
found C 58.4; H 4.7; N 13.7%
Example X)(IX
7-Phenoxysulfonyl-3,4-dihydroquinoxalin-2(1H) one A) Methyl N- [ (2-nitro-4-phenoxysulfonyl)phenyl] glycinate Phenyl 4-chloro-3-nitrobenzenesulfonate (62.7 g, 0.2 mol) and methyl glyeinate hydrochloride (100.4 g, 0.8 mol), dissolved in 250 ml of methanol, were treated with 200 ml of triethylamine, and the mixture was refluxed for 15 minutes. After cooling, the mixture was treated with 1 1 of 2N acetic acid, subjected to filtration with suction and washed with water. The residue was recrystallized from ethyl acetate and washed with methanol and diisopropyl ether, melting point 120-123C.
B) 7-Phenoxysulfonyl-3,4-dihydroquinoxalin-2(1 H)-one Methyl N-[(2-nitro-4-phenoxysulfonyl)phenyl]glycinate (36.6 9, 0.1 mol) was hydrogenated under atmospheric pressure in a mixture of 250 ml of N,N-dimethylformamide and 250 ml of methanol, with Raney nickel as catalyst.
When the uptake of hydrogen had ended, the catalyst was removed by filtration with suction, and the solution was freed from solvent in vacuo. The residue was dissolved in 40 rnl of 2-methoxyethanol, and the mixture was hea~ed ior one hour in a steam bath. The resulting precipitate was filtered off with s~ction and washeel with methanol, melting point 253-254C.
'H NMR (60 MHz, d6-DMSO): g = 4.0 (d, J = 4 Hz, 2 H), 6.6 - 7.6 (m, 9 H), 10.43 ppm (br. s, 1 H).
MS: (M ~ H)+ = 305 2 ~
Example XXX
4-(3-Methyl-2-buten-1-yl)-7-phenoxysul~onyl-3,Wihydroquinoxalin-2(1 H)-one 7-Phenoxysulfonyl-3,4-dihydroquinoxalin-2(1H)-one (1.52 g, 5.0 mmol) in 20 ml ofN,N-dimethylacetamjde was stirred for 8 hours at 100~C with 2 ml of 3-methyl-2-buten-1-yl bromide. After cooling, the mixture was treated with water and extracted with ethyl acetate. The solution was dried using magnesium sulfate andthen concentrated, and the residue was chromatographed over a silica gel column using ethyl acetate/heptane = 1:~. The fractions which contained th~ substance were evaporated on a rotary evaporator, and the product was subsequently stirredwith pentane and filtered off with suction, melting point 132~
H NMR (270 MHz, d6-DMSO): ~ = 1.73 (s, 6 H), 3.90 (s, 2 H), 3.93 (partly concealed d, J = 6 Hz, 2 H), 5.20 (br. t, J = 6 Hz, 1 H), 6.75 - 7.45 (m, 8 H), 10.66 ppm (s, 1 H).
MS: (M + H)~ = 373 The following compounds of the formula I were synthesized in analogous rnanner using the corresponding haloaromatic substances and amino acid derivatives and, if appropriate, derivatized further on nitrogen atom 4:
2~$~
Table 8 H
I
R n~ ~R 3 . . I
Nr. R1n R3 R4 Rs M.P.C l _ . I
1 7-C6H5-O-SO2 H CH2OH H 199 ¦
_ I
7-C6H5-O-SO2 H CH2OH CsHs 120 decomp. l . _ I
4 7-C6Hs-o-so2 H CH2COOH CsHs _ _ _ _ 7-C6H5-O-sO2 H CH2CONH2 H 272 decomp.
_ 7-C6Hs-O-sO2 H CH2CONH2 C5Hg 7 7-C6H5-O-sO2 H CH2-4-lmi H 216 decomp.
_ _ . , .
8 7-C6H5-O-sO2 H Ctl2-4-lmi C5H,~
_ ._ decomp.
_ ..
decomp _ _ I
11 7-C6H5-C)-sO2 H CH3 _ 148 .. - : .
2 ~
_ Nr.R1n R' R4 Rs M.P. C
127-C6H5-O-sO2 H CH3 CsHg Oil _ _ I
137-C6Hs~S02 H CH3 H 1 9E~
_ _ 147-C6Hs~SO2 H CH3 CsHs Oil 157-C6Hs-sO2 H ~H3 IPOC 108 _ _ 167-C6Hso-so2 H H H
I _ _ .
177-C~HsSO2 H H COCH3 270 ~ _ 187-C6H5-OSO2 H CH3 IPOC Resin Key: CsHg = 3-methyl-2-buten-1-yl 4-lmi = 4-imidazolyl IPC)C = isopropenyloxycarbonyl Example XXXI
6-Chloro-7-phenoxysulfonyl-1,2,3,3a-tetrahydropyrrolo[2,1-c]-quinoxalin-4(5H)-one A) Phenyl 2,4-dichloro-3-nitrobenzenesulfonate 2,6-Dichloronitrobenzene was stirred for 7 hours at 130C with an excess of 20 chlorosulfonic acid. After cooling, the mixture was poured onto ice, the sulfochloride was filtered off with suction, washeci to neutrality and dried over sodium hydroxide, melting point 91 C. The resulting sulfochlsride ~29.05 g, 0.1 mol) and phenol (11.5 g, 0.12 mol) were dissol~ed in 150 ml of acetone and treated with 14 ml of triethylamine at 10C. The mixture was stirred for 1 hour with 25 cooling, stirring was then continued for a further 4 hours at room temperature, the mixture was then treated with 200 mi of water, the resultin~ precipitate was filtered off with suction at 10C, washed with water and dried in vacuo at 80 :;, melting point 102C.
:
:
2 ~
B) N-[(3-Chloro-2-nitro-4-phenoxysulfonyl)phenyl]proline Phenyl 2,4-dichloro-3-nitrobenzenesulfonate (34.8 g, 0.1 mol), 69.0 g (0.6 mol) of L-proline, 200 ml of 2N sodium hydroxide solution and 200 ml of 2-methoxyethanolwere stirred for 10 minutes at 80C. The clear solution was acidified at 50C using concentrated hydrochloric acid and poured onto ice. The precipitate was filtered off with suction, washed with water to neutrality and ~ried at 80C. Melting point 148C (after recrystallization from methanol) C) 6-Chloro-7-phenoxysulfonyl-1 ,2,3,3a-tetrahydropyrrolo[2, 1 -c]-quinoxalin-4 (5H)-one N-[(3-Chloro-2-nitro-4-phenoxysulfonyl)phenyl]proline (38.0 9, 0.075 mol) in 500 ml of methanol and 25 ml of concentrated ammonia solution was hydrogenated under atmospheric pressure with Raney nickel as catalyst.
When the uptake of hydrogen had ended, the catalyst was removed by filtration with suction, the solution was concentrated, the residue together with 2N
hydrochloric acid was heated for approximately 30 minutes in a steam bath, cooled, subjected to filtration with suction and washed with water to neutrality. Melting point 197C (after recrystallization from glacial acetic acid) Example X~O(II
8-(4-Methyl-1 -piperazinyl)-3-(2-methylpropyl)-5-phenoxysulfonyl-3,4-dihydroquinoxalin-2(1 tl)-one A) Phenyl 2-chloro-4-(4-methyl-1-piperazinyl)-3-nitrobenzenesulfonate Phenyl 2,4~dichloro-3-nitrobenzenesulfonate (17.4 9, 0.05 mol) and 25 ml of rnethylpiperazine in 100 ml of isopropanol were refluxed for 10 minutes and subsequently concentrated. The residue was stirred with 50 mi of 50% methanol, filtered off with suction, and washed with 50% methanol and finally with water.
Melting point 94-95C (after recrystallization from cyclohexane) 2~3~5~
B) N-[(3-(4-Methyl-1-piperazinyl)-2-nitro-~-phenoxysuifonyl)-phenyl]leucine hydrochloride Phenyl 2-chloro-4-(4-methyl-1-piperazinyl)-3-nitrobenzenesulfonate t41.1 g, û.1 mol) and L-leucine (39.3 g, 0.3 mol) were stirred for 8 hours at 95C in a mixture of100 ml of N,N-dimethylformamide, 50 ml of 2-methoxyethanol and 100 ml of 2N
sodium hydroxide sslution. When cold, the reaction mixture was acidified with concentrated hydrochloric acid. The precipitate was taken up in ethyl acetate, and the mixture was dried using sodium sulfate and freed from solvent in vacuo. Thisgave an orange oil.
C) 8-(4-Methyl-1-piperæinyl)-3-(2-methylpropyl)-~-phenoxysulfonyl-3,4-dihydroquinoxalin-2(1H)-one hydrochloride N-[(3-(4-Methyl-1-piperazinyl)-2-nitro-6-phenoxysulfonyl)-phenyl]leucine hydrochloride (25.3 g, 0.05 mol) in 250 ml of methanol and 25 ml of glacial acetic acid was hydrogenated under atmospheric pressure using Raney nickel as catalyst.When the uptake of hydrogen had ended, the ca~alyst was removed by filtration with suction, the solution was concentrated, and the residue together with 2N ofhydrochloric acid was heated for approximately 10 minutes in a steam bath and then concentrated in vacuo. The residue was dissolved in water, the mixture was rendered alkaline using ammonia, and this was taken up in ethyl acetate. The oilwhich remained after concentration was dissolved in 400 ml ~f diisopropyl ether,and the mixture was rendered neutral using ethanolic hydrochloric acid. The ~5 precipitate was filtered off with suction, washed with diisopropyl ether and dried, melting point 90~C and above (decomp.).
MS: M+ = ~58 The following compounds of the forrnula I were synthesized in analogous manner using the corresponding haloaromatic substances and amino acid derivatives and, if appropriate, derivatized ~urther on nitrogen atorn 4:
2 ~ g ~
Table 9 l H3 ~N H
~0~
¦ Nr. R3 R4 Rs M.P. C
¦ 1 H (CH3)2CHCH2CsHs l _ , ~ H GH3 H (HCI) ¦ 3 tl CH3 C5Hg I _ ¦ 4 H H H 126- 127 (base) I _ H H C5Hg Key: C5Hg = 3-methyl-2-buten-1-yl Example XXXlil (3RS)-4-N-Cyclohexyl-3-rnethyl-3,4-dihydroquinoxalin-2(H)-one (3RS)-3-Methyl-3,4-dihydroquinox31in-2(1H)-one (0.81 9, 0.005 mol) and 1 ml (0.1 mol) of cyclohexanone were introduced into 20 ml vf 1,2-dichioroethans.
Trifluoroacetic acid (1.9 ml, 0.025 mol) was addsd dropwise, during which process a clear solution formed with gentle heating. 2.1 g (0.01 mol) of sodium triacetoxyborohydride were added, the exothermic reaction was then allowed to -:
2~65~5 proceed for 30 minutes with stirring, and quenching was then effected by adding saturated aqueous sodium hydrogen carbonate solution. The phases were separated, the organic phase was washed with saturated aqueous sodium chloride solution, dried (magnesium sulfate) and concentrated. The crude product was chromatographed on silica gel using ethyl acetate/heptane = 1:1. 1.15 g (94%) ofthe d~sired product were obtained, melting point 131-132~C (toluene/heptane).
'H NMR (270 MHz, d6-DMSO): ~ = 0~97 (d, J = 7 Hz, 3 H), 1.0 - 2.0 (m, 10 H), 3 39 (m, 1 H), 3.91 (q, J = 7 Hz, 1 H), 6.68 - 6.94 (rn, 4 H), 10.27 ppm (br. s, 1 H).
MS: (M + H)t = 245.
The following compounds of the formula I were synthesized in analogous manner.
Table lQ
H
R n~
_ _ I
Nr. Rln R3 R4 R5 M.P. C
I _ _ 1 CH3 H C2Hs 106 -1 07 I _ _ 2 CH3 H CH2C(CH3)3 162 . .
3 CH3 H c-C5~19 120 . _ 4 6-CI CH3 H c-~4H7 100 _ 6-CI CH3 H CsH,1 94 - 95 ~, .
112 2~59 _ Nr. R'n R3 R4 M.P.C
6 6-CI CH3 H CH2C(CH3)3 158- 160 _ 7 6-CI C2Hs H CH2C(CH3)3 158 -1 59 8 6-CI CH3 H CH =CH(:~HO 140 -146 L~ 6-CI CH3 H CH2C--CH3 166-168 6-CI CH3 H 2-Picolyl 198 -199 I _ 11 6-CI CH3 H 3-Picolyl 136 I
12 6-CI CH3 H 4-Picolyl 19t - 193 _ 13 6-CI CH3 H Furanyl-2-methyl 116- 118 14 6-CI CH3 H CH2C6H4 4-Rr 149 - 150 I
¦ 17 6-CI CH3 H CH2C6H4-3-NO2 125 I
¦ 18 6-CI CH3 H CH2C6Hq-2-NO2 153- 154 I
¦ 19 6-CI CH3 H CH2C6H4-4-CI 122 - 1~3 I . _ L~ 6-CI CH3 H CH2C6H4-3-CI 156 - 157 L~ 6-CI CH3 H CH2C6H4-2-CI 138 ¦ 22 6-CI CH3 ll CH2C6H4~-F 147 I _ ¦ 23 6-CI CH3 H CH2C6H4-4-C6H5 164-165 I _ ~ 6-CI CH3 H C;H2C6H4-4-OC6Hs il _ _ _ 26 6-CI CH3 11 CH2C6H4-4-COC)CH3 139 _ _ 27 6-CI CH3 H CH2C6H3-2,~-Cl2 190-191 2 ~ a _ _ _ ¦~ ~ R1n R3 R4 Rs M.P. C .
l _ . I
28 6-CI CH3 H CH2C6H3-3,5-Cl2 139-140 I
29 6-CI CH3 H Naphthyl-1 -methyi 164-166 I _ 6-CI CH3 H Naphthyl-2-methyl 161-164 _ 32 6-CI CH3 H Cyclohex-2-enyl Oil _ _ .
34 6-CI CH3 H Thienyl-3-rnethyl 141-142 6-CI CH3 H (5-Methyl~hienyl)- 58-60 2-methyl 36 6-CI CH3 H (3-Methylthienyl)-2- 124 methyl l _ 37 6-CI CH3 H Thienyl-2-methyl 121-123 I
~8 6-CI CH3 H CH2CH = CH-~6H5 _ I _ 6-CI CH2SCH3 H CH2C6tl4-2-NO2 134 _ 41 6-CI CH2SCH3 H 2-Picolyl Oil 42 6-CI CH2SCH3 H CH2C6H3-2,4-cL2 t43 _ _ _ 43 6-CI CH2S-i. Pr H CH2C6H3-2,4-Cl2 Oil _ 44 6-CI CH2S-Bn H Cff2C6H3-2,4-Cl2 Oil _ 6-CI CH2-S-H H CH2C6H3-2,4-Cl2 ¦__~ _~ . T-- . .. ...
46 6-CI C2H5 H 2-PiCQiyl 160-162 I _ .
1~_ 6-CI CH3 H (6-CH3)2-Picolyl 158 2 ~ 8 ~
Key: CsH11 = 3-methyl-1-butyl c-C4H7 = cyclobutyl c-CsH9 = cyclopentyl Example X)O~IV
(3RS~-3-Methyl-4-N-(3-oxo-1-butyl)-3,4-~ihydroquinoxalin-2(1 H)-one 3-Methyl-3,4-dihydroquinoxalin-2(1H)-one (0.5 y, 3.1 mmol) together with 0.35 ml(4.3 mmol) of methyl vinyl ketone and a catalytic amount of triethylamine were stirred for 20 hours at room temperature in 20 ml of anhydrous ethanol. Silica gel chromatography with methyl tert.-butyl ether/heptane = 2:1 gave 620 mg (87%) of the desired product, melting point 108-109~C (rnethyl tert.-butyl ether/heptane).
t5 1H NMR ~270 MHz, d6-DMSO): ~ = 1.03 (d, J = 7 Hz, 3 H), 2.11 (s, 3H), 2.77 (t, J=6Hz,2H),3.30(m,1H),3.50(m,1H),3.88(q,J=7Hz,1H),6.68(m, 1 H), 6.78 (m, 1 H), 6.88 (m, 1 H), 10.31 ppm (br. s, 1 H).
MS: (M + H)~ = 233, M~ = 232 Example XXXV
(3S)-6-Chloro-4-N-chlorocarbonyl-3-methyl-3,4-dihydroquinoxalin-2(1 H)-one The compound of Example IB (2.0 g, 0.01 mol~ in 100 ml of anhydrous toluene was heated with bis-(trichloromethyl) carbonate (triphosgene) (1.5 g, 0.005 mol) for 1 hour at 80C in the presence of 2 ml (0.û14 mol) of triethylamine. After cooling, the mixture was washed with water and saturated aqueous sodium chloride solu~ion and dried (magnesium sulfate), and the solvent was removed under reduced pressure. The residue (2.5 g) crystalli~ed after stirring with heptane, its purity being sufficient for preparative purposes. A sample of analytical purity was obtained by silica gel chromatography using ethyl acetate/heptane = 1:1 as eluent. Melting point 142-144C.
2 ~
'H NMR (270 MHz, d5-DMSO): ~ = 1.25 (d, J = 7 Hz, 3 H), 3.83 (q, J = 7 Hz, 1 H), 6.61 (dd, J = 6, 2 Hz, 1 H~, 6.70 (s, 2H), 10.3 ppm (br. s, 1 H).
MS: (M + H)+ = ~59 5 Example X)O~VI
(3S)-6-Chloro4-N-(2-methoxyethoxycarbonyl)-3-methyl-3,4-dihydroquinoxalin-2(1 H)-one 1Q To a solution of 0.24 ml (3.0 mmol) of 2-methoxyethanol in 10 ml of anhydrous 1,2-dimethoxyethane there was added 0.16 ~ of a 55% suspension of sodium hydride in mineral oil, and the reaction mixture was stirred for 30 minutes at room temperature. 0.50 g (1.9 mmol) of the compound of Example XXXV was subsequently added, with ice-cooling, and the mixture was allowed to warm to 15 room temperature and stirred for a further 30 rninutes. The mixture was treated with saturated aqueous sodium chloride solution, extracted several times wi~h ethyl acetate, the organic phase was washed once with saturated aqueous sodium chloride solution and dried (magnesium sulfate), and the solvent was removed in vacuo. After silica gel chromatography (ethyl acetate/heptane = 1:1) and crystallization from ether/heptane, 0.29 9 (51%) of the desired product was obtained, melting point 93-94C.
'H NMR (200 MHz, d6-DMSO): ~ = 1.13 (d, J = 7.5 Hz, 3 H), 3.32 (s, 3 H), 3.6 (m,2H), 4.24 (m, 1 H), 4.35 (m, 1 H), 4.81 (q, J = 7.5 Hz, 1 H), 6.98 (d, J = 9 Hz,1 H), 7.2 (dd, J = 9, 3 Hz, 1 H), 7.66 (d, J = 3 Hz, 1 H, 10.81 ppm (br. 2, 1 H).
MS: (M + H)+ = 299 Example XXXVII
(3S)-6-Chloro-3-methyl-4-N-[(phenylthio)carbonyl)l-3,4-dihydroquinoxalin-2(1 H)-one To a solution of 0.31 ml (3.0 mmol) of thiophenol in 10 ml of 1,2-dimethoxyethane there was added û.17 g of a 55% suspension of sodium hydride in mineral oil, with 116 20~985 ice-cooling, and the mixture was stirred for 1 hour at room temperature. 0.5 g (1.9 mmol) of the compound of Example XXXV were introduced, again with ice-cooling, and stirring was then continued for 2 hours at room temperature. For working-up, the mixture was treated with saturated aqu~ous sodium chloride 5 solution, extracted twice with ethyl acetate and dried (sodium sulfate), and the solvent was stripped off. The solid residue was recrystallized frorn heptane/isopropanol, 0.35 g (35%), melting point 194-195C.
H NMR (200 MHz, d6-DMSO): ~ = 1.10 (d, J = 7 Hz, 3 H), 4.93 (q, J = 7 Wz, 1H),7.08(d,J=9Hz,1H),7.33(dd,J=9,3Hz,1H),7.4-78.6(m,5H),7.78 (d, J = 3 Hz, 1 H), 10.16 ppm (br. s, 1 H).
MS: (M + H)' = 333, (M - C~H5SH + H)' 223 The following compounds of the formula I were synthesized in analogous manner.
15 Table 11 H
I
R n~ J~R 3 . _ Nr. R1n R3 ~4 Rs M.P. C
. _ 1 6-CI CH3 H COOCH2CH = CHCH3 1 16-1 17 2 6-CI ~H3 H COOCH2= C(CH3)2 87-89 _ . . _ I _ _ L~ 6-CI CH3 H COOCH2G ~ CCH3 135 2 ~
_. .
R~ n _ R4 Rs M . P. C
S 6-CI CH3 H COSCH2C6Hs 158 6 6-CI CH3 H COSCH2CH = CH2 Oil _ .
7 6-CI CH3 H COOCH2C(CH3) = CH2 125-127 _ 8 6-CI CH3 H COOC(CH3)3 _ 9 6-CI CH3 H COO-Cyclohex-2-en-1 -yl _ .
10 6-CI CH3 H COOCH (CH2OCH (CH3)2)2 Oil I _ 11 6-CI CH3 H COOCH (CH3)2 1 41 -1 42 I
12 6-CI CH3 H COOC2H4N ~CH3)2 Oil I _. _ _ .
I
14 6-CI CH3 H cOSC6H5 194-195 6-CI CH3 H CoocH2c6H4-3-No2 183-185 17 6-CI CH3 H COO~H2C6H4-4-CI 177-180 I .
19 6-CI CH3 H COOCH2CH = CHCH2CH3 Oil _ _ _ 20 6-CI CH3 H CO0(3-Picolyl) 160-161 _ 21 6-CI CH3 H COO(2-Picolyl) 114-116 22 6-CI CH3 H CoocH2c6H4-4-No2 230-233 _ _ ._ _ _ 23 6-GI GH3 H COOCH2CH2C(CH3) = CH2 (:)il . _ _ _ I
¦ 24 6-CI ~H3 H CO-(4-Nlethylpiperazin-1-yl) _ _ 25 6-CI CH3 H CO-N (CH2)~ 218-220 __ I
26 6-CI CH3 H CO-N (CH2)4 ~00-203 I _ _ 2~6~9~
~ R~n R3 R4 Rs ~ M.P. ~ C
I ...
27 6-CI CH3 H CO-Morpholin-1~yl 193-195 I
28 6-CI CH3 H CO-HNCH2Ph 94-96 I , , , 29 6-CI CH3 H Cyclopropyl-methyloxy- 119-122 carbonyl
166,7-(CH3)2 CH3 CH3 CsH9 173 17 6-CI C3H7 H IPOC 154-1~5 l _ ~ I
_ l 19 6-CI CH3 (2-csH4N)-cH2 175-178 6-CI CH3 H (3-C5H4N)-CH2 77 I _ 22 6-CI CH3 CH3 COOCH(CH3)2 151 l 23 6-CI CH2SCH3 H IPOC 128 l 24 6-CI H3 CH3 COOC2Hs 163 l 25 6-CI CH3 CH3 COOC3H7 164 l _ .
26 6-CI C2Hs H (2-csH4N)-cH2 162-164 27 6-CI C4Hg H IPOC 132 I _ ~ _ l 28 6-CI CH2SCH3 HCOOCH(Ctl3)2 124 l 29 6-CI CH2SCH3 J (2-csH4N)-cH2 1~9 I .
¦ 30 6-CH30 CH2S~H3 H IPOC _ 31 6-CH30 CH2SCH3 HCOC)CH(CH3)2 163 2 ~
, r-32 6-CI ¦ CH2SCH3 H ¦ C~H2C6H4-2-CI __=
Key; CsHg = 3-methyl-2-buten-1-yl IPOC = isopropenyloxycarbsnyl 5ALOC = allyloxycarbonyl CsH4N = pyridyl Example X)(IV
(3RS)-3-Methyl-4-N-(3-methyl-2-buten-1-yl)-2-methylthio-3,4-dihydroquinoxaline (3RS)-3-Methyl-4-N-(3-methyl-2-buten-1-yl)-3,4-dihydroquinoxaline-2(1 H)-thione (Table 7, No. 1) (0.49 g, 2.0 mmol) was dissolved in 20 ml of ethanol (96%), andthe solution was treated with 5.1 ml (2.2 rnmol) of a 1% strength sodium ethanolate 1~ solution. After the mixture had been stirred for 15 minutes at room temperature, û.14 ml (2.2 mmol) of methyl iodide was added dropwise, and the mixture was stirred for a further 2 hours at room temperature. The reaction solution was concentrated, and the residue was chromatographed on silica gel. 500 mg (96%) ofa yellow oil were isolated using ethyl acetate/heptane ~ 1:6.
1H NMR d6-DMSO): ~ = 0.96 (d, J = 7 Hz, 3 H), 1.72 (s, 6 H), 2.44 (s, 3 H), 3.71(dd, J = 15, 6 Hz, 1 H), 3.89 (dd, J = 15, 6 Hz, 1 H), 4.00 (q, J = 7 llz, 1 H), 5.20 (m, 1 H), 6.65 - 6.75 (m, 2 H), 7.02 (t, J = B Hz, 1 H), 7.11 ppm (d, J = 8 Hz, 1 H).
MS: (M ~ H)~ - 261 The following compound of the formula i was synthesized in the same manner:
4-lsopropenyloxycarbonyl-2-(isopropenylOXyCarbOnyl)-thiO-3,~,7,8-tetramethyl-3,4-dihydroquinoxaline.
Melting point: 11~C
2~6~
Example XXV
~3Rs)-3-Methyl-4-N-(3-methyl-2-buten-l-yl)-3l4-dihydroquinoxalirl-2(1 H)-one (3RS)-3-Methyl-3,4-dihydroquinoxalin-2(1~)-on0 (4.86 g, 0.03 mol) dissolved in 50 ml of N,N-dimethylformamide was alkylated with 4.2 ml ~0.033 mol) of 3-methyl2-buten-1-yl bromide (90%) in the presence of 4.60 9 (0.033 mol) of pulverulent potassium carbonate. The reaction mixture was stirred at room temperature until reaction of the educt was complete. The solvent was th~n stripped off in vacuo, the residue was taken up in ethyl acetate and water, the phases were separated, the aqueous phase was extracted twioe with ethyl acetate, and the combined organic extracts were washed twice with water. Dryin~ over sodium sulfa~e, concentration in vacuo and crystatlization from pentane gave 5.80 9 (84%) of white crystalline product of melting point 92-93C.
lH NMR (270 MHz, d6-DMSO): ~ = 0.99 (d, J = 7 Hz, 3 H), 1.72 (s, 6 H), 3.67 (dd,J = 15, 7 Hz, 1 H), 3.86 (q, J = 7 Hz, 1 H), 3.88 (dd, J = t5, 7 Hz, 1 H), 5.21 (m, 1 H), 6.65 - 6.9 (m, 4 H), 10.31 ppm (br. s, 1 H).
MS: (M + H)+ = 231 Example XXVI
3,3a-Dihydropyrrolo[1,2-a]quinoxaline-1,4(2H,5H)-dione 2-Fluoronitrobenzene (14.1 9, 0.1 mol) and L-glutamic acid (45.0 9, 0.3 mol) were heated in 100 ml of 2-rnethoxyethanol at 95C, with stirring, and 300 ml of 2N
sodium hydroxide solution were added dropwise. Stirring was then continued for 25 another 3 hours at this temperature. After cooling, the solution was treated with 400 ml of methanol and hydrogenated under atmospheric pressure with Raney nickel as catalyst.
When the uptake of hydrogen had ended, the catalyst was removed by filtration with suction, and the solution was concentrated under reduced pressure.
30 The residue was acidified with 250 ml of 2N hydrochloric acid and heatecl in a steam bath for approx. 30 minutes. The precipitate which resulted in this process 2~6~8~
was filtered off with suction, washed with water and alcohol and subsequently dried, melting point 255C, decomposition.
'H NMR (60 MHz, d6-DMSO): ~ = 1.9 - 2.7 ~m, 4 H), 4.5 (t, J = 8 Hz, 1 H~, 6.8 - 7.3 (m, 3 H), 7.8 - 8.2 (m, 1 H), 10.7 ppm (br. s, 1 H).
MS: (M + H)+ = 202 Example XXVII
7-Phenoxysulfonyl-3,3a-dihydropyrrolo[1 ,2-a~iquinoxaline-1 ,4~2H,5H~-dione The compound was obtained in analo~ous manner by r0acting phenyl 4-chloro 3-nitrobenzenesulfonate with L-glutamic acid, melting point 140C: (decomp.).
1H NMR (60 MHz, d6-DMSO): ~ = 1.6 - 2.5 (m, 4 H), 4.07 (t, J = 6 Hz, 1 H), 6.7 - 7.6 (m, 8 H), 10.57 ppm (br. s, 1 H).
MS: (M + H)~ = 358 Example XXVIII
3-Carboxymethyl-3,4-dihydroquinoxalin-2(1 H)-one 2-Fluoronitrobenzene (14.1 g, 0.1 mol) and L-aspartic acid (40.0 g, 0.3 mol) were heated to 95C in 100 ml of 2-rnethoxyethanol, with stirring, and 300 rnl of 2N
sodium hydroxide solution were added dropwise. Stirring was then continued for 1hour at this temperature. After the solution had cooled, it was treated with 500 ml of methanol and hydrogenated under atmospheric pressure with Raney nickel as catalyst.
When the uptake of hydrogen had ended, the catalyst was removed by filtration with suction, and the solution was concentrated under reduced pressure.
The residue was acidified with 500 ml of 2N hydrochloric acid, the mixture was subsequently concentrated, neutralized with sodium acetate anci extracted with ethyl acetate. The mixture was dried with sodium suifate, the solvent was stripped off, and the residue was then obtained which was first oily and crystailized upon stirring with water, melting point 152-154t::.
2~6~
'H NMR (60 MHz, d6-DMSO): ~ = 2.5 - 2.7 (dd partly concealed, 2 H), 4.1 (td, J = 6, 2 Hz, 1 H), 5.98 (br. s, 1 H), 6.5 - 6.9 (m, 4 H), 10.30 (br. s, 1 H), 12.37 ppm (br. s, 1 H).
MS: M+ = 206 CHN analysis: calculated C 58.2; H 4.8; N 13.6%
found C 58.4; H 4.7; N 13.7%
Example X)(IX
7-Phenoxysulfonyl-3,4-dihydroquinoxalin-2(1H) one A) Methyl N- [ (2-nitro-4-phenoxysulfonyl)phenyl] glycinate Phenyl 4-chloro-3-nitrobenzenesulfonate (62.7 g, 0.2 mol) and methyl glyeinate hydrochloride (100.4 g, 0.8 mol), dissolved in 250 ml of methanol, were treated with 200 ml of triethylamine, and the mixture was refluxed for 15 minutes. After cooling, the mixture was treated with 1 1 of 2N acetic acid, subjected to filtration with suction and washed with water. The residue was recrystallized from ethyl acetate and washed with methanol and diisopropyl ether, melting point 120-123C.
B) 7-Phenoxysulfonyl-3,4-dihydroquinoxalin-2(1 H)-one Methyl N-[(2-nitro-4-phenoxysulfonyl)phenyl]glycinate (36.6 9, 0.1 mol) was hydrogenated under atmospheric pressure in a mixture of 250 ml of N,N-dimethylformamide and 250 ml of methanol, with Raney nickel as catalyst.
When the uptake of hydrogen had ended, the catalyst was removed by filtration with suction, and the solution was freed from solvent in vacuo. The residue was dissolved in 40 rnl of 2-methoxyethanol, and the mixture was hea~ed ior one hour in a steam bath. The resulting precipitate was filtered off with s~ction and washeel with methanol, melting point 253-254C.
'H NMR (60 MHz, d6-DMSO): g = 4.0 (d, J = 4 Hz, 2 H), 6.6 - 7.6 (m, 9 H), 10.43 ppm (br. s, 1 H).
MS: (M ~ H)+ = 305 2 ~
Example XXX
4-(3-Methyl-2-buten-1-yl)-7-phenoxysul~onyl-3,Wihydroquinoxalin-2(1 H)-one 7-Phenoxysulfonyl-3,4-dihydroquinoxalin-2(1H)-one (1.52 g, 5.0 mmol) in 20 ml ofN,N-dimethylacetamjde was stirred for 8 hours at 100~C with 2 ml of 3-methyl-2-buten-1-yl bromide. After cooling, the mixture was treated with water and extracted with ethyl acetate. The solution was dried using magnesium sulfate andthen concentrated, and the residue was chromatographed over a silica gel column using ethyl acetate/heptane = 1:~. The fractions which contained th~ substance were evaporated on a rotary evaporator, and the product was subsequently stirredwith pentane and filtered off with suction, melting point 132~
H NMR (270 MHz, d6-DMSO): ~ = 1.73 (s, 6 H), 3.90 (s, 2 H), 3.93 (partly concealed d, J = 6 Hz, 2 H), 5.20 (br. t, J = 6 Hz, 1 H), 6.75 - 7.45 (m, 8 H), 10.66 ppm (s, 1 H).
MS: (M + H)~ = 373 The following compounds of the formula I were synthesized in analogous rnanner using the corresponding haloaromatic substances and amino acid derivatives and, if appropriate, derivatized further on nitrogen atom 4:
2~$~
Table 8 H
I
R n~ ~R 3 . . I
Nr. R1n R3 R4 Rs M.P.C l _ . I
1 7-C6H5-O-SO2 H CH2OH H 199 ¦
_ I
7-C6H5-O-SO2 H CH2OH CsHs 120 decomp. l . _ I
4 7-C6Hs-o-so2 H CH2COOH CsHs _ _ _ _ 7-C6H5-O-sO2 H CH2CONH2 H 272 decomp.
_ 7-C6Hs-O-sO2 H CH2CONH2 C5Hg 7 7-C6H5-O-sO2 H CH2-4-lmi H 216 decomp.
_ _ . , .
8 7-C6H5-O-sO2 H Ctl2-4-lmi C5H,~
_ ._ decomp.
_ ..
decomp _ _ I
11 7-C6H5-C)-sO2 H CH3 _ 148 .. - : .
2 ~
_ Nr.R1n R' R4 Rs M.P. C
127-C6H5-O-sO2 H CH3 CsHg Oil _ _ I
137-C6Hs~S02 H CH3 H 1 9E~
_ _ 147-C6Hs~SO2 H CH3 CsHs Oil 157-C6Hs-sO2 H ~H3 IPOC 108 _ _ 167-C6Hso-so2 H H H
I _ _ .
177-C~HsSO2 H H COCH3 270 ~ _ 187-C6H5-OSO2 H CH3 IPOC Resin Key: CsHg = 3-methyl-2-buten-1-yl 4-lmi = 4-imidazolyl IPC)C = isopropenyloxycarbonyl Example XXXI
6-Chloro-7-phenoxysulfonyl-1,2,3,3a-tetrahydropyrrolo[2,1-c]-quinoxalin-4(5H)-one A) Phenyl 2,4-dichloro-3-nitrobenzenesulfonate 2,6-Dichloronitrobenzene was stirred for 7 hours at 130C with an excess of 20 chlorosulfonic acid. After cooling, the mixture was poured onto ice, the sulfochloride was filtered off with suction, washeci to neutrality and dried over sodium hydroxide, melting point 91 C. The resulting sulfochlsride ~29.05 g, 0.1 mol) and phenol (11.5 g, 0.12 mol) were dissol~ed in 150 ml of acetone and treated with 14 ml of triethylamine at 10C. The mixture was stirred for 1 hour with 25 cooling, stirring was then continued for a further 4 hours at room temperature, the mixture was then treated with 200 mi of water, the resultin~ precipitate was filtered off with suction at 10C, washed with water and dried in vacuo at 80 :;, melting point 102C.
:
:
2 ~
B) N-[(3-Chloro-2-nitro-4-phenoxysulfonyl)phenyl]proline Phenyl 2,4-dichloro-3-nitrobenzenesulfonate (34.8 g, 0.1 mol), 69.0 g (0.6 mol) of L-proline, 200 ml of 2N sodium hydroxide solution and 200 ml of 2-methoxyethanolwere stirred for 10 minutes at 80C. The clear solution was acidified at 50C using concentrated hydrochloric acid and poured onto ice. The precipitate was filtered off with suction, washed with water to neutrality and ~ried at 80C. Melting point 148C (after recrystallization from methanol) C) 6-Chloro-7-phenoxysulfonyl-1 ,2,3,3a-tetrahydropyrrolo[2, 1 -c]-quinoxalin-4 (5H)-one N-[(3-Chloro-2-nitro-4-phenoxysulfonyl)phenyl]proline (38.0 9, 0.075 mol) in 500 ml of methanol and 25 ml of concentrated ammonia solution was hydrogenated under atmospheric pressure with Raney nickel as catalyst.
When the uptake of hydrogen had ended, the catalyst was removed by filtration with suction, the solution was concentrated, the residue together with 2N
hydrochloric acid was heated for approximately 30 minutes in a steam bath, cooled, subjected to filtration with suction and washed with water to neutrality. Melting point 197C (after recrystallization from glacial acetic acid) Example X~O(II
8-(4-Methyl-1 -piperazinyl)-3-(2-methylpropyl)-5-phenoxysulfonyl-3,4-dihydroquinoxalin-2(1 tl)-one A) Phenyl 2-chloro-4-(4-methyl-1-piperazinyl)-3-nitrobenzenesulfonate Phenyl 2,4~dichloro-3-nitrobenzenesulfonate (17.4 9, 0.05 mol) and 25 ml of rnethylpiperazine in 100 ml of isopropanol were refluxed for 10 minutes and subsequently concentrated. The residue was stirred with 50 mi of 50% methanol, filtered off with suction, and washed with 50% methanol and finally with water.
Melting point 94-95C (after recrystallization from cyclohexane) 2~3~5~
B) N-[(3-(4-Methyl-1-piperazinyl)-2-nitro-~-phenoxysuifonyl)-phenyl]leucine hydrochloride Phenyl 2-chloro-4-(4-methyl-1-piperazinyl)-3-nitrobenzenesulfonate t41.1 g, û.1 mol) and L-leucine (39.3 g, 0.3 mol) were stirred for 8 hours at 95C in a mixture of100 ml of N,N-dimethylformamide, 50 ml of 2-methoxyethanol and 100 ml of 2N
sodium hydroxide sslution. When cold, the reaction mixture was acidified with concentrated hydrochloric acid. The precipitate was taken up in ethyl acetate, and the mixture was dried using sodium sulfate and freed from solvent in vacuo. Thisgave an orange oil.
C) 8-(4-Methyl-1-piperæinyl)-3-(2-methylpropyl)-~-phenoxysulfonyl-3,4-dihydroquinoxalin-2(1H)-one hydrochloride N-[(3-(4-Methyl-1-piperazinyl)-2-nitro-6-phenoxysulfonyl)-phenyl]leucine hydrochloride (25.3 g, 0.05 mol) in 250 ml of methanol and 25 ml of glacial acetic acid was hydrogenated under atmospheric pressure using Raney nickel as catalyst.When the uptake of hydrogen had ended, the ca~alyst was removed by filtration with suction, the solution was concentrated, and the residue together with 2N ofhydrochloric acid was heated for approximately 10 minutes in a steam bath and then concentrated in vacuo. The residue was dissolved in water, the mixture was rendered alkaline using ammonia, and this was taken up in ethyl acetate. The oilwhich remained after concentration was dissolved in 400 ml ~f diisopropyl ether,and the mixture was rendered neutral using ethanolic hydrochloric acid. The ~5 precipitate was filtered off with suction, washed with diisopropyl ether and dried, melting point 90~C and above (decomp.).
MS: M+ = ~58 The following compounds of the forrnula I were synthesized in analogous manner using the corresponding haloaromatic substances and amino acid derivatives and, if appropriate, derivatized ~urther on nitrogen atorn 4:
2 ~ g ~
Table 9 l H3 ~N H
~0~
¦ Nr. R3 R4 Rs M.P. C
¦ 1 H (CH3)2CHCH2CsHs l _ , ~ H GH3 H (HCI) ¦ 3 tl CH3 C5Hg I _ ¦ 4 H H H 126- 127 (base) I _ H H C5Hg Key: C5Hg = 3-methyl-2-buten-1-yl Example XXXlil (3RS)-4-N-Cyclohexyl-3-rnethyl-3,4-dihydroquinoxalin-2(H)-one (3RS)-3-Methyl-3,4-dihydroquinox31in-2(1H)-one (0.81 9, 0.005 mol) and 1 ml (0.1 mol) of cyclohexanone were introduced into 20 ml vf 1,2-dichioroethans.
Trifluoroacetic acid (1.9 ml, 0.025 mol) was addsd dropwise, during which process a clear solution formed with gentle heating. 2.1 g (0.01 mol) of sodium triacetoxyborohydride were added, the exothermic reaction was then allowed to -:
2~65~5 proceed for 30 minutes with stirring, and quenching was then effected by adding saturated aqueous sodium hydrogen carbonate solution. The phases were separated, the organic phase was washed with saturated aqueous sodium chloride solution, dried (magnesium sulfate) and concentrated. The crude product was chromatographed on silica gel using ethyl acetate/heptane = 1:1. 1.15 g (94%) ofthe d~sired product were obtained, melting point 131-132~C (toluene/heptane).
'H NMR (270 MHz, d6-DMSO): ~ = 0~97 (d, J = 7 Hz, 3 H), 1.0 - 2.0 (m, 10 H), 3 39 (m, 1 H), 3.91 (q, J = 7 Hz, 1 H), 6.68 - 6.94 (rn, 4 H), 10.27 ppm (br. s, 1 H).
MS: (M + H)t = 245.
The following compounds of the formula I were synthesized in analogous manner.
Table lQ
H
R n~
_ _ I
Nr. Rln R3 R4 R5 M.P. C
I _ _ 1 CH3 H C2Hs 106 -1 07 I _ _ 2 CH3 H CH2C(CH3)3 162 . .
3 CH3 H c-C5~19 120 . _ 4 6-CI CH3 H c-~4H7 100 _ 6-CI CH3 H CsH,1 94 - 95 ~, .
112 2~59 _ Nr. R'n R3 R4 M.P.C
6 6-CI CH3 H CH2C(CH3)3 158- 160 _ 7 6-CI C2Hs H CH2C(CH3)3 158 -1 59 8 6-CI CH3 H CH =CH(:~HO 140 -146 L~ 6-CI CH3 H CH2C--CH3 166-168 6-CI CH3 H 2-Picolyl 198 -199 I _ 11 6-CI CH3 H 3-Picolyl 136 I
12 6-CI CH3 H 4-Picolyl 19t - 193 _ 13 6-CI CH3 H Furanyl-2-methyl 116- 118 14 6-CI CH3 H CH2C6H4 4-Rr 149 - 150 I
¦ 17 6-CI CH3 H CH2C6H4-3-NO2 125 I
¦ 18 6-CI CH3 H CH2C6Hq-2-NO2 153- 154 I
¦ 19 6-CI CH3 H CH2C6H4-4-CI 122 - 1~3 I . _ L~ 6-CI CH3 H CH2C6H4-3-CI 156 - 157 L~ 6-CI CH3 H CH2C6H4-2-CI 138 ¦ 22 6-CI CH3 ll CH2C6H4~-F 147 I _ ¦ 23 6-CI CH3 H CH2C6H4-4-C6H5 164-165 I _ ~ 6-CI CH3 H C;H2C6H4-4-OC6Hs il _ _ _ 26 6-CI CH3 11 CH2C6H4-4-COC)CH3 139 _ _ 27 6-CI CH3 H CH2C6H3-2,~-Cl2 190-191 2 ~ a _ _ _ ¦~ ~ R1n R3 R4 Rs M.P. C .
l _ . I
28 6-CI CH3 H CH2C6H3-3,5-Cl2 139-140 I
29 6-CI CH3 H Naphthyl-1 -methyi 164-166 I _ 6-CI CH3 H Naphthyl-2-methyl 161-164 _ 32 6-CI CH3 H Cyclohex-2-enyl Oil _ _ .
34 6-CI CH3 H Thienyl-3-rnethyl 141-142 6-CI CH3 H (5-Methyl~hienyl)- 58-60 2-methyl 36 6-CI CH3 H (3-Methylthienyl)-2- 124 methyl l _ 37 6-CI CH3 H Thienyl-2-methyl 121-123 I
~8 6-CI CH3 H CH2CH = CH-~6H5 _ I _ 6-CI CH2SCH3 H CH2C6tl4-2-NO2 134 _ 41 6-CI CH2SCH3 H 2-Picolyl Oil 42 6-CI CH2SCH3 H CH2C6H3-2,4-cL2 t43 _ _ _ 43 6-CI CH2S-i. Pr H CH2C6H3-2,4-Cl2 Oil _ 44 6-CI CH2S-Bn H Cff2C6H3-2,4-Cl2 Oil _ 6-CI CH2-S-H H CH2C6H3-2,4-Cl2 ¦__~ _~ . T-- . .. ...
46 6-CI C2H5 H 2-PiCQiyl 160-162 I _ .
1~_ 6-CI CH3 H (6-CH3)2-Picolyl 158 2 ~ 8 ~
Key: CsH11 = 3-methyl-1-butyl c-C4H7 = cyclobutyl c-CsH9 = cyclopentyl Example X)O~IV
(3RS~-3-Methyl-4-N-(3-oxo-1-butyl)-3,4-~ihydroquinoxalin-2(1 H)-one 3-Methyl-3,4-dihydroquinoxalin-2(1H)-one (0.5 y, 3.1 mmol) together with 0.35 ml(4.3 mmol) of methyl vinyl ketone and a catalytic amount of triethylamine were stirred for 20 hours at room temperature in 20 ml of anhydrous ethanol. Silica gel chromatography with methyl tert.-butyl ether/heptane = 2:1 gave 620 mg (87%) of the desired product, melting point 108-109~C (rnethyl tert.-butyl ether/heptane).
t5 1H NMR ~270 MHz, d6-DMSO): ~ = 1.03 (d, J = 7 Hz, 3 H), 2.11 (s, 3H), 2.77 (t, J=6Hz,2H),3.30(m,1H),3.50(m,1H),3.88(q,J=7Hz,1H),6.68(m, 1 H), 6.78 (m, 1 H), 6.88 (m, 1 H), 10.31 ppm (br. s, 1 H).
MS: (M + H)~ = 233, M~ = 232 Example XXXV
(3S)-6-Chloro-4-N-chlorocarbonyl-3-methyl-3,4-dihydroquinoxalin-2(1 H)-one The compound of Example IB (2.0 g, 0.01 mol~ in 100 ml of anhydrous toluene was heated with bis-(trichloromethyl) carbonate (triphosgene) (1.5 g, 0.005 mol) for 1 hour at 80C in the presence of 2 ml (0.û14 mol) of triethylamine. After cooling, the mixture was washed with water and saturated aqueous sodium chloride solu~ion and dried (magnesium sulfate), and the solvent was removed under reduced pressure. The residue (2.5 g) crystalli~ed after stirring with heptane, its purity being sufficient for preparative purposes. A sample of analytical purity was obtained by silica gel chromatography using ethyl acetate/heptane = 1:1 as eluent. Melting point 142-144C.
2 ~
'H NMR (270 MHz, d5-DMSO): ~ = 1.25 (d, J = 7 Hz, 3 H), 3.83 (q, J = 7 Hz, 1 H), 6.61 (dd, J = 6, 2 Hz, 1 H~, 6.70 (s, 2H), 10.3 ppm (br. s, 1 H).
MS: (M + H)+ = ~59 5 Example X)O~VI
(3S)-6-Chloro4-N-(2-methoxyethoxycarbonyl)-3-methyl-3,4-dihydroquinoxalin-2(1 H)-one 1Q To a solution of 0.24 ml (3.0 mmol) of 2-methoxyethanol in 10 ml of anhydrous 1,2-dimethoxyethane there was added 0.16 ~ of a 55% suspension of sodium hydride in mineral oil, and the reaction mixture was stirred for 30 minutes at room temperature. 0.50 g (1.9 mmol) of the compound of Example XXXV was subsequently added, with ice-cooling, and the mixture was allowed to warm to 15 room temperature and stirred for a further 30 rninutes. The mixture was treated with saturated aqueous sodium chloride solution, extracted several times wi~h ethyl acetate, the organic phase was washed once with saturated aqueous sodium chloride solution and dried (magnesium sulfate), and the solvent was removed in vacuo. After silica gel chromatography (ethyl acetate/heptane = 1:1) and crystallization from ether/heptane, 0.29 9 (51%) of the desired product was obtained, melting point 93-94C.
'H NMR (200 MHz, d6-DMSO): ~ = 1.13 (d, J = 7.5 Hz, 3 H), 3.32 (s, 3 H), 3.6 (m,2H), 4.24 (m, 1 H), 4.35 (m, 1 H), 4.81 (q, J = 7.5 Hz, 1 H), 6.98 (d, J = 9 Hz,1 H), 7.2 (dd, J = 9, 3 Hz, 1 H), 7.66 (d, J = 3 Hz, 1 H, 10.81 ppm (br. 2, 1 H).
MS: (M + H)+ = 299 Example XXXVII
(3S)-6-Chloro-3-methyl-4-N-[(phenylthio)carbonyl)l-3,4-dihydroquinoxalin-2(1 H)-one To a solution of 0.31 ml (3.0 mmol) of thiophenol in 10 ml of 1,2-dimethoxyethane there was added û.17 g of a 55% suspension of sodium hydride in mineral oil, with 116 20~985 ice-cooling, and the mixture was stirred for 1 hour at room temperature. 0.5 g (1.9 mmol) of the compound of Example XXXV were introduced, again with ice-cooling, and stirring was then continued for 2 hours at room temperature. For working-up, the mixture was treated with saturated aqu~ous sodium chloride 5 solution, extracted twice with ethyl acetate and dried (sodium sulfate), and the solvent was stripped off. The solid residue was recrystallized frorn heptane/isopropanol, 0.35 g (35%), melting point 194-195C.
H NMR (200 MHz, d6-DMSO): ~ = 1.10 (d, J = 7 Hz, 3 H), 4.93 (q, J = 7 Wz, 1H),7.08(d,J=9Hz,1H),7.33(dd,J=9,3Hz,1H),7.4-78.6(m,5H),7.78 (d, J = 3 Hz, 1 H), 10.16 ppm (br. s, 1 H).
MS: (M + H)' = 333, (M - C~H5SH + H)' 223 The following compounds of the formula I were synthesized in analogous manner.
15 Table 11 H
I
R n~ J~R 3 . _ Nr. R1n R3 ~4 Rs M.P. C
. _ 1 6-CI CH3 H COOCH2CH = CHCH3 1 16-1 17 2 6-CI ~H3 H COOCH2= C(CH3)2 87-89 _ . . _ I _ _ L~ 6-CI CH3 H COOCH2G ~ CCH3 135 2 ~
_. .
R~ n _ R4 Rs M . P. C
S 6-CI CH3 H COSCH2C6Hs 158 6 6-CI CH3 H COSCH2CH = CH2 Oil _ .
7 6-CI CH3 H COOCH2C(CH3) = CH2 125-127 _ 8 6-CI CH3 H COOC(CH3)3 _ 9 6-CI CH3 H COO-Cyclohex-2-en-1 -yl _ .
10 6-CI CH3 H COOCH (CH2OCH (CH3)2)2 Oil I _ 11 6-CI CH3 H COOCH (CH3)2 1 41 -1 42 I
12 6-CI CH3 H COOC2H4N ~CH3)2 Oil I _. _ _ .
I
14 6-CI CH3 H cOSC6H5 194-195 6-CI CH3 H CoocH2c6H4-3-No2 183-185 17 6-CI CH3 H COO~H2C6H4-4-CI 177-180 I .
19 6-CI CH3 H COOCH2CH = CHCH2CH3 Oil _ _ _ 20 6-CI CH3 H CO0(3-Picolyl) 160-161 _ 21 6-CI CH3 H COO(2-Picolyl) 114-116 22 6-CI CH3 H CoocH2c6H4-4-No2 230-233 _ _ ._ _ _ 23 6-GI GH3 H COOCH2CH2C(CH3) = CH2 (:)il . _ _ _ I
¦ 24 6-CI ~H3 H CO-(4-Nlethylpiperazin-1-yl) _ _ 25 6-CI CH3 H CO-N (CH2)~ 218-220 __ I
26 6-CI CH3 H CO-N (CH2)4 ~00-203 I _ _ 2~6~9~
~ R~n R3 R4 Rs ~ M.P. ~ C
I ...
27 6-CI CH3 H CO-Morpholin-1~yl 193-195 I
28 6-CI CH3 H CO-HNCH2Ph 94-96 I , , , 29 6-CI CH3 H Cyclopropyl-methyloxy- 119-122 carbonyl
Claims (9)
1. A compound of the formula I or Ia, (I) (Ia) and physiologically acceptable salts and prodrugs thereof, where, in formulae I and Ia, n is zero, one, two, three or four, the individual substituents R1 independently of one another are fluorine, chlorine, bromine, iodine, trifluoromethyl, trifluoromethoxy, hydroxyl, C1-C8-alkyl, C5-C8-cycloalkyl, C1-C6-alkoxy, (C1-C6-alkoxy)-(C1-C4-alkoxy), C1-C6-alkylthio, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, nitro, amino, azido, C1-C6-alkylamino, di(C1-C6-alkyl)amino, piperidino, morpholino, 4-pyrrolidinyl, 4-methylpiperazinyl, thiomorpholino, imidazolyl, triazolyi, tetrazolyl, C1-C6-acyl, C1-C6-acyloxy, C1-C6-acylarnino, cyano, carbamoyl, carboxyl, (C1-C6-alkyl)oxycarbonyl, hydroxysulfonyl, sulfamoyl or a phenyl, phenoxy, phenoxycarbonyl, phenylthio, phenylsulfinyl, phenylsulfonyl, phenoxysulfonyl, phenylsulfonyloxy, anilinosulfonyl, phenylsulfonylamino, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which issubstituted by up to five radicals R6 which are independent of one another, where R6 can be fluorine, chlorine, bromine, iodine, cyano, trifluoromethyl, trifluoromethoxy, nitro, amino, azido, C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-alkylthio, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-alkylamino, di(C1-C6-alkyl)amino, (C1-C6-alkyl)oxycarbonyl, phenyl, phenoxy, 2-, 3- or 4-pyridyl, R2 is hydrogen, C1-C6-alkoxy, hydroxyl, picolyl, cyclo-propyl or isopropenyloxycarbonyl and R5 is hydrogen, hydroxyl, C1-C6-alkoxy, aryloxy, C1-C6-acyloxy, cyano, amino, C1-C6-alkylamino, di(C1-C6-alkyl)amino, arylamino, C1-C6-acylamino, C1-C8-alkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C2-C8-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C8-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl and carbamoyl;
C3-C8-allenyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C3-C8-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C,-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amins, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkyl)-(C1-C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkenyl)-(C1-C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mcrcapto, hyclroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C1-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C2-C8-alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl,C1-C4-alkoxy, oxo, phenyl (C3-C8-cycloalkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C8-cycloalkenyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C3-Ca-cycloalkyl)-(C1-C3-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C6-cycloalkenyl)-(C1-C3-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C8-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio;
C2-C8-alkenyloxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C2-C8-alkynyloxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C8-alkylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl,C1-C4-alkoxy, oxo, phenyl;
C2-C8-alkenylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C8-alkylamino- and di(C1-C8-alkyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1-ylcarbonyl, in each case optionally substituted by C1-C4-alkyl, C2-C6-alkenyl,C1-C4-acyl, oxo, thioxo, carboxyl, or phenyl;
C2-C8-alkenylamino- and di(C1-C6-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkenylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
or aryl, arylcarbonyl, aryl(thiocarbonyl), (arylthio)carbonyl, (arylthio)thiocarbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino)thio-carbonyl, arylalkylaminocarbonyl, arylsulfonyl, arylalkyl, arylalkenyl, arylalkynyl, arylalkylcarbonyl, arylalkenylcarbonyl, arylalkoxycarbonyl or arylalkylthiocarbonyl, each of which is substituted by up to 5 radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 5 carbon atoms, and R6 being as defined above, or heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkylcarbonyl or heteroarylalkenylcarbonyl, heteroaryloxycarbonyl, (heteroarylthio)carbonyl, heteroarylaminocarbonyl, heteroarylalkyloxycarbonyl, heteroaryl(alkylthio)carbonyl or heteroarylalkylaminocarbonyl, each of which is substituted by up to three radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms, R3 and R4 are identical or different and, independently of one another, are hydrogen, C1-C8-alkyl which is optionally substituted by fluorine, chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C2-C8-alkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyl, amino,mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
aryl, arylalkyl, heteroaryl or heteroarylalkyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain 1 to 3 carbon atoms in each case, and R6 being as defined above, R3 and R4 can furthermore also be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 8 carbon atoms and which can optionally be substituted by fluorine, chlorine, hydroxyl, amino, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-acyloxy, benzoyloxy, C1-C6-alkoxy, oxo, thioxo, carboxyl, carbamoyl or phenyl, X is oxygen, sulfur, selenium or substituted nitrogen N-R2, it being possible for R2 to have the abovementioned meanings, with the exception of those compounds in which R3 and R4 are both hydrogen, and compounds in which R2 and R5 are hydrogen and R3 and/or R4 are/is arylalkyl, andcompounds in which X is oxygen and R2 and R5 are hydrogen.
C2-C8-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C8-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl and carbamoyl;
C3-C8-allenyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C3-C8-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C,-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amins, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkyl)-(C1-C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkenyl)-(C1-C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mcrcapto, hyclroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C1-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C2-C8-alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl,C1-C4-alkoxy, oxo, phenyl (C3-C8-cycloalkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C8-cycloalkenyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C3-Ca-cycloalkyl)-(C1-C3-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C6-cycloalkenyl)-(C1-C3-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C8-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio;
C2-C8-alkenyloxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C2-C8-alkynyloxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C8-alkylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl,C1-C4-alkoxy, oxo, phenyl;
C2-C8-alkenylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C8-alkylamino- and di(C1-C8-alkyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1-ylcarbonyl, in each case optionally substituted by C1-C4-alkyl, C2-C6-alkenyl,C1-C4-acyl, oxo, thioxo, carboxyl, or phenyl;
C2-C8-alkenylamino- and di(C1-C6-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkenylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
or aryl, arylcarbonyl, aryl(thiocarbonyl), (arylthio)carbonyl, (arylthio)thiocarbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino)thio-carbonyl, arylalkylaminocarbonyl, arylsulfonyl, arylalkyl, arylalkenyl, arylalkynyl, arylalkylcarbonyl, arylalkenylcarbonyl, arylalkoxycarbonyl or arylalkylthiocarbonyl, each of which is substituted by up to 5 radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 5 carbon atoms, and R6 being as defined above, or heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkylcarbonyl or heteroarylalkenylcarbonyl, heteroaryloxycarbonyl, (heteroarylthio)carbonyl, heteroarylaminocarbonyl, heteroarylalkyloxycarbonyl, heteroaryl(alkylthio)carbonyl or heteroarylalkylaminocarbonyl, each of which is substituted by up to three radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms, R3 and R4 are identical or different and, independently of one another, are hydrogen, C1-C8-alkyl which is optionally substituted by fluorine, chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C2-C8-alkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyl, amino,mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
aryl, arylalkyl, heteroaryl or heteroarylalkyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain 1 to 3 carbon atoms in each case, and R6 being as defined above, R3 and R4 can furthermore also be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 8 carbon atoms and which can optionally be substituted by fluorine, chlorine, hydroxyl, amino, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-acyloxy, benzoyloxy, C1-C6-alkoxy, oxo, thioxo, carboxyl, carbamoyl or phenyl, X is oxygen, sulfur, selenium or substituted nitrogen N-R2, it being possible for R2 to have the abovementioned meanings, with the exception of those compounds in which R3 and R4 are both hydrogen, and compounds in which R2 and R5 are hydrogen and R3 and/or R4 are/is arylalkyl, andcompounds in which X is oxygen and R2 and R5 are hydrogen.
2. A compound of the formula I or Ia as claimed in claim 1, wherein the substituents in the abovementioned formulae have the following meaning:
n is zero, one, two or three, the individual substituents R1 independently of one another are fluorine, chlorine, bromine, trifluoromethyl, trifluoromethoxy, hydroxyl, C1-C4-alkyl, C5-C6-cycloalkyl, C1-C4-alkoxy, (C1-C4-alkoxy)-(C1-C4-alkoxy), C1-C4-alkylthio, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonyl, nltro, amino, C1-C4-alkylamino, di(C1-C4-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, thiomorpholino, imidazolyl, C1-C4-acyl, C1-C4-acyloxy, C1-C4-acyiamino, cyano, carbamoyl, carboxyl, (C1-C4-alkyl)oxycarbonyl, hydroxysulfonyl or sulfamoyl or a phenyl, phenoxy, phenoxycarbonyl, phenylthio, phenylsulfinyl, phenylsulfonyl, phenoxysulfonyl, phenylsulfonyloxy, anilinosulfonyl, phenylsulfonylamino, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which issubstituted by up to two radicals R6 which are independent of one another, where R6 can be fluorine, chlorine, bromine, cyano, trifluoromethyl, nitro, amino, C1-C4-alkyl, C3-C7-cycloalkyl, C1-C4-alkoxy, C1-C4-alkylthio, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonyl, C1-C4-alkylamino, di(C1-C4-alkyl)amino, (C1-C4-alkyl)oxycarbonyl,phenyl or phenoxy, R2 is hydrogen and R5 is hydrogen, hydroxyl, cyano, amino, C1-C6-alkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C2-C8-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-allenyl, C3-C8-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkyl)-(C1-C2-alkyl) optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4 alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkenyl)-(C1-C2-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C1-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoylnxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C2-C6-alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl,C1-C4-alkoxy, oxo, phenyl;
(C3-C6-cycloalkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C6-cycloalkenyl)carbonyl, optionally substituted by fluorine, chlorinc or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C3-C6-cycloalkyl)-(C1-C2-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C6-cycloalkenyl)-(C1-C2-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio;
C2-C6-alkenyloxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C2-C6-alkynyluxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-4-alkoxy, oxo, phenyl;
C1-C6-alkylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl,C1-C4-alkoxy, oxo, phenyl;
C2-C6-alkenylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkylamino- and di(C1-C6-alkyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1-ylcarbonyl;
C2-C6-alkenylamino- and di(C1-C6-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C4-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C4-alkenylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
or aryl, arylcarbonyl, aryl(thiocarbonyl), (arylthio)carbonyl, (arylthio)thiocarbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino)thio-carbonyl, arylalkylaminocarbonyl, arylsulfonyl, arylalkyl, arylalkenyl, arylalkynyl, arylalkylcarbonyl, arylalkenylcarbonyl, or arylalkoxycarbonyl, or aryl(alkylthio)carbonyl, each of which is substituted by up to three radicais R6which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 5 carbon atoms and R6 being as defined above, or 1- or 2-naphthylmethyl, 2-, 3- or 4-picolyl, 2- or 3-furylmethyl, 2- or
n is zero, one, two or three, the individual substituents R1 independently of one another are fluorine, chlorine, bromine, trifluoromethyl, trifluoromethoxy, hydroxyl, C1-C4-alkyl, C5-C6-cycloalkyl, C1-C4-alkoxy, (C1-C4-alkoxy)-(C1-C4-alkoxy), C1-C4-alkylthio, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonyl, nltro, amino, C1-C4-alkylamino, di(C1-C4-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, thiomorpholino, imidazolyl, C1-C4-acyl, C1-C4-acyloxy, C1-C4-acyiamino, cyano, carbamoyl, carboxyl, (C1-C4-alkyl)oxycarbonyl, hydroxysulfonyl or sulfamoyl or a phenyl, phenoxy, phenoxycarbonyl, phenylthio, phenylsulfinyl, phenylsulfonyl, phenoxysulfonyl, phenylsulfonyloxy, anilinosulfonyl, phenylsulfonylamino, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which issubstituted by up to two radicals R6 which are independent of one another, where R6 can be fluorine, chlorine, bromine, cyano, trifluoromethyl, nitro, amino, C1-C4-alkyl, C3-C7-cycloalkyl, C1-C4-alkoxy, C1-C4-alkylthio, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonyl, C1-C4-alkylamino, di(C1-C4-alkyl)amino, (C1-C4-alkyl)oxycarbonyl,phenyl or phenoxy, R2 is hydrogen and R5 is hydrogen, hydroxyl, cyano, amino, C1-C6-alkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C2-C8-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-allenyl, C3-C8-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkyl)-(C1-C2-alkyl) optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4 alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkenyl)-(C1-C2-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C1-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C4-acyloxy, benzoylnxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C2-C6-alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl,C1-C4-alkoxy, oxo, phenyl;
(C3-C6-cycloalkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C6-cycloalkenyl)carbonyl, optionally substituted by fluorine, chlorinc or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C3-C6-cycloalkyl)-(C1-C2-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C6-cycloalkenyl)-(C1-C2-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio;
C2-C6-alkenyloxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C2-C6-alkynyluxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-4-alkoxy, oxo, phenyl;
C1-C6-alkylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl,C1-C4-alkoxy, oxo, phenyl;
C2-C6-alkenylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkylamino- and di(C1-C6-alkyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1-ylcarbonyl;
C2-C6-alkenylamino- and di(C1-C6-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C4-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C4-alkenylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
or aryl, arylcarbonyl, aryl(thiocarbonyl), (arylthio)carbonyl, (arylthio)thiocarbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino)thio-carbonyl, arylalkylaminocarbonyl, arylsulfonyl, arylalkyl, arylalkenyl, arylalkynyl, arylalkylcarbonyl, arylalkenylcarbonyl, or arylalkoxycarbonyl, or aryl(alkylthio)carbonyl, each of which is substituted by up to three radicais R6which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 5 carbon atoms and R6 being as defined above, or 1- or 2-naphthylmethyl, 2-, 3- or 4-picolyl, 2- or 3-furylmethyl, 2- or
3-thienylmethyl, 2- or 3-pyrroiylmethyl, 2-, 3- or 4-pyridylcarbonyl, 2- or 3-furylcarbonyl, 2- or 3-thienylcarbonyl, 2- or 3-thienylacetyl, 2-, 3- or
4-picolyloxycarbonyl, 2- or 3-furylmethyloxycarbonyl, 2- or 3-thienylmethyl-oxycarbonyl, each of which is substituted by up to two radicals R6 which are independent of one another, and R3 and R4 are identical or different and independently of one another are hydrogen, C1-C6-alkyl, optionally substituted by fluorine, chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl,carboxyl or carbamoyl;
C2-C8-alkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyl, amino,mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyioxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1 C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
aryl, arylalkyl, heteroaryl or heteroarylalkyl, each of which is substituted by up to three radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms and R6 being as defined above, R3 and R4 can furthermore also be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 7 carbon atoms and which can optionally be substituted by fluorine, chlorine, hydroxyl, amino, C1-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-acyloxy, benzoyloxy, C1-C4-alkoxy, oxo, thioxo, carboxyt, carbamoyl or phenyl, and X is oxygen, sulfur or selenium.
3. A compound of the formula I or Ia as claimed in claim 1 or 2, wherein the substituents in the abovementioned formulae have the following meanings:
n is zero, one ortwo, the individual substituents R1 independently of one another are fluorine, chlorine, bromine, trifluoromethyl, hydroxyl, C1-C4-alkyl, C1-C4-alkoxy, (C1-C4-alkoxy)-(C1-C4-alkoxy), C1-C4-alkylthio, nitro, amino, C1-C4-alkylamino, di(C1-C4-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, C1-C4-acyl, C1-C4-acyloxy, C1-C4-acylamino, cyano, carbamoyl, carboxyl, (C1-C4-alkyl)oxycarbonyl, hydroxysulfonyl or sulfamoyl, or a phenyl, phenoxy, phenylthio, phenylsulfonyl, phenoxysulfonyl, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which is substituted by up to two radicals R6 which are independent of one another, where R6 can be fluorine, chlorine, bromine, cyano, trifluoromethyl, nitro, amino, C1-C4-alkyl, C1-C4-alkoxy, (C1-C4-alkyl)oxycarbonyl, phenyl or phenoxy, R2 is hydrogen and R5 is C1-C6-alkyl, optionally substituted by fluorine) chlorine, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C2-C6-alkenyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-allenyl, C3-C8-alkynyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-acyloxy, benzoyloxy, benzyloxy,phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-acyloxy, benzoyloxy, benzyloxy,phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C4-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
(C3-C6-cycloalkyl)-(C1-C2-alkyl), optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-acyloxy, benzoyloxy, benzyloxy,phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
(C3-C6-cycloalkenyl)-(C1-C2-alkyl), optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-acyloxy, benzoyloxy, benzyloxy,phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C4-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C4-C4-alkoxy, C1-C4-alkylamino, C1-C4-alkenylamino, di(C1-C4-alkyl)amino, 1-pyrrolidinyl, piperidino, morpholino, 4-methylpiperzin-1-yl, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C2-C6-alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl;
(C3-C6-cyoloalkyl)carbonyl, (C5-C6-cycloalkenyl)carbonyl, (C3-C6-cycloalkyl)-(C1-C2-alkyl)carbonyl, (C5-C6-cycloalkenyl)-(C1-C2-alkyl)carbonyl, C1-C6-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino or C1-C4-alkyl-thio;
C2-C6-alkenyloxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-C4-alkoxy;
C2-C6-alkynyloxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-C4-alkoxy;
C1-C6-alkylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy;
C2-C6-alkenylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy;
C1-C6-alkylamino- and di(C1-C6-alkyl)aminocarbonyl, in each cass optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperzin-1-ylcarbonyl;
C2-C6-alkenylamino- and di(C1-C6-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy;
C1-C4-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy;
C1-C4-alkenylsulfonyl;
or aryl, arylcarbonyl, (arylthio)carbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino)thiocarbonyl, arylsulfonyl, arylalkylaminocarbonyl, arylalkyl, arylalkenyl, arylalkylcarbonyl, aryl(alkylthio)carbonyl or arylalkoxycarbonyl, each of which is substituted by up to two radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms and R5 being as defined above, or 1- or 2-naphthylmethyl, 2-, 3- or 4-picolyl, 2- or 3-furylmethyl, 2- or 3-thienylmethyl, 2- or 3-pyrrolylmethyl, 2-, 3- or 4-pyridylcarbonyl, 2- or 3-furylcarbonyl, 2- or 3-thienylcarbonyl, 2- or 3-thienylacetyl, 2-, 3- oder 4-picolyloxycarbonyl, 2- or 3-furylmethyloxycarbonyl, 2- or 3-thienylmethyloxycarbonyl each of which is substituted by up to two radicals R6 which are independent of one another, and R3 and R4 are identical or different and independently of one another are hydrogen, C1-C4-alkyl, optionally substituted by fluorine, chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, Cl-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C2-C6-alkenyl, optionally substituted by fluorine or chlorine;
C3-C6-cycloalkyl, optionally substituted by fluorine, chlorine. hydroxyl, amino,mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine or chlorine;
aryl, benzyl, heteroaryl or heteroarylmethyl, each of which is substituted by up to two radicals R6 which are independent of one another, R3 and R4 can furthermore also be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 6 carbon atoms and which can optionally be substituted by fluorine, chlorine, hydroxyl, amino, C1-C4-acyloxy, benzoyloxy, C1-C4-alkoxy, oxo, thioxo, carboxyl or carbamoyl, and X is oxygen or sulfur.
4. A compound of the formula I or Ia as claimed in claims 1-3, wherein the abovementioned substituents have the following meanings:
n is zero, one or two, the individual substituents R1 independently of one another are fluorine, chlorine, bromine, trifluoromethyl, hydroxyl, C1-C4-alkyl, C1-C4-alkoxy, (C1-C4-alkoxy)-(C1-C2-alkoxy), C1-C4-alkylthio, nitro, amino, C1-C4-alkylamino, di(C1-C4-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, C1-C4-acyl, C1-C4-acyloxy, C1-C4-acylamino, cyano, carbamoyl, carboxyl, (C1-C4-alkyl)oxycarbonyl, hydroxysulfonyl or sulfamoyl or a phenyl, phenoxy, phenylthio, phenylsulfonyl, phenoxysulfonyl, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which is substituted by up to two radicals R6 which are independent of one another, where R6 can be fluorine, chlorine, bromine, cyano, trifluoromethyl, nitro, amino, C1-C4-alkyl, C1-C4-alkoxy, (C1-C4-alkyl)oxycarbonyl, phenyl or phenoxy, R2 is hydrogen and R5 is C1-C6-alkyl, optionally substituted by C1-C4-alkoxy or C1-C4-alkylthio;
C2-C6-alkenyl, optionally substituted by oxo;
C3-C6-allenyl;
C3-C8-alkynyl, in particular 2-butynyl;
C3-C6-cycloalkyl;
C5-C6-cycloalkenyl;
(C3-C6-cycloalkyl)-(C1-C2-alkyl), in particular cyclopropylmethyl, optionally substituted by (1-C4-alkyl;
(C3-C6-cycloalkenyl)-(C1-C2-alkyl), in particular cyclohexenylmethyl;
C1-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, benzyloxy, phanoxy, C1-C4-alkoxy, C1-C4-alkylamino, C1-C4-alkenylamino, di(C1-C4-alkyl)amino, 1-pyrrolidinyl, piperidino, morpholino, 4-methylpiperazin-1-yl or C1-C4-alkylthio;
C2-C6-alkenylcarbonyl;
C1-C6-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino or C1-C4-alkyl-thio;
C2-C6-alkenyloxycarbonyl, in particular vinyloxycarbonyl, allyloxycarbonyl, isopropenyloxycarbonyl, butenyloxycarbonyl or pentenyloxycarbonyl;
C2-C6-alkynyloxycarbonyl, in particular propynyloxycarbonyl or butynyloxycarbonyl;
C1-C8-alkylthiocarbonyl;
C2-C6-alkenylthiocarbonyl, in particular allylthiocarbonyl;
C1-C6-alkylamino- and di(C1-C6-alkyl)aminocarbonyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1-ylcarbonyl;
C2-C6-alkenylamino- and di(C1-C6-alkenyl)aminocarbonyl;
C1-C4-alkylsulfonyl;
C1-C4-alkenylsulfonyl;
or aryl which is substituted by up to two radicals R6 which are independent of one another, in particular phenyl, arylcarbonyl, in particular benzoyl, (arylthio)carbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino)thiocarbonyl, arylalkylaminocarbonyl, arylsulfonyl, arylalkyl, in particular benzyl, phenylethyl, arylalkenyl, arylalkylcarbonyl, arylalkoxycarbonyl or aryl(alkylthio)carbonyl, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms and R6 being as defined above, or 1- or 2-naphthylmethyl, 2-, 3- or 4-picolyl, 2- or 3-furylmethyl, 2- or 3-thienylmethyl, 2- or 3-pyrrolylmethyl, 2-, 3- or 4-pyridylcarbonyl, 2- or 3-furylcarbonyl, 2- or 3-thienylcarbonyl, 2- or 3-thienylacetyl, 2-, 3- or 4-picolyloxycarbonyl, 2- or 3-furylmethyloxycarbonyl, or 2- or 3-thienyl-methyloxycarbonyt, each of which is substituted by up to two radicals R6 which are independent of one another, and R3 and R4 are identical or different and independently of one another are hydrogen, C1-C4-alkyl, optionally substituted by hydroxyl, mercapto, C1-C4-alkoxy, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C2-C6-alkenyl, aryl, benzyl, thienyl or thienylmethyl, each of which is substituted by up to two radicals R6 which are independent of one another, R6 having the meaning as defined above R3 and R4 can also be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 6 carbon atoms and can optionally be substituted by oxo or thioxo, and X is oxygen or sulfur.
C2-C8-alkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyl, amino,mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyioxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1 C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
aryl, arylalkyl, heteroaryl or heteroarylalkyl, each of which is substituted by up to three radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms and R6 being as defined above, R3 and R4 can furthermore also be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 7 carbon atoms and which can optionally be substituted by fluorine, chlorine, hydroxyl, amino, C1-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl, C1-C4-acyloxy, benzoyloxy, C1-C4-alkoxy, oxo, thioxo, carboxyt, carbamoyl or phenyl, and X is oxygen, sulfur or selenium.
3. A compound of the formula I or Ia as claimed in claim 1 or 2, wherein the substituents in the abovementioned formulae have the following meanings:
n is zero, one ortwo, the individual substituents R1 independently of one another are fluorine, chlorine, bromine, trifluoromethyl, hydroxyl, C1-C4-alkyl, C1-C4-alkoxy, (C1-C4-alkoxy)-(C1-C4-alkoxy), C1-C4-alkylthio, nitro, amino, C1-C4-alkylamino, di(C1-C4-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, C1-C4-acyl, C1-C4-acyloxy, C1-C4-acylamino, cyano, carbamoyl, carboxyl, (C1-C4-alkyl)oxycarbonyl, hydroxysulfonyl or sulfamoyl, or a phenyl, phenoxy, phenylthio, phenylsulfonyl, phenoxysulfonyl, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which is substituted by up to two radicals R6 which are independent of one another, where R6 can be fluorine, chlorine, bromine, cyano, trifluoromethyl, nitro, amino, C1-C4-alkyl, C1-C4-alkoxy, (C1-C4-alkyl)oxycarbonyl, phenyl or phenoxy, R2 is hydrogen and R5 is C1-C6-alkyl, optionally substituted by fluorine) chlorine, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C2-C6-alkenyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-allenyl, C3-C8-alkynyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-acyloxy, benzoyloxy, benzyloxy,phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-acyloxy, benzoyloxy, benzyloxy,phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C4-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
(C3-C6-cycloalkyl)-(C1-C2-alkyl), optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-acyloxy, benzoyloxy, benzyloxy,phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
(C3-C6-cycloalkenyl)-(C1-C2-alkyl), optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl, C1-C4-acyloxy, benzoyloxy, benzyloxy,phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C4-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkyl C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C4-C4-alkoxy, C1-C4-alkylamino, C1-C4-alkenylamino, di(C1-C4-alkyl)amino, 1-pyrrolidinyl, piperidino, morpholino, 4-methylpiperzin-1-yl, C1-C4-alkylthio, oxo, thioxo, carboxyl or carbamoyl;
C2-C6-alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl;
(C3-C6-cyoloalkyl)carbonyl, (C5-C6-cycloalkenyl)carbonyl, (C3-C6-cycloalkyl)-(C1-C2-alkyl)carbonyl, (C5-C6-cycloalkenyl)-(C1-C2-alkyl)carbonyl, C1-C6-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino or C1-C4-alkyl-thio;
C2-C6-alkenyloxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-C4-alkoxy;
C2-C6-alkynyloxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-C4-alkoxy;
C1-C6-alkylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy;
C2-C6-alkenylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy;
C1-C6-alkylamino- and di(C1-C6-alkyl)aminocarbonyl, in each cass optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperzin-1-ylcarbonyl;
C2-C6-alkenylamino- and di(C1-C6-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy;
C1-C4-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy;
C1-C4-alkenylsulfonyl;
or aryl, arylcarbonyl, (arylthio)carbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino)thiocarbonyl, arylsulfonyl, arylalkylaminocarbonyl, arylalkyl, arylalkenyl, arylalkylcarbonyl, aryl(alkylthio)carbonyl or arylalkoxycarbonyl, each of which is substituted by up to two radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms and R5 being as defined above, or 1- or 2-naphthylmethyl, 2-, 3- or 4-picolyl, 2- or 3-furylmethyl, 2- or 3-thienylmethyl, 2- or 3-pyrrolylmethyl, 2-, 3- or 4-pyridylcarbonyl, 2- or 3-furylcarbonyl, 2- or 3-thienylcarbonyl, 2- or 3-thienylacetyl, 2-, 3- oder 4-picolyloxycarbonyl, 2- or 3-furylmethyloxycarbonyl, 2- or 3-thienylmethyloxycarbonyl each of which is substituted by up to two radicals R6 which are independent of one another, and R3 and R4 are identical or different and independently of one another are hydrogen, C1-C4-alkyl, optionally substituted by fluorine, chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, Cl-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C2-C6-alkenyl, optionally substituted by fluorine or chlorine;
C3-C6-cycloalkyl, optionally substituted by fluorine, chlorine. hydroxyl, amino,mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine or chlorine;
aryl, benzyl, heteroaryl or heteroarylmethyl, each of which is substituted by up to two radicals R6 which are independent of one another, R3 and R4 can furthermore also be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 6 carbon atoms and which can optionally be substituted by fluorine, chlorine, hydroxyl, amino, C1-C4-acyloxy, benzoyloxy, C1-C4-alkoxy, oxo, thioxo, carboxyl or carbamoyl, and X is oxygen or sulfur.
4. A compound of the formula I or Ia as claimed in claims 1-3, wherein the abovementioned substituents have the following meanings:
n is zero, one or two, the individual substituents R1 independently of one another are fluorine, chlorine, bromine, trifluoromethyl, hydroxyl, C1-C4-alkyl, C1-C4-alkoxy, (C1-C4-alkoxy)-(C1-C2-alkoxy), C1-C4-alkylthio, nitro, amino, C1-C4-alkylamino, di(C1-C4-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, C1-C4-acyl, C1-C4-acyloxy, C1-C4-acylamino, cyano, carbamoyl, carboxyl, (C1-C4-alkyl)oxycarbonyl, hydroxysulfonyl or sulfamoyl or a phenyl, phenoxy, phenylthio, phenylsulfonyl, phenoxysulfonyl, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which is substituted by up to two radicals R6 which are independent of one another, where R6 can be fluorine, chlorine, bromine, cyano, trifluoromethyl, nitro, amino, C1-C4-alkyl, C1-C4-alkoxy, (C1-C4-alkyl)oxycarbonyl, phenyl or phenoxy, R2 is hydrogen and R5 is C1-C6-alkyl, optionally substituted by C1-C4-alkoxy or C1-C4-alkylthio;
C2-C6-alkenyl, optionally substituted by oxo;
C3-C6-allenyl;
C3-C8-alkynyl, in particular 2-butynyl;
C3-C6-cycloalkyl;
C5-C6-cycloalkenyl;
(C3-C6-cycloalkyl)-(C1-C2-alkyl), in particular cyclopropylmethyl, optionally substituted by (1-C4-alkyl;
(C3-C6-cycloalkenyl)-(C1-C2-alkyl), in particular cyclohexenylmethyl;
C1-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, benzyloxy, phanoxy, C1-C4-alkoxy, C1-C4-alkylamino, C1-C4-alkenylamino, di(C1-C4-alkyl)amino, 1-pyrrolidinyl, piperidino, morpholino, 4-methylpiperazin-1-yl or C1-C4-alkylthio;
C2-C6-alkenylcarbonyl;
C1-C6-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino or C1-C4-alkyl-thio;
C2-C6-alkenyloxycarbonyl, in particular vinyloxycarbonyl, allyloxycarbonyl, isopropenyloxycarbonyl, butenyloxycarbonyl or pentenyloxycarbonyl;
C2-C6-alkynyloxycarbonyl, in particular propynyloxycarbonyl or butynyloxycarbonyl;
C1-C8-alkylthiocarbonyl;
C2-C6-alkenylthiocarbonyl, in particular allylthiocarbonyl;
C1-C6-alkylamino- and di(C1-C6-alkyl)aminocarbonyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1-ylcarbonyl;
C2-C6-alkenylamino- and di(C1-C6-alkenyl)aminocarbonyl;
C1-C4-alkylsulfonyl;
C1-C4-alkenylsulfonyl;
or aryl which is substituted by up to two radicals R6 which are independent of one another, in particular phenyl, arylcarbonyl, in particular benzoyl, (arylthio)carbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino)thiocarbonyl, arylalkylaminocarbonyl, arylsulfonyl, arylalkyl, in particular benzyl, phenylethyl, arylalkenyl, arylalkylcarbonyl, arylalkoxycarbonyl or aryl(alkylthio)carbonyl, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms and R6 being as defined above, or 1- or 2-naphthylmethyl, 2-, 3- or 4-picolyl, 2- or 3-furylmethyl, 2- or 3-thienylmethyl, 2- or 3-pyrrolylmethyl, 2-, 3- or 4-pyridylcarbonyl, 2- or 3-furylcarbonyl, 2- or 3-thienylcarbonyl, 2- or 3-thienylacetyl, 2-, 3- or 4-picolyloxycarbonyl, 2- or 3-furylmethyloxycarbonyl, or 2- or 3-thienyl-methyloxycarbonyt, each of which is substituted by up to two radicals R6 which are independent of one another, and R3 and R4 are identical or different and independently of one another are hydrogen, C1-C4-alkyl, optionally substituted by hydroxyl, mercapto, C1-C4-alkoxy, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C2-C6-alkenyl, aryl, benzyl, thienyl or thienylmethyl, each of which is substituted by up to two radicals R6 which are independent of one another, R6 having the meaning as defined above R3 and R4 can also be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 6 carbon atoms and can optionally be substituted by oxo or thioxo, and X is oxygen or sulfur.
5. A process for the preparation of compounds of the formula I as claimed in claim 1, which comprises A) for preparing compounds of the formula I where X is oxygen and the radicals R1, R2, R3, R4 and R5 are as defined in claim 1, reacting a compound of the formula II
(II) with the definitions mentioned in claim 1 applying to R1, R3 and R4, with a compound of the formula III
R-Z (III) where R has the meanings for R5 and R2 which have been mentioned in claim 1 with the exception of hydrogen, hydroxyl, C1-C6-alkoxy, aryloxy, C1-C6-acyloxy, amino, C1-C6-alkylamino, di(C1-C6-alkyl)amino, arylamino and C1-C6-acylamino, and Z is a leaving group, or B) preparing compounds of the formula I where X is sulfur and R1, R2, R3, R4 and R5 are as defined in claim 1 by reacting a compound of the formula I where X is oxygen and the definitions mentioned in claim 1 apply to R1, R2, R3, R4 and R5, with a sulfurizing reagent, or C) preparing compounds of the formula Ia where X and the radicals R1 to R5 are as defined in claim 1, by reacting a compound of the formula IV
(IV) or (IV) where the definitions mentioned in claim 1 apply to R1, R3, R4 and R5, with a compound of the formula III
R2-Z (III) where the definitions described in claim 1 for formula I and Ia apply to R2 with the exception of hydrogen, hydroxy, C1-C6-alkoxy, aryloxy, C1-C6-acyloxy, amino, C1-C6-alkylamino, Di(C1-C6-allyl)amino, arylamino, C1-C6-acylamino and Z is a leaving group, or D) preparing compounds of the formula I where X is oxygen and the radicals R1 toR5 are as defined in claim 1 by cyclizing a compound of the formula V
V
where R1 to R5 are as defined in claim 1 and Y is hydroxyl, C1-C4-alkoxy, optionally halogenated C1-C4-acyloxy, chlorine, bromine or iodine, or E) preparing compounds of the formula I where X is oxygen, R4 and R5 are hydrogen and the definitions mentioned in claim 1 apply to R1 to R3, from the quinoxalinones of the formula XI
X I
where R1 to R3 are as defined at the outset, by addition of hydrogen on the C=N
bond, or F) preparing compounds of the formula I where X is oxygen and R1 to R5 are as defined in claim 1, from compounds of the formula VI
V I
where R1, R2 and R5 are as defined in claim 1, by reacting them with chloroform or bromoform and a carbonyl compound of the formula XIII
R3-CO-R4 (XIII) where R3 and R4 are as defined in claim 1, or with .alpha.-(trihalomethyl)alkanols of the formula XIV
Hal3C-C(OH)-R3R4 (XIV) where Hal is Cl, Br or 1, in which R3 and R4 are as defined at the outset, or G) preparing compounds of the formula I where X is oxygen and R1, R2, R3, R4 andR5 are as defined in claim 1, by reacting a compound of the formula I where X isoxygen and the definitions mentioned in claim 1 apply to R1, R2, R5 and to R3 and R4, with the exception that at least one of the radicals R3 or R4 is hydrogen, with an alkylating reagent of the formula XV
R'-Z (XV) where R' has the meanings mentioned above for R3 and R4 with the exception of hydrogen and Z is a leaving group, or H) preparing compounds of the formula I where X is oxygen, R1, R2, R3 and R4 areas defined in claim 1 and R5 is C1-C8-alkyl, optionally substituted by fluorine,chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl, carbamoyl, C3-C8-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, Cl-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C3-C8-alkylthio, cyano, carboxyl or carbamoyl, C3-C8-alkynyl, optionally substituted by fluorine, chlorine, bromine,iodine, hydroxyl, C,1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl,C4-C8-cycloalkyl, optionally substituted by fluorine, chiorine, bromine, iodine,hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl, C5-C3-cyclo-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl, (C1-C6-alkoxy)-(C1-C6-alkyl), di(C1-C6-alkylamino)-(C1-C6-alkyl) or (C3-C6-cycloalkyl)alkyl, (C6-C8-cycloalkenyl)alkyl, or arylalkyl, naphthylalkyl or heteroarylalkyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms, by reductive alkylation of a compound of the formula I where R5 is hydrogen and X
is oxygen and the definitions mentioned in claim 1 apply to R1, R2, R3 and R4, with a carbonyl compound of the formula XVI, R"-C(-O)-R''' (XVI) where R" and R''' are identical or different and independently of one another are hydrogen, C1-C7-alkyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-6-alkylthio, cyano, carboxyl or carbamoyl, C3-C7-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C8-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl, C3-C7-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl, C4-C8-cycloalkyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl, C5-cycloalkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl, (C1-C6-alkoxy)-(C1-C6-alkyl), [di(C1-C6-alkyl)amino]-(C1-C5-alkyl) or(C4-C6-cycloalkyl)alkyl, (C6-cycloalkenyl)alkyl, or arylalkyl, naphthylalkyl or heteroarylalkyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 0 to 2 carbon atoms, and where R" and R''' can be linked to each other to form a 4- to 8-membered ring, or 1) preparing compounds of the formula I where X is oxygen and R1, R2, R3 and R4 are as defined in claim 1 and R5 is C1-C8-alkyloxycarbonyl, C1-C8-alkylthiocarbonyl, C2-C8-alkenyloxycarbonyl, C2-C8-alkenylthiocarbonyl, C2-C8-alkynyloxycarbonyl, C1-C6-alkylaminocarbonyl, C3-C6-alkenylaminocarbonyl, di(C1-C6-alkyl)aminocarbonyl, pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, 4-methylpiperazin-1-ylcarbonyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
or aryloxycarbonyl arylthio(carbonyl), arylaminocarbonyl, heteroaryloxycarbonyl,heteroarylthiocarbonyl, heteroarylaminocarbonyl, arylalkyloxycarbonyl, (aryl-alkylthio)carbonyl, arylalkylaminocarbonyl, heteroalkyloxycarbonyl, (heteroalkylthio)carbonyl or heteroalkylaminocarbonyl, each of which is substi~uted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms, by reacting a compound of the formula XVII
XVII
where the definitions mentioned in claim 1 apply to R1, R2, R3 and R4, n is 0, 1, 2 or 3, X is oxygen and U is a leaving group, with a compound of the formula XVIII
Nu-H (XVIII) where Nu is C1-C8-alkoxy, C2-C8-alkenyloxy, C2-C8-alkynyloxy, C1-C8-alkylthio, C2-C8-alkenylthio, C1-C8-alkylamino- and di(C1-C8-alkyl)amino, C2-C8-alkenylamino-and di(C1-C6-aikyl)amino, optionally substituted by fluorine, chlorine, bromine,hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio,pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl- or 4-methylpiperazin-1-ylcarbonyl, optionally substituted by C1-C4-alkyl, C2-C6-alkenyl, C1-C4-acyl, oxo, thioxo, carboxyl or phenyl, or aryloxy, arylthio, arylamino, arylalkyloxy, arylalkylthio, arylalkylamino, heteroaryloxy, heteroarylthio, heteroarylamino, heteroarylalkyloxy, heteroarylalkylthio or heteroarylalkylamino, each of which is substituted by up to five radicals R6 (R6 is as defined at the outset) which areindependent of one another, it being possible for the alkyl radical to esntain in each case 1 to 3 carbon atoms.
(II) with the definitions mentioned in claim 1 applying to R1, R3 and R4, with a compound of the formula III
R-Z (III) where R has the meanings for R5 and R2 which have been mentioned in claim 1 with the exception of hydrogen, hydroxyl, C1-C6-alkoxy, aryloxy, C1-C6-acyloxy, amino, C1-C6-alkylamino, di(C1-C6-alkyl)amino, arylamino and C1-C6-acylamino, and Z is a leaving group, or B) preparing compounds of the formula I where X is sulfur and R1, R2, R3, R4 and R5 are as defined in claim 1 by reacting a compound of the formula I where X is oxygen and the definitions mentioned in claim 1 apply to R1, R2, R3, R4 and R5, with a sulfurizing reagent, or C) preparing compounds of the formula Ia where X and the radicals R1 to R5 are as defined in claim 1, by reacting a compound of the formula IV
(IV) or (IV) where the definitions mentioned in claim 1 apply to R1, R3, R4 and R5, with a compound of the formula III
R2-Z (III) where the definitions described in claim 1 for formula I and Ia apply to R2 with the exception of hydrogen, hydroxy, C1-C6-alkoxy, aryloxy, C1-C6-acyloxy, amino, C1-C6-alkylamino, Di(C1-C6-allyl)amino, arylamino, C1-C6-acylamino and Z is a leaving group, or D) preparing compounds of the formula I where X is oxygen and the radicals R1 toR5 are as defined in claim 1 by cyclizing a compound of the formula V
V
where R1 to R5 are as defined in claim 1 and Y is hydroxyl, C1-C4-alkoxy, optionally halogenated C1-C4-acyloxy, chlorine, bromine or iodine, or E) preparing compounds of the formula I where X is oxygen, R4 and R5 are hydrogen and the definitions mentioned in claim 1 apply to R1 to R3, from the quinoxalinones of the formula XI
X I
where R1 to R3 are as defined at the outset, by addition of hydrogen on the C=N
bond, or F) preparing compounds of the formula I where X is oxygen and R1 to R5 are as defined in claim 1, from compounds of the formula VI
V I
where R1, R2 and R5 are as defined in claim 1, by reacting them with chloroform or bromoform and a carbonyl compound of the formula XIII
R3-CO-R4 (XIII) where R3 and R4 are as defined in claim 1, or with .alpha.-(trihalomethyl)alkanols of the formula XIV
Hal3C-C(OH)-R3R4 (XIV) where Hal is Cl, Br or 1, in which R3 and R4 are as defined at the outset, or G) preparing compounds of the formula I where X is oxygen and R1, R2, R3, R4 andR5 are as defined in claim 1, by reacting a compound of the formula I where X isoxygen and the definitions mentioned in claim 1 apply to R1, R2, R5 and to R3 and R4, with the exception that at least one of the radicals R3 or R4 is hydrogen, with an alkylating reagent of the formula XV
R'-Z (XV) where R' has the meanings mentioned above for R3 and R4 with the exception of hydrogen and Z is a leaving group, or H) preparing compounds of the formula I where X is oxygen, R1, R2, R3 and R4 areas defined in claim 1 and R5 is C1-C8-alkyl, optionally substituted by fluorine,chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl, carbamoyl, C3-C8-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, Cl-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C3-C8-alkylthio, cyano, carboxyl or carbamoyl, C3-C8-alkynyl, optionally substituted by fluorine, chlorine, bromine,iodine, hydroxyl, C,1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl,C4-C8-cycloalkyl, optionally substituted by fluorine, chiorine, bromine, iodine,hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl, C5-C3-cyclo-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl, (C1-C6-alkoxy)-(C1-C6-alkyl), di(C1-C6-alkylamino)-(C1-C6-alkyl) or (C3-C6-cycloalkyl)alkyl, (C6-C8-cycloalkenyl)alkyl, or arylalkyl, naphthylalkyl or heteroarylalkyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms, by reductive alkylation of a compound of the formula I where R5 is hydrogen and X
is oxygen and the definitions mentioned in claim 1 apply to R1, R2, R3 and R4, with a carbonyl compound of the formula XVI, R"-C(-O)-R''' (XVI) where R" and R''' are identical or different and independently of one another are hydrogen, C1-C7-alkyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-6-alkylthio, cyano, carboxyl or carbamoyl, C3-C7-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C8-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl, C3-C7-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl, C4-C8-cycloalkyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl, C5-cycloalkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, hydroxyl, C1-C6-acyloxy, benzoyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, cyano, carboxyl or carbamoyl, (C1-C6-alkoxy)-(C1-C6-alkyl), [di(C1-C6-alkyl)amino]-(C1-C5-alkyl) or(C4-C6-cycloalkyl)alkyl, (C6-cycloalkenyl)alkyl, or arylalkyl, naphthylalkyl or heteroarylalkyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 0 to 2 carbon atoms, and where R" and R''' can be linked to each other to form a 4- to 8-membered ring, or 1) preparing compounds of the formula I where X is oxygen and R1, R2, R3 and R4 are as defined in claim 1 and R5 is C1-C8-alkyloxycarbonyl, C1-C8-alkylthiocarbonyl, C2-C8-alkenyloxycarbonyl, C2-C8-alkenylthiocarbonyl, C2-C8-alkynyloxycarbonyl, C1-C6-alkylaminocarbonyl, C3-C6-alkenylaminocarbonyl, di(C1-C6-alkyl)aminocarbonyl, pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, 4-methylpiperazin-1-ylcarbonyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
or aryloxycarbonyl arylthio(carbonyl), arylaminocarbonyl, heteroaryloxycarbonyl,heteroarylthiocarbonyl, heteroarylaminocarbonyl, arylalkyloxycarbonyl, (aryl-alkylthio)carbonyl, arylalkylaminocarbonyl, heteroalkyloxycarbonyl, (heteroalkylthio)carbonyl or heteroalkylaminocarbonyl, each of which is substi~uted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms, by reacting a compound of the formula XVII
XVII
where the definitions mentioned in claim 1 apply to R1, R2, R3 and R4, n is 0, 1, 2 or 3, X is oxygen and U is a leaving group, with a compound of the formula XVIII
Nu-H (XVIII) where Nu is C1-C8-alkoxy, C2-C8-alkenyloxy, C2-C8-alkynyloxy, C1-C8-alkylthio, C2-C8-alkenylthio, C1-C8-alkylamino- and di(C1-C8-alkyl)amino, C2-C8-alkenylamino-and di(C1-C6-aikyl)amino, optionally substituted by fluorine, chlorine, bromine,hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio,pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl- or 4-methylpiperazin-1-ylcarbonyl, optionally substituted by C1-C4-alkyl, C2-C6-alkenyl, C1-C4-acyl, oxo, thioxo, carboxyl or phenyl, or aryloxy, arylthio, arylamino, arylalkyloxy, arylalkylthio, arylalkylamino, heteroaryloxy, heteroarylthio, heteroarylamino, heteroarylalkyloxy, heteroarylalkylthio or heteroarylalkylamino, each of which is substituted by up to five radicals R6 (R6 is as defined at the outset) which areindependent of one another, it being possible for the alkyl radical to esntain in each case 1 to 3 carbon atoms.
6. The use of a compound of the formula I or Ia as claimed in one or more of claims 1-4 as a pharmaceutical.
7. A pharmaceutical comprising an effective amount of at least one compound of the formula Ia as claimed in one or more of claims 1-4.
8. A process for the preparation of a pharmaceutical as claimed in claim 7, which comprises formulating an effective amount of a compound of the formula I or Ia together with customary pharmaceutical auxiliaries to give a suitable dosage form.
9. The use of a compound of the formula I or Ia (I) (Ia) in which n is zero, one, two, three or four, the individual substituents R1 independently of one another are fluorine, chlorine, bromine, iodine, trifluoromethyi, trifluoromethoxy, hydroxyl, C1-C8-alkyl, C5-C8-cycloalkyl, C1-C6 alkoxy, (C1-C6-alkoxy) (C1-C4 alkoxy), C1-C6-alkytthio, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, nitro, amino, azido, C1-C6-alkylamino, di(C1-C6-alkyl)amino, piperidino, morpholino, 1-pyrrolidinyl, 4-methylpiperazinyl, thiomorpholino, imidazolyl, triazolyl, tetrazolyl, C1-C6-acyl, C1-C6-acyloxy, C1-C6-acylamino, cyano, carbarnoyl, carboxyl, (C1-C6-alkyl)oxycarbonyl, hydroxysuifonyl, sulfarnoyl or a phenyl, phenoxy, phenoxycarbonyl, phenyithio, phenylsulfinyl, phenylsulfonyl, phenoxysulfonyl, phenylsulfonyloxy, anilinosulfonyl, phenylsulfonylamino, benzoyl, 2-pyridyl, 3-pyridyl or 4-pyridyl radical which issubstituted by up to five radicals R6 which are independent of one another, where R6 can be fluorine, chlorine, bromine, iodine, cyano, trifluoromethyl, trifluoromethoxy, nitro, amino, azido, C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-alkoxy, C1-C6-alkylthio, C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, C1-C6-alkylamino, di(C1-C6-alkyl)amino, (C1-C6-alkyl)oxycarbonyl, phenyl, phenoxy, 2-, 3- or 4-pyridyl, R2 and R5 are identical or different and independently of one another are hydrogen, hydroxyl, C1-C6-alkoxy, aryloxy, C1-C6-acyloxy, cyano, amino, C1-C6-alkylamino, di(C1-C6-alkyl)amino, arylamino, C1-C6-acylamino, C1-C8-alkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C8-alkylthio, C1-C8-alkylsuifonyl, phenylsulfonyl, oxo, thioxo, oarboxyl or carbamoyl;
C2-C8-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl and carbamoyl;
C3-C8-allenyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C3-C8-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C8-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkyl)-(C1-C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C7-C6-alkyl)amino, C1-C5-alkylthio, (C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkenyl)-(C1-C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, (C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C1-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C2-C8-alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl,C,-C4-alkoxy, oxo, phenyl;
(C3-C8-cycloalkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C8-cycloalkenyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C3-C8-cycloalkyl)-(C1-C3-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-6-cycloalkenyl)-(C1-C3-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C8-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio;
C2-C8-alkenyloxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C2-C8-alkynyloxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C2-C8-alkylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl,C1-C4-alkoxy, oxo, phenyl;
C2-C8-alkenylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C8-alkylamino- and di(C1-C8-alkyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1-ylcarbonyl, in each case optionally substituted by C1-C4-alkyl, C2-C6-alkenyl,C1-C4-acyl, oxo, thioxo, carboxyl, or phenyl;
C2-C8-alkenylamino- and di(C1-C6-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkenylsulfonyi, optionally substituted by fluorine, chlorine, hydroxyl, Cl-C4-alkoxy, oxo, phenyl;
or aryl, arylcarbonyl, aryl(thiocarbonyl), (arylthio)carbonyl, (arylthio)thiocarbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino)thio-carbonyl, arylalkylaminocarbonyl, arylsulfonyl, arylalkyl, arylalkenyl, arylalkynyl, arylalkylcarbonyl, arylalkenylcarbonyl, arylalkoxycarbonyl or aryl(alkylthio)carbonyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 5 carbon atoms, and R6 being as defined above, or heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkylcarbonyl or heteroarylalkenylcarbonyl, heteroaryloxycarbonyl, (heteroarylthio)carbonyl, heteroarylaminocarbonyl, heteroarylalkyloxycarbonyl, heteroaryl(alkylthio)carbonyl or heteroarylalkylaminocarbonyl, each of which is substituted by up to three radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms, R3 and R4 are identical or different and, independently of one another, are hydrogen, C1-C8-alkyl which is optionally substituted by fluorine, chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C2-C8-alkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyl, amino,mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsylfinyl, carboxyl or carbamoyl;
aryl, arylalkyl, heteroaryl or heteroarylalkyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain 1 to 3 carbon atoms in each case, and R6 being as defined above, R3 and R4 or R3 and R5 can furthermore also be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 8 carbon atoms and which can optionally be substituted by fluorine, chlorine, hydroxyl, amino, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-acyloxy, benzoyloxy, C1-C6-alkoxy, oxo, thioxo, carboxyl, carbamoyl or phenyl, is oxygen, sulfur, selenium or substituted nitrogen N-R2, it being possible for R2 to have the abovementioned meanings, for the preparation of pharma-ceuticals for the treatment of diseases caused by viruses, in particular diseases caused by HIV.
C2-C8-alkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl and carbamoyl;
C3-C8-allenyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C3-C8-alkynyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C8-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkyl)-(C1-C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C7-C6-alkyl)amino, C1-C5-alkylthio, (C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
(C3-C8-cycloalkenyl)-(C1-C4-alkyl), optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, (C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C1-C6-alkylcarbonyl, optionally substituted by fluorine, chlorine, bromine, iodine, cyano, amino, mercapto, hydroxyl, C1-C6-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C6-alkoxy, C1-C6-alkylamino, di(C1-C6-alkyl)amino, C1-C6-alkylthio, C1-C6-alkylsulfonyl, phenylsulfonyl, oxo, thioxo, carboxyl or carbamoyl;
C2-C8-alkenylcarbonyl, optionally substituted by fluorine, chlorine or hydroxyl,C,-C4-alkoxy, oxo, phenyl;
(C3-C8-cycloalkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-C8-cycloalkenyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C3-C8-cycloalkyl)-(C1-C3-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
(C5-6-cycloalkenyl)-(C1-C3-alkyl)carbonyl, optionally substituted by fluorine, chlorine or hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C8-alkyloxycarbonyl, optionally substituted by fluorine, chlorine, bromine, hydroxyl, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio;
C2-C8-alkenyloxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C2-C8-alkynyloxycarbonyl, optionally substituted by fluorine, chlorine,hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C2-C8-alkylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl,C1-C4-alkoxy, oxo, phenyl;
C2-C8-alkenylthiocarbonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C8-alkylamino- and di(C1-C8-alkyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
pyrrolidin-1-yl, morpholino-, piperidino-, piperazinyl-, or 4-methylpiperazin-1-ylcarbonyl, in each case optionally substituted by C1-C4-alkyl, C2-C6-alkenyl,C1-C4-acyl, oxo, thioxo, carboxyl, or phenyl;
C2-C8-alkenylamino- and di(C1-C6-alkenyl)aminocarbonyl, in each case optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkylsulfonyl, optionally substituted by fluorine, chlorine, hydroxyl, C1-C4-alkoxy, oxo, phenyl;
C1-C6-alkenylsulfonyi, optionally substituted by fluorine, chlorine, hydroxyl, Cl-C4-alkoxy, oxo, phenyl;
or aryl, arylcarbonyl, aryl(thiocarbonyl), (arylthio)carbonyl, (arylthio)thiocarbonyl, aryloxycarbonyl, arylaminocarbonyl, (arylamino)thio-carbonyl, arylalkylaminocarbonyl, arylsulfonyl, arylalkyl, arylalkenyl, arylalkynyl, arylalkylcarbonyl, arylalkenylcarbonyl, arylalkoxycarbonyl or aryl(alkylthio)carbonyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 5 carbon atoms, and R6 being as defined above, or heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkylcarbonyl or heteroarylalkenylcarbonyl, heteroaryloxycarbonyl, (heteroarylthio)carbonyl, heteroarylaminocarbonyl, heteroarylalkyloxycarbonyl, heteroaryl(alkylthio)carbonyl or heteroarylalkylaminocarbonyl, each of which is substituted by up to three radicals R6 which are independent of one another, it being possible for the alkyl radical to contain in each case 1 to 3 carbon atoms, R3 and R4 are identical or different and, independently of one another, are hydrogen, C1-C8-alkyl which is optionally substituted by fluorine, chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C2-C8-alkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkyl, optionally substituted by fluorine, chlorine, hydroxyl, amino,mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsulfinyl, carboxyl or carbamoyl;
C3-C8-cycloalkenyl, optionally substituted by fluorine or chlorine, hydroxyl, amino, mercapto, C1-C4-acyloxy, benzoyloxy, benzyloxy, phenoxy, C1-C4-alkoxy, C1-C4-alkylamino, di(C1-C4-alkyl)amino, C1-C4-alkylthio, C1-C4-alkylsulfonyl, C1-C4-alkylsylfinyl, carboxyl or carbamoyl;
aryl, arylalkyl, heteroaryl or heteroarylalkyl, each of which is substituted by up to five radicals R6 which are independent of one another, it being possible for the alkyl radical to contain 1 to 3 carbon atoms in each case, and R6 being as defined above, R3 and R4 or R3 and R5 can furthermore also be part of a saturated or unsaturated carbo- or heterocyclic ring which has 3 to 8 carbon atoms and which can optionally be substituted by fluorine, chlorine, hydroxyl, amino, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-acyloxy, benzoyloxy, C1-C6-alkoxy, oxo, thioxo, carboxyl, carbamoyl or phenyl, is oxygen, sulfur, selenium or substituted nitrogen N-R2, it being possible for R2 to have the abovementioned meanings, for the preparation of pharma-ceuticals for the treatment of diseases caused by viruses, in particular diseases caused by HIV.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4112234 | 1991-04-15 | ||
DEP4112234.8 | 1991-04-15 | ||
DE19914142322 DE4142322A1 (en) | 1991-12-20 | 1991-12-20 | Antiviral quinoxaline deriv. |
DEP4142322.4 | 1991-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2065985A1 true CA2065985A1 (en) | 1992-10-16 |
Family
ID=25902841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002065985A Abandoned CA2065985A1 (en) | 1991-04-15 | 1992-04-14 | Quinoxalines, processes for their preparation, and their use |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0509398B1 (en) |
JP (1) | JP2718595B2 (en) |
KR (1) | KR100245138B1 (en) |
AT (1) | ATE205837T1 (en) |
AU (1) | AU654178B2 (en) |
CA (1) | CA2065985A1 (en) |
CZ (1) | CZ293825B6 (en) |
DE (1) | DE59209965D1 (en) |
DK (1) | DK0509398T3 (en) |
ES (1) | ES2164639T3 (en) |
HK (1) | HK1011971A1 (en) |
HU (1) | HU224439B1 (en) |
IE (1) | IE921187A1 (en) |
IL (1) | IL101583A (en) |
MX (1) | MX9201760A (en) |
NZ (1) | NZ242346A (en) |
PT (1) | PT509398E (en) |
TW (1) | TW207533B (en) |
ZA (1) | ZA922722B (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ251610A (en) * | 1992-04-23 | 1996-02-27 | Merrell Dow Pharma | 4-imidomethyl-1-(2-phenyl-2-oxoethyl)piperidine derivatives and pharmaceutical compositions |
TW304945B (en) * | 1992-06-27 | 1997-05-11 | Hoechst Ag | |
TW274550B (en) * | 1992-09-26 | 1996-04-21 | Hoechst Ag | |
DE4335438A1 (en) * | 1993-10-18 | 1995-04-20 | Bayer Ag | 4-cyanophenylimino heterocycles |
DE4342024A1 (en) * | 1993-12-09 | 1995-06-14 | Hoechst Ag | Combination preparations containing a quinoxaline and a nucleoside |
DE4344452A1 (en) * | 1993-12-24 | 1995-06-29 | Hoechst Ag | Aza-4-iminoquinolines, process for their preparation and their use |
DE4437406A1 (en) * | 1994-10-19 | 1996-04-25 | Hoechst Ag | Quinoxalines, process for their preparation and their use |
DE19506742A1 (en) * | 1995-02-27 | 1996-08-29 | Bayer Ag | Use of quinoxalines in combination with protease inhibitors as medicaments for the treatment of AIDS and / or HIV infections |
DE19613591A1 (en) * | 1996-04-04 | 1997-10-09 | Hoechst Ag | Substituted quinoline derivatives, process for their preparation and their use |
DE19703131A1 (en) * | 1997-01-29 | 1998-07-30 | Bayer Ag | Use of quinoxaline in a combination of three with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of AIDS and / or HIV infections |
US6288075B1 (en) | 1998-02-26 | 2001-09-11 | Rhone-Poulenc Rorer S.A. | Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same |
FR2760237B1 (en) * | 1997-02-28 | 1999-04-16 | Rhone Poulenc Rorer Sa | THIAZOLOBENZOHETEROCYCLES, THEIR PREPARATION AND THE MEDICINES CONTAINING THEM |
ES2297943T3 (en) | 1998-12-23 | 2008-05-01 | Aventis Pharma Limited | DIHIDRO-BENZO (1,4) OXACINES AND TETRAHYDROQUINOXALINS. |
DE10134721A1 (en) * | 2001-07-17 | 2003-02-06 | Bayer Ag | tetrahydroquinoxalines |
WO2005018531A2 (en) * | 2003-08-26 | 2005-03-03 | 'chemical Diversity Research Institute', Ltd. | Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof |
US7351709B2 (en) | 2004-06-09 | 2008-04-01 | Wyeth | Estrogen receptor ligands |
JP5054996B2 (en) * | 2006-03-14 | 2012-10-24 | 参天製薬株式会社 | Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
US8551991B2 (en) | 2006-03-14 | 2013-10-08 | Santen Pharmaceutical Co., Ltd. | 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
US8193187B2 (en) | 2007-05-29 | 2012-06-05 | Santen Pharmaceutical Co., Ltd. | 1,2,3,4-tetrahydroquinoxaline compound with a phenyl group substituent having a sulfonic acid ester structure or a sulfonic acid amide structure introduced therein and having glucocorticoid receptor-binding activity |
CN103242238B (en) * | 2013-05-10 | 2016-04-20 | 常州齐晖药业有限公司 | A kind of preparation method of fenbendazole |
JP6851825B2 (en) | 2013-07-15 | 2021-03-31 | ヘルムホルツ ツェントゥルム ミュンヘン ドイチェス フォルシュングスツェントゥルム フューア ゲズントハイト ウント ウムヴェルト (ゲーエムベーハー) | Spiroquinoxaline derivative as an inhibitor of non-apoptotic controlled cell death |
TW201536760A (en) * | 2013-08-09 | 2015-10-01 | 參天製藥股份有限公司 | Manufacturing method for 3,3-dimethyl-3,4-dihydro-1H-quinoxaline-2-one derivate and intermediate for the manufacturing method |
WO2016075137A1 (en) | 2014-11-10 | 2016-05-19 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE706623A (en) * | 1967-11-16 | 1968-04-01 | ||
US4032639A (en) * | 1976-03-22 | 1977-06-28 | American Home Products Corporation | 2,3,4,4A-Tetrahydro-1H-pyrazino[1,2-a,]quinoxalin-5(6H)-ones and derivatives thereof for relieving hypertension |
EP0190105A3 (en) * | 1985-01-31 | 1988-10-26 | Ciba-Geigy Ag | Herbicidal agent |
US4940708A (en) * | 1986-10-30 | 1990-07-10 | Pfizer Inc. | 4-arylsulfonyl-3,4-dihydro-2(1H)-quinoxalinone-1-alkanoic acids, esters, and salts |
US5318946A (en) * | 1991-11-27 | 1994-06-07 | American Cyanamid Company | 2-(heteroaryloxyphenoxy)alkylsulfonates useful as herbicidal agents |
-
1992
- 1992-04-09 PT PT92106158T patent/PT509398E/en unknown
- 1992-04-09 ES ES92106158T patent/ES2164639T3/en not_active Expired - Lifetime
- 1992-04-09 AT AT92106158T patent/ATE205837T1/en not_active IP Right Cessation
- 1992-04-09 EP EP92106158A patent/EP0509398B1/en not_active Expired - Lifetime
- 1992-04-09 DE DE59209965T patent/DE59209965D1/en not_active Expired - Fee Related
- 1992-04-09 DK DK92106158T patent/DK0509398T3/en active
- 1992-04-11 TW TW081102817A patent/TW207533B/zh active
- 1992-04-13 IL IL10158392A patent/IL101583A/en not_active IP Right Cessation
- 1992-04-13 NZ NZ242346A patent/NZ242346A/en not_active IP Right Cessation
- 1992-04-14 CZ CS19921136A patent/CZ293825B6/en not_active IP Right Cessation
- 1992-04-14 ZA ZA922722A patent/ZA922722B/en unknown
- 1992-04-14 CA CA002065985A patent/CA2065985A1/en not_active Abandoned
- 1992-04-14 AU AU14853/92A patent/AU654178B2/en not_active Ceased
- 1992-04-14 IE IE118792A patent/IE921187A1/en not_active IP Right Cessation
- 1992-04-14 MX MX9201760A patent/MX9201760A/en not_active IP Right Cessation
- 1992-04-15 JP JP4119936A patent/JP2718595B2/en not_active Expired - Fee Related
- 1992-04-15 HU HU9201288A patent/HU224439B1/en not_active IP Right Cessation
- 1992-04-15 KR KR1019920006378A patent/KR100245138B1/en not_active IP Right Cessation
-
1998
- 1998-12-09 HK HK98113024A patent/HK1011971A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK0509398T3 (en) | 2002-01-14 |
ZA922722B (en) | 1992-11-25 |
JPH05148243A (en) | 1993-06-15 |
EP0509398B1 (en) | 2001-09-19 |
KR100245138B1 (en) | 2000-03-02 |
DE59209965D1 (en) | 2002-10-17 |
KR920019761A (en) | 1992-11-19 |
HU224439B1 (en) | 2005-09-28 |
IL101583A0 (en) | 1992-12-30 |
HK1011971A1 (en) | 1999-07-23 |
NZ242346A (en) | 1994-12-22 |
TW207533B (en) | 1993-06-11 |
EP0509398A1 (en) | 1992-10-21 |
CZ293825B6 (en) | 2004-08-18 |
PT509398E (en) | 2002-02-28 |
IL101583A (en) | 2000-07-16 |
MX9201760A (en) | 1992-10-01 |
IE921187A1 (en) | 1992-10-21 |
HU9201288D0 (en) | 1992-07-28 |
AU1485392A (en) | 1992-10-22 |
ATE205837T1 (en) | 2001-10-15 |
HUT61004A (en) | 1992-11-30 |
CZ113692A3 (en) | 1993-01-13 |
JP2718595B2 (en) | 1998-02-25 |
ES2164639T3 (en) | 2002-03-01 |
AU654178B2 (en) | 1994-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2065985A1 (en) | Quinoxalines, processes for their preparation, and their use | |
CA2953132C (en) | Heteroaryl compounds useful as inhibitors of sumo activating enzyme | |
CN111039942B (en) | Nitrogen-containing heterocyclic compound, and preparation method, pharmaceutical composition and application thereof | |
AU2002313410B2 (en) | Hepatitis C virus polymerase inhibitors with a heterobicyclic structure | |
JPH06211855A (en) | Azaquinoxaline compound, its production, and its use | |
JP3110765B2 (en) | Pyrid [2,3-d] pyrimidine derivatives and pharmaceutical compositions thereof | |
JP2021524457A (en) | Condensed pyrimidine derivative as an A2A / A2B inhibitor | |
JPH04211662A (en) | Spirocyclic antipsychotic | |
US6369057B1 (en) | Quinoxalines, processes for their preparation and their use | |
TW200409637A (en) | Compounds | |
JP2001508395A (en) | New cycloalkyl-substituted imidazole | |
AU2005288080A1 (en) | Carbostyril compound | |
CN111163766A (en) | AHR inhibitors and uses thereof | |
IE83508B1 (en) | Quinoxalines, processes for their preparation, and their use | |
CN101679392B (en) | Quinolone compound and pharmaceutical composition | |
WO2023274251A1 (en) | Polycyclic compound for inhibiting rna helicase dhx33, and application of compound | |
EP0077983B1 (en) | Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same | |
US9416143B2 (en) | Griseofulvin derivatives | |
NZ270088A (en) | Antiviral medicaments containing a quinoxaline and a nucleoside derivative | |
AU710238B2 (en) | Substituted quinoline derivatives, a process for their preparation, and their use | |
AU670435B2 (en) | 4-iminoquinolines, processes for their preparation, and their use | |
US7951838B2 (en) | Substituted spirocyclic chromanamine compounds as Beta-Secretase modulators and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |